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                                               ABSTRACT 
 
Synoicum adareanum is a colonial tunicate commonly found on the benthos around 
Palmer Station on Anvers Island, Antarctica. A comprehensive chemical investigation of 
the lipophilic extract of the frozen tunicates gave a new series of polyketide macrolides, 
palmerolides A-E and H. The structure elucidation of these compounds was 
accomplished by extensive NMR and mass spectral studies. 
 
The palmerolides are unusual 20-membered macrolides displaying functionality more 
commonly found in sponges or cyanobacteria. Palmerolide A, the major member of the 
group, shows significant and selective in vitro cytotoxicity against melanoma with three 
orders of greater sensitivity relative to other cell lines tested, in the National Cancer 
Institute (NCI) 60 human cancer cell-line panel.  In addition, it displays potent cytostatic 
activity against several other cancer cell lines. Based on NCI’s COMPARE analysis, 
palmerolide A was investigated as a V-ATPase inhibitor and shown to bind the V0 
subunit with 2 nM inhibition. 
 
Austrodoris kerguelenensis is a common Antarctic nudibranch widely distributed in the 
High Antarctic and Sub Antarctic Zone. It is characterized by the presence of terpenoid 
glyceryl esters which are supposed to be involved in defense. Chemical investigations of 
several specimens of A. kerguelenensis collected near Palmer station Antarctica afforded 
 xviii
hitherto undescribed series of clerodane diterpenoid glycerides. The structure elucidation 
of three major compounds of this series, palmadorin A, B and C was accomplished. 
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Chapter 1. INTRODUCTION 
1.1 Drugs from the Sea 
The oceans compose more than 70% of the earth’s surface and over 90% of its volume of 
its crust.1,2 The marine environment has been an exceptional reservoir of bioactive natural 
products.3 Due to the physical and chemical features of oceans, such as extreme variation 
of temperature, pressure and salinity, marine organisms have evolved biochemical and 
physiological mechanisms that give rise to bioactive compounds with unique structural 
features, often not found among terrestrial natural products. These biomolecules play a 
pivotal role in reproduction, communication and protection against predation, infection 
and competition in the oceanic environment.4,5  
 
Many marine organisms are soft-bodied or move slow whereas some of them have 
sedentary life styles. However, they often do not have physical armament like hard 
external shells or spicules for their protection, making them extremely vulnerable to 
predation and competition.4,5 Such organisms need some form of defense. Many marine 
organisms have developed defenses employing bioactive natural products against their 
enemies.4,5 These compounds, belonging to the category of secondary metabolites, help 
them to either deter or have a competitive edge over the predators.4  
 
Some of these marine organisms have evolved the ability to synthesize their own 
secondary metabolite defense chemicals via de novo biosynthesis. Other organisms have 
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been found to derive their defense chemicals by a symbiotic relationship or simply from 
their diet.4 
 
 Beyond chemical diversity, the marine environment is known to hold enormous 
biological diversity as well. Evidence for this coming from recent research on marine 
ecosystems like the deep sea floor and coral reefs. In fact, their biodiversity is known to 
be higher than that of tropical rain forests, a terrestrial ecosystem renown for its 
enormous biodiversity.2 For instance, according to recent estimates, out of the all species 
living on this planet only 10% are known and the unexplored majority live in the sea1,3 
Meanwhile, out of the 34 fundamental phyla of life, 17 occur on land whereas 32 occur in 
the sea (with some overlap). The deep sea floor harbors millions of hither to unknown 
species including thousands of marine microorganisms.1, 2 
  
It has been estimated that  more than  10, 000 marine natural products have been isolated 
by 2000.6 Among them 25% are from algae, 33% from sponges, 24% from coelenterates 
and the remaining 24% from representatives of other invertebrate phyla such as ascidians, 
ophisthoibranch molluscs, echinoderms and bryozoans.2 Further analysis of this data 
highlighted that the search for drugs from the sea progresses at a rate of 10% per year.2 
 
During last few years several such marine natural products have successfully advanced 
into clinical trials (Table 1). However, none of these discoveries have reached a 
marketable stage. 
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Table 1. Potential therapeutic compounds isolated from marine sources (Adapted 
from reference 3) 
Condition Compound Organism Origin 
 
Cancer 
 
 
 
 
 
 
 
 HIV 
 
 
 
  
 Aplidine7 
 Bryostatin 18 
 Didemnin B9 
 Dolastanin 1010 
 Ecteinascidin 74311, 12 
 Halichondrin B13 
 Kahalaide F14 
 Mycaperoxide B15 
Cyclodidemniserol 
trisulphate16 
Lamellarin A 20 sulphate17 
 
 
Tunicate 
Bryozoan 
Tunicate 
Sea hare 
Tunicate 
Sponge 
Mollusc 
Sponge 
 
Tunicate 
Tunicate 
 
 
Mediterranean 
Gulf of California 
Caribbean 
Indian Ocean 
Caribbean 
Okinawa 
Hawaii 
Thailand 
 
Palau 
Australia 
 
 
The history of marine derived drugs dates as far back as the 1950s when Bergmann et al. 
isolated several nucleoside analogues from the Caribbean sponge Tethya crypta.18 Two of 
these compounds, spongothymidine (1) and spongouridine (2) had a rare arabinose sugar 
rather than ribose, which is more common in nucleosides. Later, the discovery of their 
antiviral activity led the researchers to synthesize a wide range of analogues19, 20 such as 
Ara-A (3) and Ara-C (4), which have demonstrated significantly improved activity. They 
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represent the only marine derived drugs in current clinical usage.3 Bergmann’s initial 
discovery can be considered a significant breakthrough as it led to the  introduction of 
nucleoside analogues in antiviral and anticancer therapy with profound success (eg. 3’-
azido-3’-deoxythymidine (AZT, Zidovudin) (5).21  
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                              Ara-C (4)                             3’-azido-3’-deoxythymidine (5) 
 
Isolated form the bryozoan Bugula neritina, bryostatin 18 (6) is one of the first drug 
candidates from the ocean to advance into clinical trials. Bryostatin 1, a complex 
polyketide which inhibits Protein Kinase C and thereby prevents cancer is in Phase ІІ 
clinical trails.22 It has been found that bryostatin 1 is not effective in cancer treatment by 
itself, but seems to enhance the activity of other anticancer drugs such as taxol and 
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cisplatin. Therefore, it may be used in combination with taxol, in the treatment of  breast, 
ovarian and lung cancers which usually respond to taxol.3 
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                                                     Bryostatin 1 (6) 
Discodermolide23 (7) is a polyketide isolated from the marine sponge Discodermia 
dissolute. It was found to be a potent antitumor agent that inhibited the polymerization of 
microtubules. Structure-activity studies of discodermolide and its synthetic analogues 
have shown that it has a greater promise and versatility than taxol. Both, the natural 
product (+)-discodermolide and its synthetic analogue (-)-discodermolide have been 
found to be active as inhibitors of cell proliferation despite their mechanism of action  
differing considerably.24 
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                                        (+)-Discodermolide (7)  
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Eleutherobin (8)25 and sarcodictyin A (9) and B (10)26 are a group of diterpenes isolated 
from different sources despite their distinct similarities in structure. Eleutherobin was 
isolated from Eleutherobia species of soft corral found in the Indian Ocean near Western 
Australia25 whereas sarcodictyins were isolated from the Mediterranean soft coral 
Sarcodictyon roseum.26 Both compounds showed microtubule stabilization properties.24,27  
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           Eleutherobin (8)                                           Sarcodictyin A (9) R = Me    
                                                                                Sarcodictyin B (10) R = Et 
 
Dolastatin 1010 (11), isolated from the sea hare Dolabella auricularia collected from the 
Indian ocean is a short polypeptide containing unique amino acids which showed 
microtubule stabilization properties.6  Later the same compound has been isolated from a 
nudibranch and a cyanobacterium. Dolastatine 10 is in Phase І clinical trials as anticancer 
agent for use in the treatment of breast and liver cancer.24   
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                                                           Dolastanin 10 (11) 
 
Ecteinascidins11,28 isolated from the colonial ascidian Ecteinascidia turbinata found in the 
Caribbean and Mediterranean, are novel cytotoxins that act via DNA intercalation. 
Ecteinascidin 743 (12) was selective against breast cancer and melanoma. Currently it is 
undergoing Phase ІІ clinical trials.3           
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                                             Ecteinascidin 743 (12) 
Recent research on the anticancer activity of ecteinascidin 743 suggestes its potential to 
prevent tumors from becoming drug resistant.29  It was discovered that it can prevent the 
formation of P-glycoprotein, a membrane protein that transports toxins out of the cancer 
cell, thereby preventing such agents from destroying the tumor. Once chemotherapy is 
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administered this protein has the ability of preventing it reaching the intended target. In 
fact, it was found that when tumors are exposed to chemotherapeutic agents, they quickly 
boost the activity of the MDR1 gene, that is responsible for the formation of P-
glycoprotein, which ultimately results in multidrug resistance.6 Therefore, ecteinascidin 
743 has the potential to increase the susceptibly of the tumor cells to chemotherapy by 
inhibiting the transcription of this gene,6  in addition to being a potent chemotherapeutic 
agent by itself.3  
 
Kahalaide F (13), a cyclic depsipeptide isolated from the sea slug Elysia rufescens, is 
another anticancer drug candidate in clinical trails.14 However, it is believed that actual 
organism which produces the compound is the green algae Bryopsis sp. on which it feeds. 
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                                                                  Kahalalide F (13) 
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Kahalaide F has a unique pattern of cytotoxicity with selective in vitro and in vivo 
cytotoxicity against prostrate cancer. In particular, it has been shown to be selective 
against hormone-independent prostrate tumor cells which are aggressive and hard to treat. 
Phase І clinical trails of kahalaide F in patients with androgen independent prostrate 
cancer have already begun.3 
 
Didemnin B (14), an unusual cyclic depsipeptide isolated from the Caribbean tunicate 
Trididemnum solidom in the 1980s, generated great excitement due to its  pronounced 
antitumor activity.7,16,30,31  Later, it was found to show antineoplastic, antiviral and 
immunosuppressive activities as well. Its mechanism of action was identified as due to 
the interference in protein synthesis. Despite its toxicity being too high to be useful as an 
antiviral or immunosuppressive agent, it has been in Phase І clinical trails as an 
anticancer agent and eventually promoted to Phase ІІ. However, its further development 
as an anticancer drug was cancelled due to the hepataotoxic side effects.6 
 
Dehydrodidemnin B (15), or aplidine, cyclic depsipeptide isolated from the 
Mediterranean tunicate Aplidium albicans, showed less toxicity and more potency than 
didemnin B. It has shown a broad spectrum of anticancer activity and has been promoted 
to Phase ІІ clinical trails.  
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Manoalide32 (16), a sesquiterpene isolated from the Indo-Pacific sponge Luffariella 
variabilis, is a potent analgesic and antiinflammatory agent. A low concentration of 
manoalide inhibited calcium channels.  It has been undergone Phase I clinical trails for 
psoriasis. It is commercially available as a standard probe for PLA2 inhibition.3, 33 
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                                                     Manoalide (16) 
Pseudopterosin A (17) is a tricyclic diterpenoid glycoside isolated from the Caribbean 
Sea whip (gorgonian) Pseudopterogorgia elisabethae (Gorgoniidae). It is a potent 
antiinflammatory and analgesic agent. Further it was found that it can inhibit eicosoniod 
biosynthesis by inhibition of both  PLA2 and 5-lipoxygenase. It is thought that the cell 
type selectivity is due to the presence of the glycoside moiety.3, 33 
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1.2 Biodiversity of Antarctica 
Research on Antarctic ecosystems has revealed that marine biota have thrived under ice  
covered seas for 20 million years, providing static environmental conditions for the 
evolution of broad biodiversity.34 Moreover, the continent has been isolated from its 
lower latitude neighbors even longer and the circumpolar current that encircles the land 
mass of Antarctica has prevented the Antarctic species exchanging genetic information 
with Northern congenors. The factors such as physical stability and isolation are 
important criteria for genetic divergence and have given rise to the high levels of 
endemism in Antarctica.34 
 
Predation and competition are the dominant forces that determine the species 
composition and distribution of such an ecosystem and eventually could facilitate the 
evolution of novel biogenetic pathways leading to bioactive secondary metabolites with 
structural diversity. In fact, being a very stable ecosystem operating under very unique set 
of ecological conditions, the benthic community of Antarctica has evolved many 
interspecies relationships where secondary metabolites perform an important role 
assisting defense against predators and competitors.35 
 
A few decades back, it was conventional wisdom that competition and predation among 
marine species are most intense in tropical waters and as a result the chemical ecology of 
marine organisms dwelling in tropical waters received more attention in drug discovery 
programs. However, recent research on organisms from the Southern Ocean sea floor 
suggested that predation and competition similarly drive the chemical defense.4,36 
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An expedition undertaken to study the benthos of McMurdo Sound, Antarctica, in 1980 
revealed that the sea floor under the ice is rich in marine life and is covered with an 
immense community of sponges, soft corals, molluscs, tunicates and echinoderms. Many 
of these organisms are immobile and therefore cannot move to less densely populated 
regions if the area they occupy becomes overgrown with competitors, nor can they escape 
predators. Nevertheless, they manage to survive. Hence, it is apparent either these sessile 
organisms do not have predators or they have a defensive stategy.4 
 
Further studies of Antarctic invertebrates showed that they do have many predators. 
These include swarms of the voracious Paramoera antractica, a one centimeter-long 
crustacean resembling shrimp and dense populations of sea stars.4,35 In addition, it was 
evident that the benthic invertebrates are pressured by fouling diatoms, invertebrate 
larvae, algal spores and potentially infectious water column microorganisms. These 
environmental features suggest the likelihood of the evolution of chemically mediated 
defensive strategies.35 Thus, the attention was focused on the chemistry of these bottom 
dwellers in search of secondary metabolites that might provide chemical defense. 
Subsequently, chemical investigations have been performed on Antarctic organisms and 
numerous bioactive molecules have been characterized.35 
 
Sponges of McMurdo Sound Antarctica are subject to predation by sea stars, and it is 
considered to be a dominant ecological factor that might drive the production of defense 
chemicals.35 The bright yellow Antarctic sponge Isodictiya erinacea which lacks physical 
defense such as spicules and mucus, is one of several chemically defended sponges in the 
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region. An investigation of its secondary metabolites showed the presence of purine and 
nucleoside metabolites including previously unreported erinacean (18) which showed 
cytotoxicity.37 The tryptophane derivative erebusinone (19), which is a yellow pigment 
found in the sponge, showed molt inhibition in crustaceans, a possible strategy of 
chemical defense.38  
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             Erinacean (18)                                              Erebusinone (19)39 
The bright yellow Antarctic cactus sponge was observed as extremely slow growing, but 
never observed to be eaten by the spongivorous sea star Perknaster fuscus.34 It has 
neither apparent spicules nor mucus suggesting a chemical defense. Chemical 
investigation of this sponge, Dendrilla membranosa, yielded three new diterpenoids, 
membranolides B (20), C (21), D (22) and membranolide (23) which is reported to have 
antibiotic activity.39-42 
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         Membranolide B (20)                         Membranolide C (21) R1 = OMe R2 = H                                    
                                                                                                       Membranolide D (22) R1 = H   R2 = OMe 
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                                                   Membranolide (23) 
Suberites sp. is a common McMurdo Sound sponge that has a muted yellow coloration. 
Suberitenones A (24) and B (25) are two sesterterpenes that have been described from 
sponge collected at several sites around Antarctica and are suspected to be involved in 
chemical defense of the sponge.43 Suberitenones have shown activity in both sea star tube 
foot retraction feeding deterrent assay and an antibacterial assay using sympatric 
bacteria.44 The former assay was first developed to study the feeding relationships 
between the sea star Perkanaster fuscus and the sponges in McMurdo Sound. The tube 
feet of the sea star are known to be chemosensory, and when they are in contact with an 
unsuitable sponge extract, they illicit a retraction, indicative of feeding deterrence. 
 
Another sponge that elicits a significant sea star tube foot retraction is Latrunculia 
apicalis. A subsequent fractionation of the sponge produced discorhabdin alkaloids, a 
group of pigments first isolated from temperate sponges, including discorhabdin G (26) 
and C (27), the latter of which was identified as a potent mammalian cytotoxin.35, 45 
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 Leucetta leptorhapsis, a calcareous sponge commonly known as the rubber sponge due 
to its appearance as being stretched, is a common member of the McMurdo Sound 
benthic community. Comprehensive study of this organism yielded the cytotoxic agent 
rhapsamine (28).46  
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The pteropod Clione antarctica is a shell-less pelagic mollusc which blooms in each 
austral summer in McMurdo Sound. It has an intriguing relationship with the amphipod 
Hyperiella dilatata where the amphipod positions the mollusc on its dorsum and defends 
itself from predatory fish utilizing the defense chemicals of the mollusc.47 A bioassay 
guided fractionation of the mollusc afforded the feeding deterrent pteroenone (29).48 
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                                                    Pteroenone (29) 
It has been observed that among the Antarctic deep water octocorals, some are replete 
with calcareous spicules and others are devoid of them. The octocorals that have spicules 
were found to yield chemical extracts palatable to Odontaster validus, a common 
predaceous sea star in Antarctica, whereas ocotcorals that did not have spicules produced 
extracts that deterred predation, suggesting the presence of a chemical defense. Chemical 
investigation of one such horny corals, Ainigmaptilon antarctcus,  afforded two bioactive 
sesquiterpenoids, ainigmaptilone A (30) and B (31) based on the eudesmane carbon 
skeleton, which is fairly uncommon in corals.49 
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Macroalgae are known to pay a role in structuring the near shore Antarctic benthos. 
Delisea pulchra, a marine red algae collected near Palmer Station, yielded three new 
dimeric halogenated furanones, pulchralides A (32), B (33), C (34) along with fimbrolide 
(35), acetoxyfimbrolide (36) and hydroxyfimbrolide (37). The latter two compounds have 
shown significant antibacterial properties.50  
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         Pulchraide A (32) R = R1= OAc, R2 = R3 = H         Fimbrolide (35) R = H 
         Pulchraide B (33) R = R1 = R2 = R3=H                   Acetoxyfimbrolide (36) R = OAc 
         Pulchraide C (34)   R= OAc, R1 = R2 = R3 = H       Hydroxyfimbrolide (37) R = OH 
 
Plocamium cartilagineum, a common red alga found in shallow-water Antarctic 
environments produces halogenated monoterpenes including anverene (38), 
epiplocamene D (39) and pyranoid 40.50 Anverene, which induces feeding deterrence in 
the amphipod Gondogeneia antarctica, displayed modest but selective antibiotic activity 
whereas 40 showed selective antifungal activity. Epiplocamene D exhibited a greater 
degree of feeding deterrence by the amphipod than the other two compounds. However 
all three compounds had no effect on the sea star Odontaster validus.50 
 
 
 19
       Cl Br
Cl
Br
Br
    Cl
Cl
Cl     
O
Cl
Br
Br
OH
 
  Anverene (38)                       Epiplocamene D (39)                            40 
 
 
1.3 Research Objectives  
The benthos of Antarctica harbors many organisms that have not been investigated for 
their chemistry and bioactivity.  The unique features of its ecosystem and dynamic 
relationship between the predators and prey could lead to the evolution of biosynthetic 
pathways leading to molecules with interesting biological activity. Therefore, in terms of 
drug discovery a comprehensive chemical investigation of Antarctic species is very 
important. 
 
In addition, there are many parts of the Antarctic Peninsula that have never been 
explored. Considering the significant variations in chemistry of the species that have been 
studied from the regions of McMurdo Sound and Palmer Station35 a comprehensive 
investigation of the chemistry and the bioactivity is of considerable interest from a 
chemical ecological stand point. 
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1.4 Summary 
Due to the ecological features of their habitat, many marine organisms have adopted 
chemical defense strategies. As a result, the marine realm has been an exceptional 
reservoir of bioactive natural products with a great structural diversity. Numbers of 
secondary metabolites isolated from marine organisms have advanced into clinical trials 
for drug development. The research on Antarctic marine biota emphasizes its potential to 
give rise to novel biogenetic pathways leading to secondary metabolites with attractive 
biological activities. 
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Chapter 2. CHEMICAL INVESTGATION OF ANTARCTIC TUNICATE 
                               SYNOICUM ADAREANUM 
2.1. INTRODUCTION 
2.1.1 Tunicates: a rich source of bioactive natural products 
The tunicates, classified in the phylum Chordata under the subphylum Urochordata, 
represent one of the most evolved groups of animals that are known to produce secondary 
metabolites.51 They are commonly referred to as tunicates, due to the sac like covering or 
tunic made of cellulose that covers their body.52 The subphylum Urochordata consists of 
three classes, Ascidiaceae, Larvacae and Thaliaceae. The members of class ascidiaceae 
are referred to as ascidians. They are also known as sea squirts, as many species expel 
water through a siphon when disturbed.52  The adult ascidians are exclusively marine, and 
share no resemblance with other Chordates. Their larvae are similar to amphibian 
tadpoles, they have notochords, pharyngeal slits and dorsal hollow nerve chords, the 
features that make them classify as Chordates which are ultimately lost during the course 
of development.53  
 
Adult ascidians are sessile filter feeders that have either colonial or solitary lifestyles. 
They prefer the regions where there is minimal effect from the shock created by wave 
action, but have a considerable free flow of seawater. The ascidian morphology is 
diverse. A solitary tunicate can grow as long as 15 cm or as small as 1 cm, where as a 
colonial tunicates found encrusted in rocks, can be extremely thin and delicate.52  
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The first interest on the chemistry of tunicates was ignited by the scientist’s curiosity to 
unfold the mysteries behind the color changes observed in the blood samples of tunicates 
as early as in 1847.54 Subsequent research led to the discovery of a series of pigments 
called tunichromes (41) and vanadium sequestration.55, 56 The focus on other bioactive 
secondary metabolites from tunicates originated in the early 1970s when the first ascidian 
metabolite, geranyl hydroquinone (42), was isolated. It was found to be active against 
leukemia, Rous sarcoma and mammary carcinoma in animal tests.51  
 
Since then, especially during the last two decades, tunicates have emerged as a rich 
source of bioactive natural products bearing unique structural features. Several such 
compounds have already advanced into clinical stages of drug development.  The 
majority of bioactive compounds described from ascidians are nitrogen containing 
metabolites and fall into the categories of peptides or amino acid derived alkaloids. 
However, they have given rise to a smaller number of non-nitrogenous metabolites 
derived through diverse biogenetic pathways as well.51  
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The tunicates have yielded a broad array of compounds with potent cytotoxicity. The 
ecteinascidins (11)11, 12 and didemnins9 (13) have already advanced into clinical trails as 
prospective anticancer drugs. Eudistomins, a group of β-carboline alkaloids isolated from 
the colonial ascidian Eudistoma olivaceum, are potent antiviral compounds.57-59 These 
compounds fall into five different general classes (Group 1: simple β-carbolines such as: 
eudistomin D (43), Group 2: pyrrolyl-β-carbolines such as eudistomin A (44), Group 3: 
pyrrolinyl-β-carbolines such as  eudistomin G (45), Group 4: 2-phenylacetyl-β-carbolines 
such as eudistomin R (46) and Group 5: tetrahydro-β-carbolines such as eudistomin C 
(47)).  
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2.12 Chemistry of the genus Synoicum 
Despite the fact that there is a growing interest in the chemistry of tunicates, out of many 
species of ascidians in the genus Synoicum only few have been subjected to chemical 
investigation. Studies on Synoicum prunum, a colonial ascidian collected from North 
Stradbroke Island in Queensland, Australia, have yielded a series of tetraphenolic, bis-
spiroketals, prunolides A-C (48-50),60 which showed week cytotoxicity, along with 
rubrolide A (51).61 It is believed that prunolides arise from oxidative dimerization of a 
rubrolide precursor.   
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The red colonial tunicate Synoicum blochmanni collected from Tarifa Island, Spain, 
afforded six new nitrogenous metabolites, rubrolides I - N (51-56) along with four related 
known compounds. Rubrolides I, L, and M showed weak cytotoxicity.61 
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    Rubrolide I (51) X = Cl                               Rubrolide K (53) X = Br,  Y = Cl 
    Rubrolide J (52) X = H                                Rubrolide M (55) X = Cl,  Y = H               
    Rubrolide L (54) X = Cl                              Rubrolide N (56) X = Br,  Y = Cl 
                                                                           
Chemical investigation of the ascidian Synoicum macroglossum collected from the Indian 
Ocean near Tamilnadu, India, found the  guanidino alkaloid, tiruchanduramine (57), 
which showed potent α–glucocidase activity.62 
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2.1.3   Research Objectives 
Despite the enormous promise that the tunicates have shown as a rich source of bioactive 
secondary metabolites, the chemistry of Antarctic tunicates have not been completely 
explored. The unique ecological features found in Antarctica, and the dynamic interaction 
between these tunicates and other benthic organisms, could facilitate the development of 
biogenetic pathways leading to secondary metabolites with novel structural features. 
Therefore, it is of interest to study the chemistry of tunicates found on the benthos of 
Antarctica. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 1.  Synoicum adareanum at Palmer Station, Antarctica (Photograph supplied by 
Bill J. Baker, University of South Florida)   
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Synoicum adareanum is a colonial ascidian that is commonly found in the shallow water 
around Palmer Station, Antarctica. Its liphophilic extract showed feeding deterrence 
towards the Antarctic sea star Odontaster validus, indicating the presence of defense 
chemicals. Therefore, as part of our comprehensive chemical investigation of Antarctic 
tunicates, S. adareanum was studied to identify the secondary metabolites responsible for 
this activity. 
 
2.2 RESULTS AND DISCUSSION 
2.2.1 Extraction and isolation of secondary metabolites 
Synoicum adareanum tunicates were collected from the ocean near Anvers Island (64◦ 
46’ S, 64◦ 03’W), Antarctica, in 2003.  The freeze dried tunicates were extracted in 
CH2Cl2/MeOH for three days. After evaporating the solvent the resultant reddish-brown 
semi-solid was partitioned with EtOAc and water. The EtOAc layer was washed, dried 
and the solvent removed. The resultant EtOAc extract of the tunicates was fractionated by 
flash chromatography to obtain 18 fractions (Scheme 1).   
 
Further separation of these factions with flash chromatography and subsequent 
purification by HPLC on C-18 afforded palmerolide A (58) (200 mg, 0.02% dry wt), 
palmerolide C (59) (4 mg, 0.0004% dry wt), palmerolide D (60) (2 mg, 0.0002% dry wt) 
and palmerolide E (61) (4 mg, 0.0004% dry wt) (Scheme 1). Fractions 8, 9 and 10, upon 
further purification by HPLC using 50% water in MeCN (isocratic elution, 2 mL per min) 
yielded palmerolide B (62) (2 mg, 0.0002% dry wt) and palmerolide H (63) (1 mg, 
0.0001% dry wt).  
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Freeze dried Tunicates (520 g)
1. Extraction with CH2Cl2/MeOH 1:1 3 X 24 hrs
2. Evaporation of solvent
3. Partion with EtOAc/MeOH
4. EtOAc layer separated, washed and dried (anhydrous MgSO4)
EtOAc Extract (3.1 g)
Gradiant flash chrmatography over silica
Hexane/ EtOAc / MeOH
Fr 1, 2
( 900 mg)
Fr 3
(300 mg)
Fr 4, 5
(310 mg)
Fr 6, 7
(310 mg)
Fr 8-10
(200 mg)
Fr 11-18
(800 mg)
Gradiant elution
over silica gel
1-6% MeOH/CHCl3
Gradiant elution
over silica gel
1-20% MeOH/CHCl3
Fr 40-48 Fr 54-60
Palmerolide A (58)
(200 mg)
Palmerolide C (59)
(1.2 mg)
Palmerolide B (62)
(2 mg)
PalmerolideH (63)
(1 mg)
HPLC  ODS
H2O : MeCN 4:6
Isochratic elution
HPLC  ODS
H2O : MeCN 1:1
Isochratic elution
Gradiant elution
over silica gel
1-10% MeOH/CHCl3
Fr-30-32 (20 mg) Fr 33-37 (9 mg) Fr 38-39 (9 mg)
HPLC  ODS
H2O : MeCN 4:6
Isochratic elution
HPLC  ODS
H2O : MeCN 4:6
Isochratic elutionPalmerolide C (59)
       3.5 mg
Palmerolide E (61)
       3.5 mg
Palmerolide C (59)
       3.5 mg
Palmerolide D (60)
       3.5 mg
Palmerolide E (61)
       3.5 mg
Palmerolide D (60)
       3.5 mg
HPLC  ODS
H2O : MeCN 4:6
Isochratic elution
                   Scheme 1. Extraction and purification of the palmerolides 
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Compound 62 was first isolated from a 2001 collection of Synoicum adareanum. 
However it was found to be unstable in DMSO as it decomposed in the NMR tube while 
the 2D NMR data were being obtained. Therefore, all the NMR experiments of fractions 
leading to palmerolides B and H were performed in CD3OD. 
 
 
2.2.2 Characterization of Palmerolide A (58) 
Palmerolide A (58) was isolated as a white solid. The low resolution FABMS analysis 
displayed a prominent peak at m/z 585, which was assigned as [M + 1]+ (Figure 2). The 
HRFABMS provided a molecular formula of C33H48N2O7 (HRFAMBS m/z 585.3539, ∆ 
0.1 mmu for [M + 1]+). 
 
 
 
Figure 2.  LRFABMS spectrum of palmerolide A (58) 
The 13C NMR spectrum of compound 58 (Figure 3) displayed 33 carbon signals. These 
signals were further edited by DEPT 135 (Figure 4) and DEPT 90 experiments which 
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established that palmerolide A is composed of five methyls, six methylenes, sixteen 
methines and six quaternary carbon signals. The quaternary signals at δ 165.3, 156.6 and 
163.1 were assigned as carbons at the oxidation state of a carboxylic acid, whereas the 
signals at δ 73.7, 72.5, 69.0 and δ 75.3 indicated hydroxymethines. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  13C Spectrum of palmerolide A (58) (125 MHz, DMSO-d6) 
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Figure 4.  DEPT 135 Spectrum of palmerolide A (58) (125 MHz, DMSO-d6) 
 
Analysis of the 1H NMR spectrum of palmerolide A (58) (Figure 5a), showed a series of 
proton signals in the region of 5-7 ppm (Figure 5b), characteristic of olefins, confirming a 
high degree of unsaturation. The singlets (3H) at δ 1.61, 170, 1.83, 2.12 and the doublet δ 
0.90 indicated five methyls (Figure 5c). A comprehensive investigation of the structure of 
palmerolide A was undertaken using gHMQC and gHMBC techniques. The C-1 to C-24 
carbon backbone of palmerolide A (58) could be unambiguously assigned based on 1H-
13C assignments (Table 2) from the gHMBC spectrum (Figure 6), to establish a 20 
member macrocycle. The ester carbonyl δ 166.1 (C-1) correlated with the H-2 and H-3 
olefins, the latter of which must be disposed trans (J = 15.2 Hz). 
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Figure 5.  1H NMR spectrum of palmerolide A (58) (500 MHz, DMSO-d6) 
 
 
Three methylene carbons (δ 32.6, 24.8 and 38.3) were observed by both gCOSY (Figures 
8, 9) and gHMBC between the C-2/C-3 olefin and a hydroxymethine at δ 3.82 (H-7). A 
trans-disubstituted olefin (J = 15 Hz) could be positioned between that hydroxymethine 
and another at δ 4.14 (H-10). While H-10 showed no HMBC correlations, H-8, -9 and -11 
all correlated to C-10. H-11 was found correlated not only with C-10 and C-12/13 (C-12 
and -13 were coincident in the 13C NMR spectrum) but also with an ester-type carbonyl 
(OCOX) which displayed no further connectivity using these techniques. 
10 8 6 4 2 0 P
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Table 2.  NMR data of palmerolide A (58) (1H, 500 MHz, 13C, 125 MHz, DMSO-d6)a 
 δ 13C δ  1H (ppm, mult, J (Hz)) gHMBC 
1 
2 
3 
4 
5 
 
6 
 
7 
8 
9 
10 
11 
12 
 
13 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
27 
1′ 
2′ 
3′ 
4′ 
5′ 
OCONH2 
24-NH 
10-OH 
7-OH 
 
165.3 
120.3 
149.2 
  32.6 
  24.8 
  24.8 
  38.0 
  38.0 
  72.5 
133.6 
128.9 
  69.0 
  72.3 
  29.5 
  29.5 
  29.5 
132.0 
126.1 
125.7 
131.5 
  43.6 
  43.6 
  73.7 
  36.9 
129.7 
132.5 
116.4 
121.8 
  12.6 
  16.9 
  16.2 
163.1 
117.9 
151.7 
  27.1 
  19.2 
156.6 
 
 
5.77 (1H, d, 15.3) 
6.71 (1H, ddd, 5.0, 9.9, 15.2) 
2.11 (2H, m) 
1.30 (1H, m) 
1.05 (1H, m) 
1.50 (1H, ddd, 4.5, 8.2, 11.2) 
1.30 (1H, m) 
3.82 (1H, ddd, 4.4, 7.4, 7.6) 
5.54 (1H, dd, 7.7, 15.0) 
5.48 (1H, dd, 2.9, 15.6) 
4.14 (1H, br s) 
4.48 (1H, dd, 5.0, 10.5) 
1.59 (1H, m) 
0.98 (1H, m) 
1.96 (2H, m) 
5.41 (1H, ddd, 4.7, 10.1, 14.6) 
6.04 (1H, dd, 11.1, 14.6) 
5.59 (1H, d, 11.4)  
 
2.17 (1H, dd, 1.3, 13.2) 
2.00 (1H, dd, 11.2, 13.2) 
4.84 (1H, ddd, 1.3, 7.4, 11.2) 
2.68 (1H, qdd, 6.5, 7.4, 9.6) 
5.13 (1H, d, 9.6) 
 
5.85 (1H, d, 14.2) 
6.85 (1H, dd, 10.1, 14.2) 
1.70 (3H, s) 
0.90 (3H, d, 6.5) 
1.61 (3H, s) 
 
5.69 (1H, br s, 1.0) 
 
1.83 (3H, s) 
2.12 (3H, s) 
6.49 (2H, br) 
9.84 (1H, d, 10.1) 
5.20 (1H, d, 4.9) 
4.72 (1H, d, 3.9) 
 
1, 4 
1, 2, 4, 5 
2, 3, 5, 6 
7 
6 
5, 7, 8 
5, 7, 8 
5, 9 
6, 7, 9, 10 
7, 8, 10 
 
9, 10, 12/13, OCONH2 
12/13 
11, 12/13 
12/13, 14, 15 
12/13, 16 
12/13, 16, 17 
14, 15, 18, 25 
 8, 9, 11, 12/13 
16, 17, 19, 25 
16, 17, 19, 20, 25 
1, 17, 18, 20, 21, 26 
18, 19, 21, 22, 26 
19, 20, 23, 26, 27 
 
21, 22, 24, 27 
22, 23, 1` 
16, 17, 18 
19, 20, 21 
21, 22, 23 
 
1′, 3′, 4′, 5′ 
 
1′, 2′, 3′, 5′ 
1′, 2′, 3′, 4′ 
 
23, 24, 1′ 
9, 10, 11 
6, 7, 8 
 
aProton carbon assignments based on gHSQC spectrum (Figure 7) 
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Figure 6. gHMBC spectrum of  palmerolide A (58) (500 MHz, DMSO-d6) 
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    Figure 7.    gHSQC spectrum of palmerolide A (58) (500 MHz, DMSO-d6) 
In the gHMBC spectrum, H-13 was coupled back in to the olefinic region to C’s -14 and -
15. The C-14/15 trans-olefin (J = 14.6 Hz) was shown to be conjugated to a trisubstituted 
olefin in positions C-16 and C-17 by gHMBC correlations of H-14, -15, -18 and -19 as 
well as H3-25. The C-16/C-17 olefin must be trans based on the correlations of the 
ROESY spectrum for H3-25 and H-15. The methylene group at C-18 (δ 43.9) intervenes 
between the C-16/C-17 olefin and an oxygen bearing methine (C-19, δ 75.9), based on 
gHMBC correlations of H-16 and H3-25 to C-18 as well as H-19 and H-20 correlations to 
C-18. The macrocycle was completed by observation of correlation between H-19 and 
the C-1 ester carbonyl. 
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The features of the C20 macrocycle were established by extensive analysis of 2D NMR 
data. In addition to the four trans olefins described above, one methyl group and three 
oxygen atoms were pendant on the macrocycle. Hydroxymethine protons at H-7 and H-
10 were conclusively assigned based on the observation of coupling of hydroxyl protons 
in both the gHMBC and gCOSY spectra; in the gHMBC spectrum, the hydroxyl protons 
correlated to the respective α- and β-carbons, while the gHMBC correlations were 
observed between the hydroxyl protons and their respective hydroxylmethines. The third 
oxygen bearing carbon (C-11) as described earlier correlates with an ester-type carbonyl 
(OCOX). 
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Figure 8.  Key gHMBC and gCOSY correlations of palmerolide A 
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Figure 9. gCOSY spectrum of  palmerolide A (58) (500 MHz, DMSO-d6) 
Also pendant on the macrocycle was the C-19 side chain. gHMBC and gCOSY 
correlations of the multiplet at δ 2.68 (H-20), which was clearly coupled (gCOSY) to a 
methyl group (C-26, δ 0.90), could be extended to a conjugated diene system based on 
gHMBC correlations of H-19 and H-20 to olefin C-21 (δ 129.7). Both the C-21 / C-22 
and C-23 / C-24 olefins were determined to be trans based, in the former case of by 
ROESY correlation between H3-27 and H-19, and in the latter case, J =14.2 Hz.  
Connectivity of the C-23/ C-24 olefin could be established based on gHMBC correlations 
of H-23 to C-21, -22, -24 and -27. C-24 marked the terminus of the continuous carbon 
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chain and could be shown to bear an –NH group due to gHMBC correlations of a amide 
proton at δ 9.84 to carbons C-23, C-24 and an amide carbonyl, C-1′ (δ 163.1). The 
presence of amide group was confirmed by an 15N gHSQC experiment. 
 
The isopentenoyl substructure (C-1′ to C-5′) was unusual in displaying 4J CH coupling in 
the gHMBC spectrum between the amide carbonyl (C-1′) and both vinyl methyl groups 
(C-4′ and C-5′). Only one vinyl methyl can be placed within the 3J CH reach of the typical 
HMBC experiment optimized for 8 Hz. Presence of another alternative structure, the 2-
methyl-2-butenoyl isomer,  wherein one vinyl methyl resides three bonds away from the 
carbonyl and the second resides four bonds distant, is consistent with these HMBC 
correlations. However, it was rules out on chemical shift grounds and by the observations 
of gHMBC correlations between both vinyl methyls. The substructure was secured as the 
isopentenoyl group by observation of very small coupling constants (J = 1.0 Hz) of the 
vinyl proton (H-2′) to both vinyl methyl groups (C-4′ and C-5′), excluding a vicinal 
relationship between the vinyl proton and the vinyl methyl required by the 2-methyl-2 
butenoyl isomer. The isopentenoyl structure could be connected to the vinyl proton at δ 
6.82 (C-24) based on gHMBC cross peak between amide carbonyl (C-1′) and H-24. 
 
The above described connectivity established the full planer structure of palmerolide A 
(Figure 10) with the exception of a single open valence, the ester-type carbonyl attached 
to the macrolide at C-11. Remaining to be accounted from the known molecular formula 
was –NH2. That the C-11 functional group was a carbamate is supported by the 
precedence of that functional group on other polyketides, most notably the anticancer 
agent discodermolide (7).23 
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Figure 10. Plainer structure of palmerolide A (58). 
 
2.2.3 Stereochemical determination  
Stereochemical assignment of the five stereocenters of palmerolide A was established by 
application of the modified Mosher’s63 and Murata64 methods. Further support for 
stereochemistry assignment was obtained by ROESY and selective 1D NOESY 
experiments. 
 
 
2.2.3.1 Application of Mosher’s method 
Mosher’s method has been a very successful method to determine the absolute 
stereochemistry of chiral centers associated with secondary alcohols.64  Out of the five 
stereocenters in palmerolide A (58), C-7 and C-10 both have secondary alcohols making 
them suitable candidates to employ Mosher’s method. 
 
Palmerolide A (58) was treated with both R- and S-MTPACl separately and the reaction 
was monitored by TLC. It was observed that in each case two products were formed. In 
each case, the formation of the first product, which was the major product, was observed 
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after one hour and the formation of the second product was noticed after 16 hours. This 
can be explained as due to the substitution of one secondary hydroxyl in palmerolide A 
giving rise to R and S monoesters (64 and 65) initially, and then subsequently substitution 
of the other secondary hydroxyl giving rise to R and S diesters (66 and 67). The products 
64 and 65 were less polar than 66 and 67 in agreement with above explanation.  
 
 
 
 
 
 
 
 
 
Each product was isolated by chromatography on silica gel and purified by HPLC. A 
comprehensive structure elucidation was undertaken of each of these products using 2D 
NMR and mass spectroscopy. 
 
 
2.2.3.1.1 R-MTPA monoester of palmerolide A (64) 
Analysis of the more polar product 64 by ESIMS showed a mass peak at m/z = 823.1 
representing [M + Na]+. The HRESIMS experiment performed on this ion showed a 
molecular weight of 823.3776 amu consistent with molecular formulae of 
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C43H55N2O9F3Na suggesting the incorporation of one MTPA group. This explains the 
more polar nature and the faster rate of formation of 64 as compared to the disubstituted 
product 66. The 1H NMR spectrum (Figure 11) indicated significant chemical shift 
changes around C-7 (Figure 12). The multiplets at δ 7.51 and 7.43 represented the MTPA 
phenyl group whereas the singlet at δ 3.63 indicated the OCH3 group. The multiplet δ 
5.47 assigned for H-7, show a significant deshielding accounting for an esterification at 
C-7. The observation of a gHMBC correlation between H-7 and δ 165.9 assigned as the 
carbonyl carbon of the MTPA group, confirmed the attachment of MTPA at C-7, giving 
rise to palmerolide A R-MTPA monoester (64). 
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Figure 11. 1H NMR spectrum palmerolide A R-MTPA monoester (64) (500 MHz, 
CD3OD) 
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Figure 12. Key gHMBC correlations demonstrating the attachment of the MTPA moiety 
in compound (64) 
 
2.2.3.1.2  R, R-MTPA diester of palmerolide A (66) 
The less polar product (66) from the reaction of palmerolide A (58) with MTPA-Cl 
showed a m/z = 1039.1 in the ESIMS, consistent with [M + Na]+. HRESIMS indicated a 
molecular weight of 1039.4145 amu, consistent with molecular formula of 
C53H62N2O11F6Na and indicative of incorporation of two MTPA moieties. The 1H NMR 
spectrum (Figure 13) indicated significant chemical shift changes around C-7 and C-10 
(Figure 14). 
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Figure 13. 1H NMR spectrum of palmerolide A R, R-MTPA diester (66) (500 MHz, 
CD3OD) 
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The multiplets at δ 7.46 and 7.35 could be assigned as the MTPA phenyl group whereas 
the two singlets at δ 3.47 (3H) and 3.56 (3H) were due to the two OCH3 groups of two 
MTPA moieties.  H-7 and H-10 both displayed significant deshielding demonstrating the 
formation of ester bonds. A spectroscopic investigation using gHMBC COSY and HSQC 
experiments around C-7 and C-10 confirmed the attachment of two MTPA molecules at 
C-7 and C-10 to give rise to palmerolide A R, R-MTPA diester (66). 
 
 
O
O
H H
O
H H
H
H H H H
O
MeO Ph
CF3
CF3
MeO
Ph
O
NH2
O
1.12
1.64
1.29
29.5
1.49
165.38
5.53 5.55
4.83
158.30
75.63
5.56 5.73
131.80 128.00 165.61
75.80
72.06
33.2
H
H
1.42
1.10
31.2
 
                     
Figure 14. Key gHMBC correlations demonstrating the attachment of MTPA in 
compound (66) 
 
2.2.3.1.3  S-MTPA monoester of palmerolide A (65) 
The HRESIMS of 65 showed a molecular weight of 823.3747 amu consistent with 
molecular formula of C43H55N2O9F3Na, affirming the substitution of one MTPA moiety. 
In addition, it explained the more polar nature and the faster rate of formation of 65 as 
compared to the disubstituted product 67. The 1H NMR spectrum (Figure 15) indicated 
significant chemical shift changes around C-7 (Figure 16). The multiplets at δ 7.41, 7.44, 
7.50 and 7.60 can account for the aromatic protons of the MTPA moieties and the singlet 
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at δ 3.55 was due to the OCH3 group of MTPA moiety.  H-7 showed a significant 
deshielding demonstrating the formation of an ester linkage. In addition it displayed 
gHMBC correlation with δ 165.8 assigned for the ester carbonyl of MTPA moiety, 
further accounting for the attachment of a MTPA molecule at C-7. 
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Figure 15. 1H NMR spectrum of palmerolide A S-MTPA monoester (65) (500 MHz, 
CD3OD) 
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Figure 16. Key gHMBC correlations demonstrating the attachment of the MTPA moiety 
in compound 65. 
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2.2.3.1.4  S, S- MTPA diester of palmerolide A (67) 
The less polar product from esterification of palmerolide A (58), 67, showed a prominent 
mass peak at m/z = 1039.1 in the ESIMS indicative of [M + Na]+. HRESIMS indicated a 
molecular weight of 1039.4151 amu that was consistent with molecular formula of 
C53H62N2O11F3Na, indicative of incorporation of two MTPA moieties. The 1H NMR 
spectrums (Figure 17) indicated significant chemical shift changes around C-7 and C-10 
(Figure 18). The multiplets at δ 7.61, 7.50, 7.43 and 7.39 represented the aromatic 
protons of the MTPA moieties whereas the two singlets (3H) at δ 3.41, 3.57 indicated the 
two OCH3 groups of two MTPA groups.  H-7 and H-10 both displayed significant 
deshielding due to the formation of ester bonds that attach two MTPA groups at C-7 and 
C-10 in order to form palmerolide A S, S-MTPA diester (67). 
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Figure 17. 1H NMR spectrum of palmerolide A S, S-MTPA diester (67) (500 MHz, 
CD3OD) 
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Figure 18. Key gHMBC correlations demonstrating the attachment of the MTPA in 
compound (67) 
 
2.2.3.1.5  Absolute stereochemistry assignment at C-7 of palmerolide A (58) 
According to Mosher’s method,63 the chemical shifts of all the neighboring protons in the 
either side of the desired chiral center of both R- and S-MTPA monoesters of palmerolide 
A (58) were assigned as shown in previous sections.  In the next step, for each proton, the 
value of the ∆δ chemical shifts were calculated employing following formula: 
 
δ S – δ R = ∆δ 
∆δ values were placed on the model designed as described in Mosher’s method (Figure 
19) so that all positive ∆δ chemical shift differences are assigned to the right hand side of 
the MTPA plane, whereas all negative ∆δ chemical shift difference are assigned to the 
left hand side. 
HH
H
H
H
H
OH OCONH2
H
MTPAO
H
H
-10-20
-50-90
0.00+70
+60  
Figure 19. ∆δ Chemial shift differences (∆δ * 1000) of palmerolide A MTPA R- and S-    
monoesters 
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Once a model is built satisfying all requirements described in Mosher’s method,63 the 
model (Figure 20) should have the absolute stereochemistry of the desired chiral center 
involving a secondary hydroxyl group. Therefore, in the case of palmerolide A the 
absolute stereochemistry at C-7 was assigned as R. 
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Figure 20.  MTPA model for configuration correlations 
 
2.2.3.1.6 Absolute stereochemistry assignment at C-10 of palmerolide A (58) 
Similarly the ∆δ chemical shift values were calculated for the MTPA diesters of 
palmerolide A and applied to a Mosher’ model63 as shown in Figure 21. Application of 
the Mosher’s method indicated that the absolute stereochemistry of C-10 of palmerolide 
A as R. 
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+74
-34
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Figure 21. ∆δ Chemial shift values (∆δ * 1000) of palmerolide A MTPA R, R- and S, S- 
diesters  
 50
2.2.3.2 Application of Murata’s method64 
Matura’s method is based on configuration analysis using heteronuclear coupling 
constants. It has been successfully applied to the stereochemical elucidation of number of 
natural products.64 The gHSQMBC experiment based on this principle has proven as a 
very successful method to determine stereochemistry of macrolides.65 Hence, a 
gHSQMBC experiment was acquired using a concentrated sample of palmerolide A (58) 
(Figure 22). Heteronuclear coupling constants were obtained by analyzing the coupled 
proton and carbon signals in the corresponding 1D spectrum (Figure 23). Based on the 
magnitude of the coupling constants the stereochemical relationships between the 
respective atoms are determined. 
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     Figure 22. gHSQMBC spectrum of plamerolide A (58) (500 MHz, DMSO-d6)     
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In order to determine the heteroneuclear coupling constants, for each gHSQMBC cross 
peak, the 1D gHSQMBC slice was extracted. The heteroneuclear coupling constant was 
derived by the subtraction of the 1H NMR spectrum from itself, offset by the equivalent 
magnitude of  the coupling constant, to produce a difference spectrum which matched the 
gHSQMBC slice. 
2JC-12/ H-10
 
    Figure 23. 1D analysis of the gHSQMBC cross peak of the respective slice 
 
Figure 24. Determination of the coupling constant by the subtraction of 1H NMR 
spectrum; Offset = 2JC-12 /H-10 
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Configuration analysis of fragment C-10 /C-11 showed a gauche relationship between H-
10 and H-11, based on the small 3JH-10/ H-11 observed between the vicinal protons and the 
large 3JCH for both the H-10/C-12 and H-11/C-9 relationships. Further support for the 
conformation was found in 2JC-11/H-10 and 2JC-10/H-11 both of which are large and negative 
defining the absolute stereochemistry of C-11 as R.64  
 
Similarly, configurational analysis of C-19/C-20 system suggested an anti relationship 
for the respective protons, based on the large 3JH-19/H-20, small 3JC-21/H-19 and 3JC-18/H-20 as 
well as large 2JC-19/H-20. The relative position of C-18 was secured by an observation of 
ROESY correlations (Figures 25, 26) between H2-18 as well as H-20 and H3-26 while no 
ROESY correlation was observed between H2-18 and H-21 requiring the relative 
configuration 19R, 20S.  
 
                      
C9
O H10
H11
OC12
H
H
H20
C26 C21
H19
OC18
H
H
H
ROESY
correlations
                                           
                 3JC-12/H-10  = 6.9 Hz   Large                          3JC-21/H-19 =  3.4 Hz  Small       
                3JC-9/H-11    = 5.2 Hz    Large                         3JC-18/H-20  =   2.9 Hz Small 
                 2JC-11/H-10  = -6.2 Hz  Large                          3JC-26/H-19 =   3.9 Hz Small 
                 2JC-10/H-11  = -4.8 Hz   Large                         2JC-19/H-20 = -5.9 Hz large 
 
         Figure 25. Coupling constant based configuration analysis64  
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Figure 26.      ROESY spectrum of palmerolide A (58) (500 MHz, DMSO-d6)          
 
The four olefins in the macrocycle constrain the flexibility often found in macrolides, 
facilitating stereochemical analysis by NOE studies. Further analysis of the ROESY 
spectrum (Figure 26) revealed the macrolide to adopt  two largely planer sides of  a tear 
drop shaped cycle, one side consisting of C-1 through C-6, the other C-11 through C-19, 
with C-7 through C-10 providing a curvilinear connection. In particular, H-9, H3-27, H-
15 and H2-13 are sequentially correlated in the ROESY Spectrum, as are H3-26, H2-18, 
H-16, H-14 and H-12, defining the periphery of the top and bottom face of the western 
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hemisphere (Figure 27). H-11 correlates only to the top series of protons, a result 
consistent only with C-19 and C-11 both adopting the R configuration. The absolute 
stereochemistry of the C-19/C-20 fragment is therefore assigned as 19R, 20S (Figure 28). 
 
                         
Figure 27. Key ROESY correlations supporting the stereochemistry determination of C-
19 and C-20. 
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Figure 28. Full stereochemical assignment of palmerolide A (58) 
The presence of type 1 polyketides like palmerolide A (58), is not a common feature 
among tunicates. Palmerolide A, bearing unusual 20-membered macrolide, display 
functionality more commonly found in sponges or cyanobacteria than the secondary 
metabolites generally found in tunicates.  For instance, the vinyl amide is a feature very 
commonly associated with cyanophyte derived macrolides such as tolytoxin. 
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2.2.4. Characterization of palmerolide C (59) 
Palmerolide C (59), was isolated as a yellow solid and showed a molecular ion at m/z 
585.3 in the low resolution LRESIMS. The HRESIMS (Figure 28) showed that it was 
consistent with the molecular formula of C33H49N2O7, identical to that of palmerolide A 
(58).  
 
 
Figure 29. Palmerolide C (59) HRESIMS spectrum 
 
Analysis of the 13C NMR spectrum (Figure 29) with DEPT 135 (Figure 30) suggested 
that palmerolide C (59) resemble palmerolide A further by having five methyls, six 
methylenes, sixteen methines and six quaternary carbon signals. In fact, out of the six 
methines, four were assigned to hydroxymethines as found in palmerolide A (58). 
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Figure 30. 13C NMR spectrum of palmerolide C (59) (125 MHz, DMSO-d6) 
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Figure 31. DEPT 135 spectrum of palmerolide C (59) (125 MHz, DMSO-d6) 
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Interpretation of HMBC (Figure 32) and COSY (Figure 33) spectrum indicated that 
palmerolide C (59) is also composed of a 20 member macrocyclic ring with a side chain 
(Figure 34). The structure of the side chain was the same as that of palmerolide A (58), 
however, there were significant rearrangements of the structural features in C-3 through 
C-13 in the macrocyclic ring.   
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Figure 32. gHMBC spectrum of palmerolide C (59) (500 MHz, DMSO-d6) 
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Figure 33. gCOSY spectrum of palmerolide C (59) (500 MHz, DMSO-d6) 
 
The doublet δ 5.73 (1H, J = 15.5 Hz) assigned to H-2 (Figure 35) showed HMBC 
coupling to ester carbonyl (C-1) δ 166.9 and methylene at δ 31.7 (C-4). The multiplet at δ 
6.77 (H-3) correlated to C-1 and a methine at δ 149.8 (C-2). All these observations were 
consistent with a trans olefin conjugated to an ester carbonyl as found in palmerolide A. 
H-3 showed further HMBC correlation to two methylenes, C-4 and C-5 (Table 3), 
indicating the extension of the carbon backbone by two methylenes after the double bond. 
The COSY correlations of H-5 and H-6 and HMBC correlation of H-6 to C-5 and -7 
confirmed this observation. 
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                      Figure 34. Key gHMBC and gCOSY correlations of palmerolide C (59) 
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Figure 35. 1H NMR spectrum of compound (59) (500 MHz, DMSO-d6) 
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 Figure 36. gHMQC spectrum of palmerolide C (59) (500 MHz,  DMSO-d6) 
 
Based on the gCOSY and gHMBC correlations of H-8, H-9 and H-10, the three 
hydroxymethines C-8, C-9 and C-10 were positioned between the C-7 and C-11. Further 
H-10 was correlated to an ester-type carbonyl (OCOX). COSY correlations of H-11a, and 
H-11b with H2-12 and that of H2-12 with H-13a and H-13b established the connectivity 
between methylenes C-11, C-12 and C-13. The latter two showed overlapping carbon 
signals in the carbon spectrum. 
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Table 3. NMR data of palmerolide C (59) (1H, 500 MHz, 13C, 125 MHz, DMSO-d6) 
              δ  13C δ1H (ppm, mult, J (Hz) gHMBC 
       1 
2 
3 
4 
 
5 
 
6 
7 
8 
9 
10 
11 
 
12 
13 
 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
27 
1′ 
2′ 
3′ 
4′ 
5′ 
OCONH2 
24-NH 
8-OH 
    9-OH 
166.9 
122.0 
149.8 
31.7 
31.7 
32.2 
32.2 
131.8 
131.1 
72.8 
75.6 
74.2 
28.7 
28.7 
30.1 
30.1 
30.1 
132.3 
127.2 
128.8 
132.5 
44.1 
44.1 
74.7 
37.4 
130.5 
133.3 
117.2 
122.8 
13.3 
17.8 
16.5 
164.0 
118.8 
152.5 
27.4 
20.3 
 
 
5.73 (1H, d, 15.5) 
6.77 (1H, ddd, 7.4, 7.5,15.4) 
1.30 (1H, m) 
2.13 (1H, m) 
1.89 (1H, m) 
1.98 (1H, m) 
5.54 (1H, m) 
5.58 (1H, m) 
3.96 (1H, m) 
3.56 (1H, m) 
4.56 (1H, ddd, 3, 7.5, 10.5) 
1.30 (1H, m) 
1.49 (1H, m) 
1.95 (1H, m) 
1.90 (1H, m) 
1.99 (1H, m) 
5.46 (1H, ddd, 5, 10, 15) 
6.08 (1H, dd, 12, 15) 
5.63 (1H, d, 11) 
 
2.07 (1H, m) 
2.18 (1H, m) 
4.85 (1H, ddd, 2.8, 7.8, 10.5) 
2.70 (1H, qdd, 6.7, 6.7, 9.8) 
5.15 (1H, d, 9.5) 
 
5.85 (1H, d, 14.5) 
6.85 (1H, dd, 9, 14.6) 
1.69 (3H, s) 
0.90 (3H, d, 7) 
1.59 (3H, s) 
 
5.68 (1H, s) 
 
1.82 (3H, s) 
2.11 (3H, s) 
6.37 (2H, br) 
9.85 (1H, d, 10) 
4.62 (1H, d, 5) 
4.72 (1H, d, 4.5) 
 
 
1, 4 
1, 2, 4, 5 
2, 3. 5, 6 
2, 6 
6, 7 
3, 7 
5, 7 
6, 8 
6, 7, 9 
10 
11, OCONH2 
10, 12 
10, 12 
10 
15 
15 
13, 15,16 
13, 14, 16, 17 
14, 15, 25 
 
16, 17, 19, 25 
16, 17, 19, 20, 25 
1, 17, 18, 20, 21, 26 
16, 19, 21, 22, 26 
19, 20, 23, 26, 27 
 
21, 22, 24, 27 
22, 23, 1` 
16, 17, 18 
19, 20, 21 
21, 22, 23 
 
1′, 3′, 4′, 5′ 
 
1′, 2′, 3′, 5′ 
1′, 2′, 3′, 4′ 
 
23, 24, 1′ 
7, 8, 9 
8, 9, 10 
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The remaining portion of the carbon backbone of the macrocycle was identical to that of 
palmerolide A (58). Connectivity of double bond C-14/C-15 to C-13 and was established 
by COSY correlation between H-13b and H-14 and the coupling observed in the HMBC 
between H-14 and H-15 with C-13. A large coupling constant (J = 15 Hz) indicated that 
H-14 and H-15 have a trans relationship. This olefin was conjugated to a trisubstituted 
double bond based on HMBC correlation of H-16 with carbons C-14, C-15 and C-25. H3-
25 showed HMBC correlations with C-16, C-17 and C-18, consistent with this 
assignment. H-19 demonstrated HMBC correlations with C-1, C-17 and C-18 completing 
the 20 memebered macrocycle. 
 
The side chain of palmerolide C (59) showed features similar to that of palmerolide A 
(58). The doublet at δ 0.90 (H3-26) showed coupling in the COSY spectrum with H-20. 
In addition, this methyl group displayed gHMBC correlation to C-19, C-20 and C-21, 
confirming, that it is located between C-19 and C-21 and attached to C-20. Meanwhile, 
olefinic methine H-21 was correlated to another olefinic methine C-23 and C-27 in the  
gHMBC spectrum. However, evidence from the gHSQC spectrum showed that the latter 
carbon belongs to the vinylic methyl H3-27. Based on the coupling constant (J = 14 Hz) 
the relationship between olefinic protons H-23 and H-24 was trans.  These correlations 
are consistent with a trisubstituted double bond conjugated to a trans olefin at C-23/C-24. 
The doublet δ 9.85 representing N-H, which was coupled to H-24 as established by 
gCOSY, displayed HMBC correlations to C-23, C-24 and C-1′. The latter assigned to a 
carbonyl. The gHMBC relationship of broad singlet H-2′ with C-1’ and the unusual 4JCH 
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HMBC coupling of two vinyl methyl groups C-4′ and C-5′ as observed in palmerolide A 
suggested an isopentenoyl connected to the amide described earlier. 
 
These data established the full planer structure of palmerolide C (59) with the exception 
of a single open valence, the ester carbonyl attached to the macrolide at C-10. Remaining 
to be accounted from the established molecular formula was an -NH2, suggesting the 
presence of a carbamate group as it was observed in the case of  palmerolide A (58). 
 
 
2.2.5 Characterization of palmerolide D (60) 
 
Palmerolide D (60) which was separated as a yellow solid, showed a [M + 1]+ peak at m/z 
625.6 in the low resonance ESIMS spectrum. Analysis by HREISMS (Figure 37) 
indicated a molecular formula of C36H53N2O7   (625.3864, calc 625.3853). 
 
The 13C NMR spectrum of (60) (Figure 38), taken with the DEPT 135 spectrum (Figure 
39) showed the presence of five methyls, eights methylenes, sixteen methines and seven 
quaternary carbon signals. 2D NMR investigation (Figure 40) of palmerolide D (60) 
indicated that it has a macrocyclic ring similar to that of palmerolide A (58). The 
quaternary carbon at δ 166.1 was assigned as an ester carbonyl (C-1) and was correlated 
to olefinic protons H-2 and H-3 by gHMBC (Figure 41). These two protons showed a 
coupling constant of 15.8 Hz indicating a trans double bond. 
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Figure 37. HRESIMS spectrum of palmerolide D (60) 
 
 
                Figure 38. 13C NMR spectrum of palmerolide D (60) (125 MHz, DMSO-d6) 
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               Figure 39. DEPT 135 spectrum of palmerolide D (60) (125 MHz, DMSO-d6) 
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Figure 40. Key gHMBC and gCOSY correlations of palmerolide D (60) 
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    Figure 41. gHMBC spectrum of palmerolide D (60) (500 MHz, DMSO-d6) 
 
Three methylenes were positioned between C-3 and hydroxymethine C-7 based on 
gHMBC correlation of H-4 with C-5, H-5 with C-3 and that of H-5 and H-7 with C-6. In 
addition, H-7 displayed HMBC resonance with C-8 and C-9, assigned as olefinic 
methines (Figure 43) indicating the presence of a double bond attached to C-7. The 
location of two hydroxymethines C-10 and C-11, adjacent to each other was established 
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by the COSY correlations (Figure 42) of H-10 and H-11 and further confirmed by HMBC 
correlations observed for H-11 with C-9 and C-10. In addition, H-11 showed HMBC 
correlations to the quaternary carbon at δ 156.4 which was assigned as an ester-type 
carbonyl carbon.   
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Figure 42. gCOSY spectrum of palmerolide D (60) (500 MHz, DMSO-d6) 
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Figure 43. gHMQC spectrum of palmerolide D (60) (500 MHz, DMSO-d6) 
 
The two methylenes C-12 and C-13, appeared overlapped with each other as a one carbon 
signal in the 13C NMR spectrum. Their linkage with hydroxymethine C-11 and olefinic 
methine C-14 was established by gHMBC correlations with H-10, H-11 and H-14. Based 
on the HMBC spectrum it was evident that the trans (J = 14.6 Hz) double bond (C-14 
and C-15) is conjugated to a trisubstituted double bond (C-16 and -17). The methylene C-
18 was positioned between the hydroxymethine C-19 and quaternary carbon C-17 based 
on gHMBC correlation of H-19, observed with C-18 and C-17. The 20 member 
macrocylce was completed by the observation of HMBC cross peak identified for H-19 
and C-1.  
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The doublet at δ 0.89 in the 1H NMR spectrum (Figure 44) was assigned as a methyl (H3-
26) and showed COSY coupling to H-20. In addition, this methyl group displayed 
gHMBC correlation to C-19, C-20 and C-21 confirming that it is located between C-19 
and C-21 attached to C-20. Meanwhile, H-21 representing an olefinic methine was 
correlated to another olefinic methine C-23 and C-25 by HMBC. However, HSQC 
evidence showed that the latter carbon belong to the vinylic methyl H3-27. Based on the 
coupling constant (J = 14.6 Hz) the realtionship between olefinic protons H-23 and H-24 
was identified as trans.  These correlations are consistent with a trisubstituted double 
bond conjugated with a trans olefin at C-23/C-24. The doublet δ 9.85 representing N-H, 
which was coupled to H-24 by gCOSY, displayed gHMBC resonance with C-23, C-24 
and C-1`.  
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Figure 44. 1H NMR spectrum of palmerolide D (60) (500 MHz, DMSO-d6) 
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Table 4.  NMR data of palmerolide D (60) (1H, 500 MHz, 13C, 125 MHz, DMSO-d6) 
              δ  13C    δ 1H (ppm, mult, J (Hz)) gHMBC 
1 
2 
3 
4 
 
5 
 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
27 
 
1′ 
2′ 
3′ 
4′ 
5′ 
6′  
7′  
8′ 
OCONH2 
24-NH 
7-OH 
  10-OH 
166.1 
121.2 
150.0 
33.0 
33.0 
30.1 
38.4 
38.4 
 73.2 
134.2 
129.6 
  69.9 
  75.8 
   30.0 
   30.0 
 133.6 
 127.0 
 128.4 
 132.2 
   43.9 
   43.9 
   74.5 
   37.3 
 130.7 
 133.3 
 117.5 
 122.7 
   16.8 
   17.7 
   13.3 
  
 163.5 
 120.3 
 153.2 
   40.8 
 143.6 
 112.6 
   22.7 
   24.8 
  157.4 
  
            
   5.76 (1H, d, 15.8) 
   6.71 (1H, ddd, 4, 11.5, 15.7) 
   2.11 (1H, m) 
   2.15 (1H, m) 
, 5,   1.98 (1H, m) 
   1.30 (1H, m) 
   1.48 (1H, m) 
   3.82 (1H, m) 
   5.53 (1H, m) 
   5.49 (1H, m) 
   4.15 (1H, m) 
   4.48 (1H, m) 
   1.94 (2H, m) 
   1.94 (2H, m) 
   5.41 (1H, ddd 10, 14.9) 
   6.04 (1H, dd, 11.6, 14) 
   5.59 (1H, d, 12) 
    
   2.16 (1H, m) 
   2.00 (1H, m) 
   4.84 (1H, m) 
   2.68 (1H, m) 
   5.14 (1H, d, 9.7) 
    
   5.86 (1H, d, 14.6) 
   6.85 (1H, dd, 10.4, 15 ) 
   1.60 (3H, s) 
   0.89 (3H, d, 6,7) 
   1.70 (3H, s) 
 
   
   5.81 (1H, s) 
 
    3.34 (2H, s) 
 
   4.72 (2H, d,  ) 
   1.61  (3H, s) 
   1.76 (3H, s)    
   6.45 (2H, br) 
   9.94 (1H, d, 10.3) 
   4.53 (1H, m) 
   5.19 (1H, m) 
 
1, 3, 4 
1, 2, 4 
2, 3, 5 
2, 3 
3, 4 
3, 6 
 
6, 8, 9 
7, 9, 10 
7, 8, 11, 12 
8. 9. 12 
9, 10, 13 OCONH2 
 
 
13, 15, 16 
14, 16 
14, 15, 25 
15, 16, 18, 25 
16, 19, 25 
16. 19 
17, 18, 20, 26 
18, 19, 21, 26 
19, 20, 26, 27 
21, 23, 27 
21, 24, 27 
22, 23, 1` 
15, 16, 18 
19, 20, 21 
 21, 23 
 
 
1′, 4′, 7′ 
 
2′, 3′, 5′, 7′ 
 
4′, 8′ 
4′, 5′, 6′ 
2′, 3′, 4′  
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From C-1′ onwards the side chain showed further modification by the elongation of the 
C-1′ - C-5′ moiety in palmerolide A (58). The quaternary carbon at δ 153.2 (C-3′) and 
methine at δ 120.3 assigned for C-2′  showed distinct gHMBC correlation with the proton 
signal at δ 3.34 a methylene, by the analysis of gHMQC and DEPT 135 spectra. This 
peak further displays gHMBC correlation to quaternary carbons at δ 143.6 (C-5′) and δ 
112.6 (C-6′), further defining an extended side chain. The carbon signal at δ 112.6 (C-6′) 
was found to be an exomethylene based on its HMQC correlation to the proton signal at δ 
4.72, which integrates for two hydrogens. Attachment of the vinylic methyl at δ 1.61 to 
C-5′  was based on gHMBC correlations with C-4′, C-5′  and C-6′.  
 
The above discussed correlations established the full planer structure of palmerolide D 
(Figure 45) with the exception of a single open valence, the ester type carbonyl attached 
to the macrolide at C-11. As it was previously observed in respect of palmerolides A and 
C,  to be accounted from molecular formula obtained by HREIMS, was an –NH2, 
suggesting the presence of a carbamate group. 
 
 
 
 
 
 
Figure 45. Planer structure of  palmerolide D (60) 
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2.2.6 Characterization of palmerolide E (61) 
Palmerolide E (61), isolated as a pale yellow solid, displayed a [M + Na]+ peak at m/z 
512 in the LRESIMS spectrum. Analysis by HRESIMS (Figure 46) afforded the 
molecular formula of C27H39NO7Na (m/z 512.2634, calc 512.2624). 
 
 
Figure 46. Palmerolide E (61) HRESIMS spectrum 
 
2D NMR study (Figure 47) of palmerolide E (61) indicated that it has a 20 member 
macrocyclic ring similar to that of palmerolide A (58). However, the side chain attached 
to C-19 was shorter with only one olefinic group. The sharp singlet at δ 9.41 in the 1H 
NMR spectrum (Figure 48) displayed gHMQC correlation (Figure 49) with a quaternary 
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carbon resonating at δ 196.3 suggesting the presence of an aldehyde. The aldehyde was 
further correlated to olefins C-21 and C-22 in the gHMBC spectrum (Figure 50), 
confirming the presence of an aldehyde carbonyl conjugated to the C-21/C-22 double 
bond at the terminus of the side chain. 
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Figure 47. Key gHMBC and gCOSY correlations of palmerolide E (61) 
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Figure 48. 1H NMR spectrum of palmerolide E (61) (500 MHz, DMSO-d6) 
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Figure 49. gHMQC spectrum of palmerolide E (61) (500 MHz, DMSO-d6) 
 
The quaternary carbon at δ 166.1 was assigned as an ester carbonyl (C-1), which 
correlated to olefinic protons H-2 and H-3 in the gHMBC. These two protons showed a 
coupling constant of 15.7 Hz indicating a trans double bond. Three methylenes were 
positioned between C-3 and hydroxymethine C-7, based on gHMBC correlations of H-2 
with C-4, H-5 with C-6 and H-8 with C-6. This was further supported by the observation 
of gCOSY correlations (Figure 51) between H-4a and H-5b, H-5a and H-6b and H-7 with 
H-6a and H-6b. In addition, H-7 displayed a HMBC correlation to olefinic methines C-8 
and C-9 (Table 5). Location of two hydroxymethines, C-10 and C-11 adjacent to each 
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other was established by the COSY correlations of H-9, H-10 and H-11 and further 
confirmed by HMBC correlation observed for H-11 with C-9 and C-10. In addition, H-11 
showed HMBC correlation to the quaternary carbon at δ 156.4 which was assigned as the 
carbonyl carbon of the carbamate group. 
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           Figure 50. gHMBC spectrum of palmerolide E (61) (500 MHz, DMSO-d6) 
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Table 5.  NMR data of palmerolide E (61) (1H, 500 MHz, 13C, 125 MHz, DMSO-d6) 
   
δ  13C 
  
 δ 1H (ppm, mult, J (Hz) 
 
gHMBC 
1 
2 
3 
4 
 
5 
 
6 
 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
OCONH2 
      
166.1 
121.2 
150.8 
  33.4 
  33.4 
  25.9 
  25.9 
  38.5 
  38.5 
  73.3 
134.3 
129.6 
  70.1 
  76.1 
  29.8 
  29.8 
132.9 
127.3 
128.7 
133.0 
  43.9 
  43.9 
  73.0 
  38.1 
155.8 
139.6 
196.3 
  17.0 
  16.5 
    9.9 
 
5.78  (1H, d, 15.7) 
6.74  (1H,  ddd, 4.3, 11.5, 15.7 ) 
2.11   (1H, m) 
2.14   (1H, m) 
1.30   (1H, m) 
1.05  (1H, m) 
1.49  (1H, m) 
1.29  (1H, m) 
3.81  (1H, m) 
5.53  (1H, dd, 1.4, 8) 
5.49  (1H, d, 2.9) 
4.12  (1H, m) 
4.47  (1H, ddd, 1.5, 5.1,10.7) 
1.05  (1H, m) 
1.95  (1H, m) 
5.42 (1H, m) 
6.05 (1H, dd, 10.8, 14.8) 
5.61 (1H, d, 10.6) 
 
2.09 (1H, m) 
2.16 (1H, m) 
5.02 (1H, ddd, 2.1, 7.5, 10.) 
2.64 (1H, qdd, 6.8, 7.1, 9.3) 
6.55 (1H, dd, 1.5, 10.2) 
 
9.41 (1H, s) 
1.63 (3H, s) 
1.01 (3H, d, 6.8) 
1.67 (3H, d, 1.2) 
6.48 (2H, br) 
 
 
1, 3, 4 
1, 2,  
2, 3,  
2, 3,  
6 
 
 
 
8, 9 
6, 9, 10 
8, 10 
8, 9, 11, 12/13 
9, 10, 12/13, CONH2 
10, 13 
12, 14, 15 
12/13, 16, 
13, 14, 16 
14, 15, 18, 24 
15, 16, 18, 24 
16, 17, 19, 24 
16, 17, 19, 24 
1, 17, 20, 23, 25,  
19, 21, 22, 25 
19,  23, 25, 26 
 
21, 22, 26 
16, 17, 18 
19, 20, 21 
21, 22, 23 
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Figure 51. gCOSY spectrum of palmerolide E (61) (500 MHz, DMSO-d6) 
 
The two methylenes, C-12 and C-13, appeared overlapped with each other as a one 
carbon signal in the 13C NMR spectrum. Their linkage with hydroxymethine C-11 and 
olefinic methine C-14 was established by HMBC correlations of H-10, H-11 and H-14. 
Based on the HMBC relations of H-14, H-15 and H3-25, it was evident that the trans (J = 
14.8 Hz) double bond (C-14 and C-15) is conjugated to a trisubstituted double bond (C-
16 and 17). Methylene C-18 was positioned between the hydroxymethine C-19 and 
quaternary carbon (C-17) based on gHMBC relationships of H-19, observed with C-18 
and C-17. The 20 member macrocycle was completed by the observation of the HMBC 
cross peak identified for H-19 and C-1. 
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2.2.7 Characterization of palmerolide B (62). 
 
Palmerolide B (62), was isolated as a colorless, sticky solid. Its 1H NMR spectrum 
(Figure 52) showed signals characteristic of palmerolides despite that it was isolated form 
a more polar fraction than the fractions that contained other palmerolides. Further, 
palmerolide B showed a distinctly low Rf value when compared with other palmerolides 
in thin layer chromatography in normal phase, affirming its higher polarity. 
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Figure 52. 1H NMR spectrum of palmerolide B (62) (500 MHz, CD3OD) 
The 13C NMR spectrum (Figure 53) showed that compound 62 had 33 carbon as observed 
in palmerolide A (58). Further analysis of DEPT 135 (Figure 54) and gHSQC (Figure 55) 
spectra suggested that it is composed of five methyls, six methylenes, sixteen methines 
and six quaternary carbon signals. Out of the six methines, four were indicative of 
hydroxymethines. All these observations were also consistent with the structural features 
of palmerolide A. 
 79
 
Figure 53. 13C NMR spectrum of palmerolide B (62) (125 MHz, CD3OD) 
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Figure 54. DEPT 135 spectrum of palmerolide B (62) (125 MHz, CD3OD) 
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                   Figure 55. gHSQC spectrum of palmerolide B (62)  (500 MHz, CD3OD)                                
The interpretation of gHMBC (Figure 56) and gCOSY (Figures 57, 58) data of 
palmerolide B (62) revealed that it has a 20 member macrocyclic ring with a significant 
rearrangement of the structural features in C-3 through C-12. Nevertheless, structure of 
the side chain was identified as identical to that of palmerolide A (58). A quaternary 
carbon δ 168.2 which was assigned as an ester carbonyl (C-1), showed gHMBC 
correlation to H-3, which in turn displayed HMBC correlation to two adjacent 
methylenes, C-4 and C-5. The linkage between the nest two methylenes, C-5 and C-6, 
was established by observation of COSY correlations between them. These spectral 
evidence was consistent with an ester carbonyl with a conjugated trans olefin (J = 15.3 
Hz) attached to these methylenes.  
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Figure 56. gHMBC spectrum of palmerolide B (62)  (500 MHz, CD3OD)    
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                Figure 57. Key gCOSY and gHMBC correlations of palmerolide B (62) 
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Figure 58. gCOSY spectrum of palmerolide B (62)  (500 MHz, CD3OD) 
 
The hydroxymethine δ 77.4 can be positioned at C-7, between the methylene C-5 and 
another hydroxymethine δ 72.1 (C-8) based on gHMBC correlations of H-7 with C-6 and 
the COSY correlations of H-7 with H-6a and H-8.  The presence of another olefin at C-
9/C-10 attached to the latter hydroxymethine was supported by gHMBC correlations of 
H-8 with C-9 and that of H-9 with C-8. This assignment was consistent with the 
observation of COSY correaltions between H-7 and H-8 and H-8 and H-9. In addition, H-
7 displayed further HMBC correlations with the quaternary carbon δ 159.8 characteristic 
of the carbonyl attached to carbamate group present in all palmerolides. 
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Table 6.  NMR data of palmerolide B (62) (1H, 500 MHz, 13C, 125 MHz, CD3OD) 
 δ 13C δ 1H (ppm, mult, J (Hz) gHMBC 
 
1 
2 
3 
4 
 
5 
 
6 
 
7 
8 
9 
10 
11 
12 
 
13 
 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
27 
1′ 
2′ 
3′ 
4′ 
5′ 
OCONH2 
 
 
168.2 
122.3 
150.7 
34.0 
34.0 
26.1 
26.1 
31.8 
31.8 
77.4 
72.1 
133.4 
131.0 
81.6 
36.6 
36.6 
30.9 
30.9 
133.3 
128.0 
129.8 
132.8 
45.2 
45.2 
76.6 
38.7 
132.2 
134.5 
119.6 
122.7 
16.7 
17.7 
13.2 
166.7 
118.9 
154.9 
27.7 
20.4 
159.8 
 
 
 
5.70 (1H, d, 15) 
6.74 (1H, ddd, 4.0, 11, 15) 
2.14 (2H, m) 
2.10 (1H, m) 
1.34 (1H, m) 
1.14 (1H, m) 
1.08 (1H, m) 
1.55 (1H, m) 
4.57 (1H, m) 
4.20 (1H, m) 
5.72 (1H, m) 
5.64 (1H, m) 
4.64 (1H, m) 
1.53 (1H, m) 
1.79 (2H, m) 
1.21 (1H, m) 
1.96 (1H, m) 
5.38 (1H, ddd, 14.5, 10.5, 4)  
6.01 (1H, dd, 10.5, 14.5) 
5.57 (1H, d, 10.9) 
 
1.99 (1H, m) 
2.15 (1H 
4.82 (1H, m) 
2.68(1H, qdd, 5, 10, 10) 
5.08 (1H, d, 10) 
 
5.85 (1H, d, 15) 
6.86 (1H, d, 14.5) 
1.58 (3H, s) 
0.88 (3H, d, 6.5) 
1.71 (3H, s) 
 
5.64 (1H, br s) 
 
1.81 (3H, s) 
2.09 (3H, s) 
 
 
 
1, 4 
1, 4, 5 
 
 
 
 
 
 
6, 8, OCONH2 
9 
8, 10 
8, 11 
 
11 
11,  
 
 
15 
14, 17 
15, 18 
 
20 
 
1, 20 
 
19, 20, 22, 25 
 
21, 22, 24, 25 
22, 23, 1′ 
16, 17, 18 
19, 20, 21 
21, 22, 23 
 
1′, 3′, 4′, 5′ 
1′, 2′, 3′, 5′ 
1′, 2′, 3′, 4′ 
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Another hydroxymethine (C-11) could be placed between the former olefin and another 
methylene (C-12) based on HMBC correlations of H-10, H-12a and H-12b with C-11. 
The connectivity between the methylenes C-12 and C-13 was confirmed by gCOSY data. 
The latter methine protons displayed COSY coupling with proton signal δ 5.38 indicating 
the presence of two methylenes between hydroxymethine C-11 and olefinic methine C-
14. The stereochemistry of this olefin was determined as trans based on the coupling 
constant between H-14 and H-15. Considering the gHMBC correlations of olefinic 
protons H-15 to C-14 and the quaternary carbon C-17 and that of vinylic methyl at δ 1.58 
(H3-25) to C-18, C-17 and C-15 a trisubstituted double bond was positioned at C-17/C-16 
conjugated to the former olefin. 
 
The hydroxymethine at δ 76.1 was assigned to C-19, based on HMBC correlations 
between H-18a and H-18b and COSY correlations of the latter protons to δ 4.82, 
representing H-19. The 20 macrolide was completed by the observations of gHMBC 
correlation between H-19 and C-1.  
 
The side chain of palmerolide B showed features similar to that of palmerolide A. The 
doublet at δ 0.88 in the 1H NMR spectrum assigned for the methyl (H3-26) showed 
COSY correlation to H-20. In addition this methyl group displayed gHMBC correlation 
to C-19, C-20 and C-21 confirming that its located between C-19 and C-21, and attached 
to C-20. Meanwhile, H-21, an olefinic methine, was correlated to olefinic methines C-23 
and C-25 in the gHMBC spectrum. However, gHSQC evidence showed that the latter 
carbon belong to the vinylic methyl H3-27. Based on the coupling constant (J = 15 Hz), 
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the stereochemistry of olefinic protons H-23 and H-24 was identified as trans.  These 
correlations are consistent with a trisubstituted double bond conjugated with a trans 
olefin at C-23/C-24. H-24 displayed gHMBC correlation to C-23, C-24 and C-1′assigned 
for an ester carbonyl. The HMBC correlation of broad singlet H-2′ with C-1′ and the 
unusual 4J HMBC coupling of two vinyl methyl groups C-4′ and C-5′ as observed in 
palmerolide A suggested an isopentenoyl connected to C-24 via an ester linkage.  
 
When the compound 62 was analyzed by LRESIMS it displayed a major peak at m/z = 
663.2 indicative of [M - H]+. However, in LRESIMS it afforded a major peak at m/z = 
567.4. This was explained as due to [M + H - H2SO4]+, suggesting the presence of a 
sulphate group attached to one of the secondary hydroxyl groups of palmerolide B. These 
observations were further confirmed by performing HRESIMS experiments on both 
above peaks using respective modes of ionization. The HREIMS negative mode (Figure 
59) gave a molecular mass of 663.2957 consistent with a formula of C33H48N2O10S. In 
addition this data indicates the presence of two nitrogens confirming the presence of a 
carbamate attached to C-7 and an amide between C-24 and C-1′ as was observed in other 
palmerolides. 
 
The site of attachment of the sulphate group was assigned as C-11 by the observation of 
relatively high proton and carbon chemical shifts for H-11 and C-11 as compared to 
corresponding chemicals shifts in other palmerolides. In addition, generation of a stable 
mass peak at m/z = 567.3 in ESIMS can be explained as due to formation of a double 
bond between C-11 and C-12, after the loss of a sulphuric acid (Figure 60). 
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Figure 59. HRESIMS spectrum of palmerolide B (62) 
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Figure 60. Fragmentation of palmerolide B (62) in ESIMS (positive mode) 
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2.2.8 Characterization of palmerolide H (63) 
 
 
Further purification of the HPLC fractions containing palmerolide B (62) afforded 
another compound with 1H NMR signals (Figure 61) indicative of palmerolides, which 
was identified as palmerolide H (63), after a comprehensive structure elucidation with 2D 
NMR spectroscopy and mass spectrometry. 
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Figure 61. 1H NMR spectrum of palmerolide H (63) (500 MHz, CD3OD) 
 
The 13C NMR spectrum (125 MHz) (Figure 62) showed that palmerolide H has 36 carbon 
signals. Further analysis of gHSQC spectra (500 MHz) (Figure 63) accounted for five 
methyls, eight methylenes, sixteen methines and six quaternary carbon signals. Out of 
these methines, four represented hydroxymethines.  
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Figure 62. 13C NMR spectrum of palmerolide H (63) (125 MHz, CD3OD) 
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Figure 63. gHSQC spectrum of palmerolide H (63) (500 MHz, CD3OD) 
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Extensive study of the gHMBC (Figure 64) and gCOSY spectra (Figure 65) of 
palmerolide H (63) indicated that it has a 20 member macrocyclic ring similar to that of 
palmerolide B, in planer structure (Figure 66). The quaternary carbon at δ 168.2 could be 
assigned to an ester carbonyl (C-1) based on analogy with other palmerolides, and 
showed HMBC correlation to H-3, which in turn displayed gHMBC correlation with two 
adjacent methylenes, C-4 and C-5. The connectivity between two methylenes, C-5 and C-
6, was established by gCOSY correlations. These spectral data were consistent with an 
ester carbonyl bearing a conjugated trans olefin (J = 15.5 Hz) followed by C-4 and C-5. 
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Figure 64. gHMBC Spectrum of palmerolide H (63) (500 MHz,CD3OD) 
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Figure 65. gCOSY spectrum of palmerolide H (63) (500 MHz, CD3OD). 
 
O
O
O
H
N
O
O
S
O
O
1 2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
27 26 25
1'
2'
3'
4'
5'
6'
7'
8'
gCOSY
gHMBC O-
O
NH2
HO
 
 
Figure 66. Key gHMBC and gCOSY correlations of palmerolide H (63). 
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The hydroxymethine at δ 77.5 can be positioned between the methine at C-6 and another 
hydroxymethine δ 72.2 (C-8) based on the gHMBC correlation of H-8 to C-6 and C-7. 
This assignment was confirmed by respective gCOSY correlations. H-7 was correlated to 
an olefinic methine δ 133.4 (C-9) by HMBC suggesting the presence of an olefin at C-
9/C-10, which was further supported by gCOSY correlations between H-8 and H-9. H-7 
displayed further gHMBC correlation with the quaternary carbon at δ 159.9 indicative of 
carbonyl that was characteristic of the carbamate group present in other palmerolides. 
 
Another hydroxymethine (C-11) could be placed between the former olefin and another 
methylene δ 35.5 (C-12) based on gHMBC correlation of H-10, H-12a and H-12b with 
C-11. The connectivity between the methylenes C-12 and C-13 was confirmed by 
gCOSY data. The latter methine protons displayed COSY correlation with a proton signal 
at δ 5.38 indicating the presence of two methyls between hydroxymethine C-11 and 
olefinic methine C-14. The stereochemistry of this olefin was determined to be trans 
based on the coupling constant between H-14 and H-15.  Considering the gHMBC 
correlation of olefinic proton H-15 with C-14 and the quaternary carbon C-17 and that of 
vinylic methyl at δ 1.58 (H3-25) to C-18, C-17 and C-15, a trisubstituted double bond was 
positioned at C-17/C-16, conjugated to the former olefin. The hydroxymethine δ 76.2 was 
assigned to C-19 based on HMBC correlations between H-18a and H-18b and COSY 
correlations of the latter protons with and that of δ 4.82, H-19. The 20 membered 
macrolide was completed by the observation of gHMBC correlation between H-19 and 
C-1 (Table 7).  
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Table 7.   NMR data of palmerolide H (63) (1H, 500 MHz, 13C, 125 MHz, CD3OD) 
 
               δ  13C     δ 1H (ppm, mult, J (Hz) gHMBC 
1 
2 
3 
4 
 
5 
 
6 
 
7 
8 
9 
10 
11 
12 
 
13 
 
14 
15 
16 
17 
18 
 
19 
20 
21 
22 
23 
24 
25 
26 
27 
1′ 
2′ 
3′ 
4′ 
5′ 
6′ 
7′ 
8′ 
OCONH2 
 
168.2 
122.3 
150.7 
33.9 
33.9 
26.1 
26.1 
31.8 
31.8 
77.5 
72.2 
132.3 
131.1 
81.7 
36.6 
36.6 
30.8 
30.8  
133.4 
128.1 
129.7 
133.0 
45.2 
45.2 
76.2 
38.7 
132.3 
134.5 
119.7 
122.8 
13.2 
17.7 
16.6 
166.0 
120.5 
155.7 
42.1 
144.6 
112.6 
22.4 
24.8 
159.9 
            
   5.70 (1H, d, 15.5) 
   6.75 (1H, ddd, 4, 11.5, 15.7) 
   2.10 (1H, m) 
   2.14 (1H, m) 
   1.18 (1H, m) 
   1.32 (1H, m) 
   1.10 (1H, m) 
   1.56 (1H, m) 
   4.58 (1H, m) 
   4.20 (1H, m) 
   5.74 (1H, m) 
   5.63 (1H, m) 
   4.66 (1H, m) 
   1.55 (1H, m) 
   1.80 (1H, m) 
   1.21 (1H, m) 
   1.96 (1H, m) 
   5.38 (1H, m) 
   6.02 (1H, dd, 10, 14.5) 
   5.57 (1H, d, 11.5) 
    
   2.00 (1H, m) 
   2.15 (1H, m) 
   4.84 (1H, m) 
   2.68 (1H, m) 
   5.09 (1H, d, 10) 
    
   5.87(1H, d, 14.6) 
   6.87 (1H, d, 14.5) 
   1.59 (3H, s) 
   0.89 (3H, d, 6, 7) 
   1.72 (3H, s) 
   
   5.76 (1H, s) 
 
   3.44 (2H, s) 
 
   4.69 (2H, s) 
   1.61  (3H, s) 
   1.76 (3H, s)   
    
 
1, 3, 4 
1, 2, 4 
2, 3, 5 
2, 3 
3, 4 
3, 6 
 
6, 8, 9 
7, 9, 10 
7, 8, 11, 12 
8. 9. 12 
9, 10, 13 OCONH2 
 
 
13, 15, 16 
14, 16 
14, 15, 25 
15, 16, 18, 25 
16, 19, 25 
16. 19 
17, 18, 20, 26 
18, 19, 21, 26 
19, 20, 26, 27 
21, 23, 27 
21, 24, 27 
22, 23, 1’ 
15, 16, 18 
22, 24.25 
22, 23, C-1` 
16, 18 
19, 20, 21 
22, 23 
 
 
1′, 4′, 8′ 
 
2′, 3′, 5′, 7′  
 
4′, 8′ 
4′, 5′, 6′ 
2′, 3′, 4 
 94
The side chain of palmerolide H (63) showed features similar to that of palmerolide D 
(60), The doublet at δ 0.89 in the proton NMR spectrum assigned for the methyl (H3-26), 
showed COSY correlation to H-20. In addition, this methyl group displayed gHMBC 
correlations with C-19, C-20 and C-21 confirming that it is positioned between C-19 and 
C-21, and attached to C-20. Meanwhile, H-21, an olefinic methine, was correlated to 
another olefinic methine (C-23) and C-25 by observation of a cross peak in the gHMBC 
spectrum. However, gHSQC data showed that the latter carbon belong to the vinylic 
methyl H3-27. Considering the coupling constant (J = 14.5 Hz), the orientation of olefinic 
protons H-23 and H-24 was assigned as trans.  These correlations are consistent with a 
trisubstituted double bond conjugated with a trans olefin at C-23/C-24.  
 
The doublet at δ 6.87 (H-24) displayed gHMBC correlation to the quaternary carbon at δ 
166.0 (C-1′). The singlet at δ 5.83 (H-2′) was correlated to C-1′, the methyl at δ 23.8 (C-
8′) and a methylene at δ 42.1 (C-4′) in the HMBC spectrum. The sharp singlet observed 
at δ 3.54, (H-4′) in turn showed HMBC correlation with C-3′ and C-8′ constituting a 
trisubstituted double bond between the above carbonyl and latter methylene.  
 
The singlet at δ 3.54 showed further gHMBC correlations with the vinylic methyl C-7′, 
the quaternary carbon at δ 144.6 (C-5′) and an exomethylene carbon at δ 112.6 (C-6′), 
demonstrating the further elongation of the side chain, giving rise to another disubstituted 
double bond which defines the terminus in the form of an exomethylene at C-6′. 
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In the LRESIMS spectrum, the compound (63) displayed a major peak at m/z = 703.3 
indicative of [M - H]+. However, the LRESIMS positive mode spectrum demonstrated a 
major peak at m/z = 607.3, which was  explained as due to [M + H - H2SO4]+ suggesting 
the presence of a sulphate group attached to one of the secondary hydroxyl groups of 
palmerolide H (63). These observations were further confirmed by performing HRESIMS 
analysis (Figure 67). 
 
 
Figure 67. HRESIMS spectrum of palmerolide H (63) 
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The HRESIMS spectrum gave a molecular mass of 703.3258 consistent with a formula of 
C36H52N2O10S (Figure 67). In addition, this mass spectral data indicated the presence of 
two nitrogens affirming the presence of a carbamate attached to C-7 and an amide 
between C-24 and C-1′ as was observed in other palmerolides. 
 
2.2.9  Bioactivity of palmerolides 
Unique structural features of palmerolide A (58), and the attractive biological activity 
reported from macrolides with similar appendages, warranted an investigation of its 
biological activity. Therefore, palmerolide A was tested for anticancer properties at the 
National Cancer Institute.66 The very promising anticancer activity displayed by 
palmerolide A prompted the bioactivity investigation of plamerolide C (59) and D (60) as 
well. 
 
2.2.9.1 In vitro cytotoxicity of palmerolide A (58) 
Palmerolide A displayed reproducible in vitro cytotoxicity towards several melanoma cell 
lines (Appendix A), UACC-62 (LC50 0.018 µM), MI14 (LC50 0.076 µM), SK-MEL-5 
(LC50 6.8 µM) and LOX IMVI (LC50 9.8 µM) in the NCI 60 human cancer cell line 
panel.  Besides melanoma, it showed cytotoxicity against one colon cancer cell line, 
(HCC-2998, LC50 6.5 µM) and one renal cancer cell line (RFX 393, LC50 6.5 µM). One 
of the main features of its activity profile was that it was largely devoid of other 
cytotoxicity (LC50>10 µM) making it a promising anticancer drug candidate. 
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Apart from that, palmerolide A (58) showed potent cytostatic activity against, leukemia 
(RPMI-8226), colon cancer (HT-116), melanoma cell lines (LOXIMVI, SKMEL-5, 
UACC-62), ovarian cancer (OVCAR-3) and breast cancel (MDA-MB-231A/ATCC). 
 
 
2.2.9.2 In vivo cytotoxicity of palmerolide A (58) 
 
Palmerolide A was subjected to the NCI hollow fiber assay,67 a standard bioassay used by 
National Cancer Institute to determine in vivo cytotoxicity of anticancer agents. The 
hollow fiber assay has established as a very efficient bioassay that can provide 
quantitative information of drug efficacy with minimum expenditures of time and 
materials. Therefore, it is currently being utilized as the initial in vivo test for agents 
found to have reproducible activity in the initial in vitro anticancer drug screen. 
The hollow fiber assay involves standard panel of 12 tumor cell lines. The cancer cell 
suspensions are flushed into polyvinylidene fluoride hollow fibers that are heat-sealed at 
2 cm intervals. The samples generated from these seals are placed into tissue culture 
medium and incubated prior to implantation. Each mouse receives three intraperitoneal 
(Ip) implants (1 of each tumor line) and 3 subcutaneous (Sc) implants (1 of each tumor 
line). On the day of implantation, samples of each tumor cell line preparation are 
quantitated for viable cell mass so that the time zero cell mass is known. Mice are treated 
with experimental agents starting on day 3 or 4 following fiber implantation and 
continuing daily for 4 days. Each agent is administered by intraperitoneal (Ip) injection at 
2 dose levels. The fibers are collected from the mice on the day following the fourth 
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compound treatment and the viable cell mass in determined again to analyze the efficacy 
of the drug.67 
The percent net growth for each cell line in each treatment group is calculated and 
compared to the percent net growth in the controls. A 50% or greater reduction in percent 
net growth in the treated samples compared to the control samples is considered a 
positive result. Each positive result is given a score of 2 and all of the scores are totaled 
for a given compound. The maximum possible score for an agent is 96 (12 cell lines X 2 
sites X 2 dose levels X 2 [score]). A compound is advanced to the xenograft assay, if it 
has a combined Ip + Sc score of 20 or greater, a Sc score of 8 or greater, or produces cell 
kill of any cell line at either dose level evaluated.67 
Palmerolide A showed a score of 12 for intraperitoneal implants and a score of 16 of 
subcutaneous implants giving a total score of 28 which was reproducible, indicating its 
potent in vivo cytotoxicity. Therefore it was advanced to the xenograft assay. 
 
2.2.9.3   In vitro Cytotoxicity of palmerolide C (59) 
Palmerolide C showed in vitro cytotoxicity, and cytostatic activity against leukemia 
(RPMI-8226, LC50 7.33 µM), colon cancer (HCC-2998, LC50 7.10 µM and HCT-15, LC50 
9.87 µM), CNS cancer (SF-295, LC50 4.02 µM), melanoma (M-14, LC50 1.69 µM), 
ovarian cancer (OVCAR-3, LC50 7.89 µM) and beast cancer (MDM-MB-435, LC50 7.75 
µM). 
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2.2.9.4   In vitro cytotoxicity of palmerolide E (61) 
Palmerolide E showed in vitro cytotoxicity against non small cell lung cancer cell line 
(HOP-62, LC50 9.58 µM), colon cancer (HCC-2998, LC50 7.60 µM and HCT-116 LC50 
7.16 µM), CNS cancer (SF-295, LC50 7.35 µM) and melanoma cell line (M-14, LC50 0.56 
µM). It also showed cytostatic activity against melanoma. 
 
2.2.9.5 Mechanism of action of palmerolides 
By comparison with the activity profiles of the other known anticancer agents, the mode 
of action of a novel compound can often be predicted.68 It was found that the activity 
profiles of palmerolides are similar to a series of compounds isolated from several other 
organisms that have been identified as vacuolar ATPase (V-ATPase) inhibitors.  
 
2.2.9.6 V-ATPase 
The vacuolar ATPase comprises a class of enzymes that is widely distributed throughout 
eukaryotes. These enzymes occur in many tissues of multicellular organisms. The major 
function of V-ATPase is to pump protons from one side of a membrane to the other in 
order to regulate the pH levels. Hence vacuolar-ATPase performs this function in 
membranes of vacuoles.69 
 
It has been found that V-ATPases are involved in the onset of diseases such as 
osteoporosis, diabetes, pancreatitis and melanoma. In bones, resorption and remodeling is 
conducted by osteocasts, specialized cells which possess a V-ATPase on their plasma 
membrane. Release of V-ATPase acidifies the bone surface thus dissolving the bone 
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matrix and activating osteoclast secreted acid hydrolases. Defects in osteoclast V-ATPase 
function have been found to be related to the defects of this enzyme. Involvement of V-
ATPase has been proposed in metastatic invasion through degradation of the extra 
cellular matrix by tumor cells as well. Besides, it has been implicated in the development 
of melanoma as it was found that organellar pH contributes to the lack of pigmentation in 
tyrosinase–positive amelanotic melanoma cells. Therefore, V-ATPase inhibitors have 
emerged as a very attractive target for drug development against osteoporosis and 
melanoma.69 
 
 
2.2.9.7 Known V-ATPase inhibitors 
Salicylihalamides A (64) and B (65), two macrolides isolated from the marine sponge 
Haliciona sp. showed very selective cytotoxicity against melanoma in the NCI 60 cell 
line screen.70  However, their activity profile did not match that of any standard clinical 
agent although a correlation was observed with the patterns of two known V-ATPase 
inhibitors, concanamycin (66)71 and bafilomycin A (67),72 which were considered 
unsuitable as anticancer drugs due to high cytotoxicity.  
 
Lobatamide A (68),73,74 belongs to a group of structurally related macrocyclic enamids, 
isolated from the ascidian Aplidium lobatom and showed a cell growth inhibition profile 
similar that of salicylihalamides. Later, apicularin A (69),75,76 oximidine I (70) and 
oximidine II (71),77 which resemble the structure of salicylihalamides more closely, were 
isolated from marine microbes and also demonstrated similar activity.69      
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Based on the strong correlations observed between the patterns of cytotoxicity of 
salicylihalamide A (64) and bafilomycin derivatives, the V-ATPase inhibition activity of 
salicylihalamides and lobatamides have been tested and they have shown excellent 
inhibitory activity.69 These observations have simulated interest in these compounds and 
the functional role of the enamide group, a feature common to most of these compounds  
in V-ATPase inhibition.68 However, low yields of above compounds from their natural 
sources have limited the progress of further research. 
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2.2.9.8 Palmerolides as V-ATPase inhibitor. 
Palmerolide A (58) showed inhibition of V-ATPase at 2 nM concentration (Table 8 ). 
Further, it was found out that it binds with V-ATPase enzyme at nearly 1:1 molar ratio. 
Palmerolide C, which has a different ring structure from palmerolide A, displayed lesser 
activity against V-ATPase at a concentration of 150 nM. Both palmerolides A and C 
possess an enamide as a part of its side chain and above results are consistent with other 
macrolides having similar features.68,69 Nevertheless, palmerolide E which does not have 
an enamide in its structure has only week V-ATPase activity (10 µM) despite 
submicromolar cytotoxicity against melanoma. These observations suggest the presence 
of mechanism of action independent of the enamide. 
 
Table 8.. Comparison of cytotoxicity and V-ATPase activity 
 Palmerolide A Palmerolide C Palmerolide E 
V-ATPase activity 2 nM       150 nM          10 µM 
Activity against  
Melanoma 
18 nM UACC-62 1.7 µM MI-14 560  nM MI-14 
 
 
2.3 Summary 
 
Antarctic tunicate Synoicum adareanum elaborates a new series of polyketide macrolides, 
palmerolides. They are composed of a 20 member macrocycle and a side chain. 
Characteristic features of the palmerolides include a carbamate group and two secondary 
hydroxyls attached to the macrolide ring. However, within the series, they show 
variations in the arrangement of the functional group attached to the ring and side chain. 
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The structural novelty of palmerolides prompted their bioactivity investigation in NCI 60 
cancer cell line panel. The principal member of the series, palmerolide A, showed very 
potent and selective in vitro cytotoxicity against several melanoma at nanomolar 
concentrations. In addition, it showed potent cytostatic activity against a number of other 
cell lines. The in vivo cytotoxicity of palmerolide A was determined by the hollow fiber 
assay. Palmerolides have been investigated as V-ATPase inhibitors. 
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Chapter 3 CHEMICAL INVESTIGATION OF THE ANTARCTIC 
                   NUDIBRANCH AUSTRODORIS KERGUELENENSIS 
 
3.1 Introduction 
 
3.1.1 Nudibranchs 
 
Nudibranchs are a group of marine molluscs that do not have external shells. They are 
soft bodied, very often brightly colored and do not have external armaments. The name 
nudibranchs literaly means “naked gills”, as their gills are prominently displayed in the 
dorsal side in many species. In general, the nudibranchs are carnivores.5 They feed on 
variety of other animals, sponges, anemones, tunicates, corals, bryozoans, barnacles and 
sometimes other nudibranchs.5, 78 
 
Their high visibility, low mobility and lack of physical defense make the nudibranchs 
extremely vulnerable to predators. Nevertheless, reports of predation are virtually non- 
existent as they appear to employ chemical defense.79 Most nudibranchs obtain their 
defensive chemicals from their diet, whereas there is a small group of nudibranchs that 
can synthesize them via de novo biosynthesis.5 
 
The secondary metabolite composition of the former category of nudibranchs most often 
portrays their choice of food. In addition, their chemistry varies according to the 
location.78 Many such sequestered chemicals obtained from other species are toxic and 
often stored in specialized spherical dorsal glands called mantle dermal formations, a part 
of the animal that is most susceptible to predation. This further facilitates the usage of a 
bioactive chemical as a defense weapon with minimal toxic side effects.5, 78 
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It is understood that nudibranchs can selectively concentrate certain allochemicals from 
their diet or modify the chemistry of the ingested compounds.80 For instance, the 
Mediterranean nudibranch Hypselodoris orsini has shown the remarkable ability to 
convert dietary scalaradial (72) into deoxoscalarin (73) which is concentrated in viscera, 
and to 6-keto-deoxoscalarin (74), located in mantle dermal formations.5, 81  
      H
H
CHO
CHO
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H
H
OAc
H
X
O
HO
 
 Scalaradial (72)                                          Deoxoscalarin (73) X = H2                  
                                                                 6-keto-deoxoscalarin (74) X = O 
 
 
It has been reported that nudibranch Glossodoris pallida sequesters scalaradial (72), a 
sesterterpene identified as a sponge metabolite, and converts it into deoxoscalarin (73). 
However, it was also noted that it does not sequester scalarin (75), another sesterterpene 
which is the major sponge metabolite.80 On the other hand, the concentration of 
deoxyscalarin was found to be significantly higher than the corresponding sponge 
metabolites. Deoxoscalarin is found in the reproductive system, eggs, and mantle border 
of G. pallida. Although removal of the nudibranch mantle increase susceptibility to 
predation by reef fish, the specific location of the diet-derived compounds was not 
significant.   It was concluded that the localization of compounds in the mantle tissue, 
may prevent autotoxicity.  However, the egg masses of G. pallida, were found to be low 
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in the major sesterterpenoid secondary metabolites and are reported to be eaten by a 
variety of fish.5, 80  
 
H
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O
 
Scalarin   (75) 
The nudibranchs have also adapted to feed on soft corals, ascidians, bryozoans, or on 
other molluscs.5, 78  The nudibranch Ovula ovum, for example, was reported to sequester 
the toxic terpene sarcophytoxide (76) from soft coral Sarcophyton sp. and transform it 
into the less toxic derivative 77. 82  
 
                O
O
             O  
         Sarcophytoxide (76)                                           77 
 
A distinct feature of nudibranchs that have the ability to biosynthesize their own defense 
chemicals was their preference to an invertebrate diet lacking secondary metabolites.  In 
addition, their chemistry is independent of the location that they are collected.  
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Feeding experiments performed using 14C- labeled precursors illustrated the ability of the 
some nudibranchs to undertake  de novo biosynthesis.5 Injection of 14C labeled 
mevalonate into three species of dorid nudibranchs (Dendrodoris limbata, D. grandiflora, 
and D. arborescens) demonstrated incorporation of label into three drimane 
sesquiterponoids, polygodial (78), 6-β-acetoxyolepupuane (79) and the sesquiterpene 
ester 80. Incorporation of 13C-labelled glucose confirmed these terpenes were synthesized 
de novo via the classical mevalonic acid pathway.5, 83   
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Poligodial (78)                6-β-acetoxyolepupuane (79)                   80 
 
In biosynthetic studies involving the Canadian nudibranchs Archidoris montereyensis and 
A. odhneri, a low rate of  incorporation of mevalonic acid into the sesquiterpenoids and 
diterpenoid acid glyceride metabolites 81, 82 and 83 was reported.5, 83  
O OH
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             81                                                                    82 
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Use of stable isotopically labeled precursors has led to the convincing experimental 
evidence for de novo biosynthesis in nudibranchs.  It was found that effective 
incorporation levels of respective isotopes can be achieved by simulation of the particular 
ecological roles of the metabolites. Therefore, handling of the nudibranchs prior to 
injection leads to release of defensive substances in their mucus and activates the 
biosynthetic pathways so that the chemical defenses can be unleashed.5  Implementation 
of this strategy demonstrated significantly high incorporations of [1, 2-13C2] acetate into 
the aldehydes nanaimoal (84), acanthodoral (85), and isoacanthodoral (86) in 
Acanthodoris nanaimoensis.84 
       
O
             H
O
                  H
O
 
 Nanaimol (84)                         Acanthodoral (85)                     Isoacanthodoral (86) 
 
Subsequent 13C studies by the Faulkner and Andersen groups established the mevalonate 
origin of the terpene portion of glyceride metabolites (81), (83) and tanyolide B (87) in 
various nudibranchs. Similarly de novo biosynthesis of the sesquiterpene metabolites 
albicanylacetate (88), cadlinaldehyde (89), and luteone (90), isolated from Cadlina 
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luteomarginate, was established. It was further understood that the biosynthesis of above 
metabolites can be regulated according to the need.84,85  
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Tanyolide B (87) Albicanyl acetate (88)
Cadlinaldehide (89) Luteone (90)               
The cadlinaldehyde and luteane skeletons were shown to be formed by degradation of a 
sesterterpenoid precursor. The acetyl residue of albicanylacetate was labeled and its 
incorporation into the terpene portion was monitored. However, it was only evident 
during the egg-laying period illustrating that the biosynthesis is regulated.85  
 
It has been found that some nudibranchs utilize both biosynthetic strategies and are able 
to carry out de novo biosynthesis as well as sequestering metabolites.  The North 
American nudibranch Cadlina luteomarginata is characterized by the presence number of 
different sesquiterponoid and diterpenoid constituents representing 37 carbon skeletons. 
The origin of most of these have been traced to local sponges. However, the nudibranch 
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consistently yielded albicanyl acetate (88), a reasonably potent fish deterrent metabolite, 
from all collection sites. Meanwhile, 1α,2α-albicanyl acetate (91) was found in egg 
masses but never found in skin or whole body extracts suggesting that it was produced by 
the nudibranch.  Thus, the nudibranch produces major defense compounds de novo in 
order to ensure reproductive success, but makes use of  local sponge toxins for additional 
protection.86,87 Similarly, Dendrodoris grandiflora was found to produce drimane 
sesquiterpenes via de novo biosynthesis for egg masses, even though  is known to store 
some sponge metabolites. 88 
OOAc
AcO
O
 
1α, 2α-albicanyl acetate (91) 
It has been debated as to whether the nudibranchs lost their shell, a major defensive 
structure, due to the availability of elaborate and efficient defense strategies in the form 
of chemical defense. On the other hand, the ability to use the toxic substances 
biosynthesized in other organisms has reduced the metabolic cost to make them on their 
own.78 
 
3.1.2 Chemistry of Austrodoris 
Nudibranchs belonging to the family Doridae are known to employ ichthyotoxic acyl 
glyceryl esters of diterpenoids or sesquiterpenoids for their protection against predators.5 
They are only present in the mantle tissues of the animals suggesting their function in 
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defending the shell-less molluscs. These glycerols were first found in the British 
Columbian nudibranchs Archidoris monotereyensis and Archidoris odhneri.89-91 
Subsequently, they have been isolated from the Mediterranean nudibranch Doris 
verrucosa, The Antarctic nudibranch Austrodoris kerguelenensis and two Archidoris 
species A. tuberculata and A. carvi which were collected from Northern Spain and 
Argentina respectively.83,92,93 
 
Austrodris kerguelenensis, a common Antarctic nudibranch widely distributed in the high 
Antarctic and Subantarctic Zone has been subjected to extensive studies for the presence 
of defensive chemicals. Studies on different collections of A. kerguelenensis have led to a 
series of ent-labdane, halimane and isocopalane diterpenoid glycerols along with some 
nor-sesquiterpenoids.91 
 
 
 
 
 
 
 
 
 
Figure 68.  Austrodoris kerguelenensis at Bonaparte Point, Antarctica (Photograph 
supplied by Bill J. Baker, University of South Florida)   
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Chemical investigation of the mantle tissues of a specimen of Austrodoris kerguelenensis 
collected from McMurdo Sound Antarctica, gave five diterpenoid glyceryl esters 92-96 
belonging to labdane family of diterpenoids.79 It has been proposed that the oxidative 
cleavage of the B ring of 92 and 93 between C-8 and C-9 would have given rise to 
diketones 94 and  95.79 
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O
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O
OR1
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O
H
 
        92  R1= OAc,  R2 = H                                            94  R1 = OAc,  R2 = H                                            
        93  R1 = H,   R2 = OAc                                          95  R1 = H,   R2 = OAc 
O
O
OH
OH
O
H  
(96) 
Austrodorin (97), a diterpenoid with an unusual halimane skeleton, was reported with its 
diaceylated derivative from a sample collected from Tethys Bay, of Antarctica.93 It may 
have arisen by a rearrangement of analogous compound having a labdane skeleton. Later, 
more compounds with this skeleton 98, and 99 were isolated along with labdanes 92 and 
93.90,94 After synthetic studies to determine the absolute stereochemistry, the absolute 
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configuration of C-2′ of all these glycerides was established as S.95 Consequently, the 
stereochemistry of C-2′ of 92 and 93 was assigned as in 100 and 101.91  Further, 
reinvestigation of the structures of compounds 99 and 101, led to their revision to 102 
and 103.91 
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Austrodorin (97) R1 = H,  R2 =H                            (100) R1 = H, R2 = OAc 
                     98R1 = H, R2 = OAc                           (101) R1 = OAc, R2 = H 
                     99 R1 = OAc, R2=H 
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O
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                (107)                                                               (108) 
 
Another specimen of Austrodoris kerguelenensis collected at South Shetland Island 
Antarctica, yielded two isocopalane diterpenoids austrodorin A (104) and B (105).90 
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            Austrodorin A (104)                                           Austrodorin B (105) 
 
The skin extracts of A. kerguelenensis nudibranch collected from Terra Nova Bay, 
Antarctica, gave two nor-sesquiterpenoids austrodoral (106) and its oxidized product 
austrodoric acid (107).96  In addition, it afforded clerodane diterpenoid acyl glyceride 
(108) which had the same clerodane diterpenoid residue as archiodrin (109) isolated from 
Archidoris  tuberculata.91 
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O
O
OH
OH
             
O
O
OH
O
O
 
 
                     108                                               Archidorin (109)  
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The observation of the close resemblance of the diterpenoid glycerides of Austrodris 
kerguelenensis to that isolated from Archidoris montereyensis, Archidoris odhnery and D. 
verrucosa, which are established to be products of  de novo biosynthesis, led to the 
suggestion that they also may be biosynthesized de novo.83, 97 
 
 3.1.3 Bioactivity 
The biological role of these diterpenoid esters only present in the mantle tissue is linked 
to the protection of the shell-less molluscs. They have shown toxicity against fresh water 
fish98 and antifeedant activity against marine fish99 in different bioassays. The 1,2-
diacylglycerols have demonstrated more activity than corresponding 1,3-diacylglycerols. 
Further, 1,2-diaclyglycerols have exhibited potent activity in activation of protein kinase 
C and in the regenerative tests with fresh water hydrazoan, Hydra vulgaris.100    
 
3.1.4 Research Objectives 
 
Different collections of Austrodris kerguelenensis have shown differences in chemical 
composition based on the location of the sample collection.79,93 Significant variations of 
chemistry have been already observed in McMurdo Sound and Palmer Station, in 
Antarctica.35 Therefore, it was of interest to undertake a chemical investigation on the 
specimens of A. kerguelenensis collected from Palmer Station. 
 
 
 
 
 
 
 
 117
3.2  Results and Discussion 
 
3.2.1 Extraction and isolation of secondary metabolites 
Austodoris kerguelenensis nudibranchs were collected from the ocean near Palmer 
Station, Antarctica. The CHCl3 extract of the nudibranchs were fractionated to 12 
factions by flash chromatography on silica (Scheme 2). Further purification of fractions 
7, 9 and 10 by HPLC on silica gel and C-18 yielded palmadorin A (110) (24 mg, 0.006% 
dry wt), palmadorin B (111) (7 mg, 0.002% dry wt) and palmadorin C (112) (7 mg 
0.002% dry wt).  
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Scheme 2. Extraction and purification of palmadorins 
 
 
3.2.2 Characterization of palmadorin A (110) 
 
 
Palmadorin A (110), isolated as a viscous oil, showed a [M + 1] + peak at m/z = 379.3 
(Figure 69) in the LRFABMS spectrum. The HRFABMS analysis provided a molecular 
weight of 379.2842 amu consistent with the molecular formula of C23H38O4. 
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Figure 69. LRFABMS spectrum of palmadorin A (110) 
 
The 13C NMR spectrum of palmadorin A (110) showed 22 carbon signals (Figure 70). 
The signals at δ 163.9, 160.7, 114.6 and 102.8 were assigned as olefins whereas the δ 
167.0 was assigned as an ester carbonyl. The carbon resonances δ 74.6 and 62.9 could be 
assigned as oxygen bearing carbons. The latter signal exhibited unusually high intensity 
indicative of coincident signals. 
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              Figure 70. 13C NMR spectrum of palmadorin A (110) (125 MHz, CDC13) 
 
 
The 1H NMR spectrum of compound 110 (Figure 71) showed a distinct sharp doublet at δ 
4.48 (H-18) that integrated for two hydrogens. H-18 exhibited gHSQC correlation 
(Figure 72) with carbon signal at δ 102.8, suggesting the presence of an exomethylene. 
These exomethylene protons displayed strong HMBC (Figures 73, 74) correlations to the 
quaternary carbon resonances at δ 160.7 (C-4), 40.2 (C-5) and the methylene carbon 
signal at δ 33.2 (C-3). The proton signal δ 2.09 (H-3a) displayed HMBC correlations with 
carbons δ 160.4 (C-4), 40.0 (C-5) and 102.5 (C-18). In addition, H-3a shows HMBC 
correlation with one carbon resonance at δ 21.9 (C-1). On the other hand, the proton 
signal at δ 2.27 (H-3b) displays HMBC correlations with carbons δ 160.4 (C-4), 102.5 
(C-18) and  28.9 (C-2). 
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Figure 71. 1H NMR spectrum of palmadorin A (110) (500 MHz, CDC13 ) 
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  Figure 72. gHSQC spectrum of palmadorin A (110) (500 MHz, CDCl3) 
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Figure 73. gHMBC spectrum of palmadorin A (110) (500 MHz, CDCl3) 
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  Figure 74.   Key gHMBC and gCOSY correlations of palmadorin A (110) 
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The singlet at δ 1.02 (H-19) integrated for three protons and exhibited HMBC 
correlations to quaternary carbons 160.4 (C-4), C-5 (40.0), methine at δ 48.9 (C-10) and a 
methylene at δ 37.4 (C-6). The proton signal at δ 1.03 (H-10), in turn shows HMBC 
correlations to δ 28.6 (C-2), 40.0 (C-5) and 20.8 (C-19), confirming the structural 
assignments for the A ring of palmadorin A.  
 
The 3H singlet at δ 0.71 shows HMBC correlation to δ 48.7 (C-10), the quaternary 
carbon at δ 39.5 (C-9) and a methine at δ 36.9 (C-8). Meanwhile, the doublet at δ 0.79, 
indicative of another methyl, exhibits HMBC correlations to the same carbons suggesting 
that they are located on adjacent carbons. In addition, it shows further HMBC 
correlations with the methine at δ 27.6 (C-7). Both protons attached to C-7, δ 1.44 (H-7a) 
and δ 1.47 (H-7b) exhibit HMBC connectivity to C-8 and C-5 constituting the B ring of 
palmadorin A (110) (Table 8). 
 
The broad singlet at δ 5.68 indicative of an olefin displayed HMBC correlation to the 
quaternary carbon δ 167.0 (C-15), assigned as an ester carbonyl, as well as methylene δ 
34.8 and methyl at δ 19.7 (C-16). The proton resonance of the latter methyl signal was 
observed as a doublet at δ 2.14 in turn displayed HMBC correlations to the former 
carbonyl, another quaternary carbon signal at δ 163.9 and the above methylene. These 
assignments are consistent with a trisubstituted double bond attached to the ester carbonyl 
and of a methylene group adjacent to the quaternary carbon (C-13). Both protons attached 
to this methine show distinct HMBC correlations with δ 163.7 (C-13), 114.4 (C-14), 19.5 
(C-16) and 36.1 (C-11). The proton signals at δ 1.33 and 1.43 (H-11a and H-11b) show 
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HMBC connectivity to carbons δ 36.6 (C-8), 39.3(C-9), 48.7 (C-10), 34.6 (C-12), 163.7 
(C-13) and δ 18.1 (C-20) defining the side chain of the B ring at C-9. 
 
 
 
Table 9.  NMR data for palmadorin A (108) (1H, 500 MHz, 13C, 125 MHz, CDC13) 
              
                                    δ  13 C 
 
δ1H (ppm, mult. J (Hz) 
 
           gHMBC 
 
1 
 
2 
 
3 
 
4 
5 
6 
 
7 
 
8 
9 
10 
11 
 
12 
 
13 
14 
15 
16 
17 
18 
19 
20 
1` 
2` 
3` 
 
  21.6
  28.6
  33.0
160.4
  40.0
  37.2
  27.4
 36.7
 39.3
 48.7
 36.1
 34.6
163.7
114.3
166.7
  19.5
  16.0
102.5
  20.8
  18.0
  62.7
  74.4
  62.7
 
               1.43 (1H, m) 
              1.48 (1H, m) 
              1.23 (1H, m) 
              1.87 (1H, m) 
              2.09 (1H, m) 
              2.27 (1H, m) 
 
 
              1.50 (1H, m) 
              1.58 (1H, m) 
              1.44 (1H, m) 
              1.47 (1H, m) 
              1.39 (1H, m) 
 
              1.03 (1H, m) 
              1.33 (1H, m) 
              1.44 (1H, m) 
              1.85 (1H, m) 
              1.96 (1H, m) 
 
              5.68 (brs s)) 
 
             2.14 (3H, s) 
             0.79 (3H, d, 6) 
             4.48 (2H, d, 1.5) 
             1.02 (3H, s) 
             0.71 (3H, s, 6.0) 
             3.83 (2H, d, 4.5) 
             4.91 (1H, m) 
             3.83 (2H, d, 4.5) 
 
 
 
1, 3 
 
1, 4, 5, 18 
2, 4, 18 
 
 
5,  8 
5, 7, 10, 19 
5, 8 
5, 8 
 
 
2, 5, 19, 20 
8, 9, 10, 12, 13, 20 
8, 9, 10, 12, 13, 20 
11, 13, 14, 16 
11, 13, 14, 16 
 
12, 15, 16 
 
12, 13, 14 
7, 8, 9 
3, 4, 5 
4, 5, 6, 10 
8, 9, 10, 11 
2′, 3′ 
1′, 3′, 15 
1′, 2′ 
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The C-15 ester carbonyl at δ 166.7 displays HMBC correlation to the multiplet at δ 4.91 
(H-2′). H-2′ in turn displayed COSY correlation to the doublet at δ 3.83 (H-1′/ H-3′) 
suggesting their presence on neighboring carbons that have downfield shifts due to an 
oxygen substituent. Meanwhile the latter signal, δ 3.83 (H-1′/ H-3′) integrated for four 
protons and the carbon attached to it showed significantly increased signal intensity in the 
13C NMR spectrum suggesting they are hydroxymethylene groups with identical carbon 
(δ 62.7) and proton (δ 3.83) chemical shifts.  Therefore, a glyceride moiety must be 
attached to the ester carbonyl at C-2′of the glycerol. 
 
The diterpenoid acid involved in the formation of palmadorin A belongs to the category 
of clerodane diterpenoids. This carbon skeleton has been reported earlier from tropical 
plants belonging to the family Annonaceae.101,102 
 
3.2.3 Stereochemical determination of palmadorin A (110) 
The decalin of palmadorin A (110) can exist in either cis or trans conformations. In order 
to determine the correct conformation, the ROESY spectrum (Figure 75) of palmadorin A 
was investigated. In addition, the specific proton signals belonging to the appendages that 
are most likely to reflect the stereochemistry were irradiated selectively employing a 1D 
NOESY experiments (Figure 76) to further confirm those observations. 
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Figure 75 ROESY spectrum of palmadorin A (110) (500 MHz,  CDC13) 
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Figure 76. Selective 1D NOE experiments of palmadorin A (110) (500 MHz, CDCl3) 
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The protons of the C-19 methyl group of palmadorin A (110) show distinct ROESY 
correlation to H-3b, H-7b and H-11b defining the top face of the A ring of palmadorin A 
(Figure 75). The axial orientation of H3-20 on the top face of the decalin was confirmed 
by the observation of strong NOE between H3-20 and H-19, when both peaks were 
irradiated separately (Figures 76, 77). H-2b and H-10 show ROESY cross peaks 
demonstrating that they belong on the bottom face of the A ring. The exomethylene 
protons at C-18 show strong correlations with H-3a and H-6b affirming that the former 
was equatorial and the latter was axial.  
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                    Figure 77. Key ROESY correlations of palmadorin A (110) 
 
H3-20 shows further cross peaks with H-11b, H-12b and H3-17, confirming the axial 
orientation of C-20. These assignments were consistent with the trans decalin 
conformation for palmadorin A as depicted in Figure 77. 
 
3.2.3.1 Absolute stereochemistry determination  
Circular dichroism spectroscopy is a very convenient method to determine absolute 
stereochemistry of organic compounds. In the case of compound 110 this technique can 
be implemented to determine the absolute stereochemistry of C-5 by converting the A 
ring that has an exomethylene at C-4 into a cyclohexanone which could give rise to n-π* 
transitions creating a CD spectrum indicative of its stereochemistry.  
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Hence, palmadorin A (110) was subjected to ozonolysis under oxidative conditions and 
the product was separated and purified by silica gel chromatography. Interpretation of the 
2D NMR data of the product established its identity as the diketone 111 (Scheme 3). 
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     Palmadorin A (110)                                                                      Diketone 113 
                                          
Scheme 3. Ozonolysis of palmadorin A (110) 
 
The product showed two quaternary carbon signals at δ 216.3 (C-4) and 209.1 (C-13) 
indicating the presence of two ketones. The former carbon resonance showed distinct 
HMBC connectivity (Figure 79) with proton signals δ 2.58 (H-3a) and 1.15 (H3-15) 
resulting in its assignment as C-4.  The latter quaternary carbon was correlated to proton 
signals δ 2.16 (H3-14) and 2.34 (H-12b) providing evidence for the presence of another 
ketone at C-13. Based on the key HMBC correlations of the methyls H3-15, H3-17 and 
methine proton H-10 the structure of the product was confirmed as 113. This  
demonstrated the cleavage of both double bonds in palmadorin A (110) during the 
ozonolysis to give rise to two ketones. 
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Figure 78. Key gHMBC correlations of 113 
 
The ROESY correlations discussed earlier confirmed the trans decalin conformation of 
the A and B rings of palmerolide A. Nevertheless, this trans decalin conformation can 
exist in two possible enantiomeric forms (Figure 78). Identification of the correct 
enantiomer was accomplished using circular dichroism spectroscopy.  
 
 
 
 
 
 
 
                      
Cotton effect value 96 = +0.07  
Figure 79. Two possible trans decalin enatiomers for palmadorin A ozonolysis product 
 
According to the principles of CD spectroscopy when the octant rule is applied to the 
above two enantiomers, 113a should give a positive cotton effect where as 113b should 
indicate a negative cotton effect.103 Therefore, the cotton effect observed for the diketone 
O
O
113a 113b
O
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113 can be used to distinguish the particular enatiomeric form of palmadorin A. When 
the CD spectrum of diketone 113 was recorded (Figure 80), it displayed a negative cotton 
effect confirming that palmadorin A exist as enantiomeric form 113b. Hence the absolute 
stereochemistry of palmadorin A was established as 5S, 8S, 9R and 10S (110). 
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Figure 80. CD spectrum of compound 113 showing a negative cotton effect  
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         Figure 81. Absolute stereochemistry of   Palmadorin A (108) 
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3.2.4 Characterization of palmadorin B (111) 
 
Palmadorin B (111) was isolated as colorless, viscous oil and showed an intense FABMS 
peak at   m/z = 379.4 (Figure 82), indicative of [M - (CH3CO)]+. It further displayed 
another prominent peak at m/z = 421.4, indicative of [M - H]+. Analysis of the 
HRFABMS data, gave an accurate mass of 421.2974, consistent with the molecular 
formula C25H41O5. 
 
 
Figure 82. LRFABMS spectrum of palmadorin B (111) 
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The 13C NMR spectrum (Figure 83) of palmadorin exhibited 25 carbon signals supporting 
the HRFBMS data. The carbon signals at δ 171.2 and 166.3 were assigned as ester 
carbonyls whereas the signals at δ 163.6, 160.6, 114.6 and 102.8 appeared to be olefinic 
carbons.  The three carbon signals at δ 71.6, 62.7 and 61.9 were characteristic of carbons 
bearing oxygen. 
 
 
             Figure 83. 13C NMR spectrum of palmadorin B (111) (125 MHz, CDC13) 
 
 
A complete structure elucidation of palmadorin B was accomplished by an extensive 
analysis of its HMBC (Figure 84) and HSQC (Figure 85) data. The COSY spectrum 
(Figure 86, 87) was used to get supporting information wherever it was appropriate. 
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Figure 84. gHMBC spectrum of palmadorin B (111) (500 MHz, CDC13) 
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Figure 85. gHSQC spectrum of palmadorin B (111) (500 MHz, CDC13) 
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Figure 86. gCOSY spectrum of palmadorin B (111) (500 MHz, CDC13) 
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Figure 87.       Key HMBC and COSY correlations of palmadorin B (111) 
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The sharp doublet at δ 4.48 in the 1H NMR spectrum (Figure 88) of the compound (111) 
integrated for two hydrogens and showed HSQC correlations with a single carbon at δ 
102.8 demonstrating that it was an exomethylene. These exomethylene protons showed 
distinct HMBC correlations to carbons δ 34.8 (C-3), 160.6 (C-4) and 40.2 (C-5), 
respectively. The methylene proton H-3a (δ 2.08) exhibited HMBC correlation to δ 29.0 
(C-2), 40.4 (C-5) and 102.9 (C-18) whereas H-3b (δ 2.26) is related to only δ 29.4 (C-2) 
and 102.9 (C-18) (Table 9). 
 
 
 
Figure 88. 1H NMR spectrum of palmadorin B (111) (500 MHz, CDC13) 
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Table 10.     NMR data of palmadorin B (111) (1H, 500 MHz, 13C, 125 MHz, CDC13) 
 
        δ 13C 
 
δ 1H (ppm, mult. J (Hz) 
 
           gHMBC 
 
1 
 
2 
 
3 
 
4 
5 
6 
 
7 
 
8 
9 
10 
11 
 
12 
 
13 
14 
15 
16 
17 
18 
19 
20 
 1′ 
 2′ 
 3′ 
COOCH3 
COOCH3 
 
 
21.8 
 
29.0 
 
34.4 
 
     160.7 
40.4 
37.7 
 
 27.8 
 
 37.0 
 39.7 
 49.1 
 36.4 
 
 34.9 
 
163.9 
114.7 
166.8 
  19.8 
  16.4 
102.9 
  22.3 
  18.5 
  62.9 
  72.0 
62.2 
21.2 
    171.2 
 
            1.42 (m) 
           1.46 (m) 
           1.21 (m) 
           1.86 (m) 
           2.09 (m) 
           2.27 (m) 
 
 
           1.47 (m) 
           1.57 (m) 
           1.44 (m) 
           1.47 (m) 
           1.39 (m) 
 
           1.03 (m) 
           1.33 (m) 
           1.44 (m) 
           1.85 (m) 
           1.96 (m) 
 
           5.68 (br s) 
 
           2.14 (3H, s) 
           0.78 (3H, d, 6.5) 
           4.48 (2H, d, 1) 
           1.02 (3H, s) 
           0.72 (3H, s) 
           4.26 (2H, m ) 
           5.06 (1H, m) 
           3.72 (2H, d, 4) 
           2.05 (3H, s) 
 
 
 
 
3 
 
2, 5, 18 
2, 18 
 
 
8, 19 
5, 7, 8, 10, 19 
 
 
 
 
5, 6, 7, 8 
9, 10, 12 
8, 9, 10, 12, 20 
11, 16 
11, 16 
 
12, 15, 16 
 
12, 13, 14 
7, 8, 9 
3, 4, 5 
4, 5, 6, 10 
8, 9, 10, 11 
2′, 3′ COOCH3 
15, 1′ 
1′, 2′,  
COOCH3 
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The 3H singlet at δ 1.02 (C-19), exhibited HMBC correlation to the quaternary carbons δ 
δ 160.6 (C-4), 40.4 (C-5), 37.7 (C-6) and 49.1 (C-10), establishing a major portion of the 
A ring (Figure 87). The rest of the six memebered ring was characterized by the COSY 
correlations between H-2a, H-2b and H-1a, H-1b and H-10. 
 
The sharp 3H singlet at δ 0.72 (H3-20) displayed HMBC correlations to carbons δ 37.0 
(C-8), 39.7 (C-9), 49.1(C-10), 36.4 (C-11). Meanwhile, the 3H doublet at δ 0.78 (H3-17) 
exhibited HMBC cross peaks with carbons δ 27.8 (C-7), 37.0 (C-8), and 39.7 (C-9). 
Unambiguous assignment of the rest of the B ring was accomplished on the basis of 
HMBC correlation of H-6b (δ 1.57) with carbons δ 40.4 (C-5), 37.0 (C-8) and 49.1 (C-
10) and that of H-6a (δ 1.47) with δ 37.0 (C-8). 
 
The broad singlet observed at δ 5.64 (H-14) showed HMBC correlation to the ester 
carbonyl δ 166.3 (C-15) and the methylene δ 34.9 (C-12). On the other hand, the 3H 
doublet at δ 2.12, indicative of a vinyl methyl, displayed HMBC correlation with δ 34.9, 
a quaternary carbon at δ 163.6 and a methine at δ 114.6. All these observation were 
consistent with a trisubstituted double bond conjugated to an ester carbonyl.  The 
connectivity between this side chain into the A and B rings could be established by the 
HMBC correlations of δ 1.33 (H-11a) and 1.44 (H-11b) with 39.7 (C-9), 49.1 (C-10) and 
34.9 (C-12). 
 
The ester carbonyl at δ 166.3 (C-15) exhibited HMBC correlation to the proton signal at δ 
5.06, observed as a multiplet. The doublets at δ 3.73 and 4.26 correlated in the COSY 
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spectrum with the proton at δ 5.06 (H-2′), establishing the presence of the glyceride 
moiety. The proton resonances at δ 4.26 (H-1′) not only shows HMBC coupling with 
carbon shifts 72.0 (C-2′) and 62.2 (C-3′), but also with the ester carbonyl at δ 171.2. The 
proton at 4.26 (H-1′) also correlates to the methyl singlet δ 2.05 which suggest the 
presence of an acetyl group.  All these observations are consistent with a glyceride 
moiety attached to a carbonyl via an ester linkage at C-2′ which is acetylated at C-1′. 
 
 
3.2.5 Stereochemistry determination of palmadorin B (111) 
 
The stereochemical elucidation of palmadorin B (111) was undertaken by analysis of its 
ROESY spectrum. Selective one dimensional NOE experiments were also employed to 
confirm these assignments.  
 
The carbon and proton spectral data of the A and B rings of palmadorin A and B showed 
significant similarities suggesting that they have similar stereochemistry. As observed in 
palmadorin A, methyl group C-19 showed ROESY correlations (Figure 89) to H-3b, H-
7a indicating that they define the top face of the A ring (Figure 90). In addition, the H3-19 
methyl shows a strong ROESY correlation with H3-20 demonstrating that they both are 
on the top face of the decalin with an axial orientation. Further, the exomethylene protons 
at C-18 displayed ROSEY cross peaks with H-3a and H-6a, in agreement with this 
observation. 
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Figure 89.  ROESY spectrum of palmadorin B (111) (500 MHz, CDC13) 
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                   Figure 90.    Palmadorin B (111) ROESY correlations 
 
 
Therefore, the stereochemistry of compound 109 can be illustrated as displayed in Figure 
91. Hence, by analogy with the stereochemical features of palmadorin A, the absolute 
stereochemistry of palmadorin B is assigned as 5S, 8S, 9R and 10S. 
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                Figure 91. Absolute stereochemistry of  palmadorin B (111)  
 
3.2.6 Characterization of palmadorin C (112) 
Palmadorin C (112) was isolated as colorless oil. The LRFABMS (Figure 92) provided a 
m/z = 377.3 indicative of [M - H2O]+. HRFABMS on this mass peak suggested molecular 
formulae of C23H38O4. 
 
 
Figure 92. LRFABMS spectrum of palmadorin C (112) 
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Analysis of the 13C NMR spectrum (Figure 93) of palmadorin C (112) showed 23 signals. 
The carbon resonance at δ 166.9 was assigned as an ester carbonyl where as the signals at 
δ 163.5, 163.5, 145.1, 120.0 and 114.8 were indicative of olefins. Meanwhile, the signals 
δ 74.6, 73.8, 63.0 and 62.9 indicated four carbons bearing oxygen. 
 
                Figure 93. 13C NMR spectrum of palmadorin C (112) (125 MHz, CDCl3) 
 
According to HSQC spectrum (Figure 94) the 1H NMR peak at δ 5.13 (Figure 95) 
correlated to the carbon resonance at δ 120.0. The carbon signals at δ 145.1 (C-4) and 
37.8 (C-5) did not show HSQC correlation suggesting that they were quaternary. The 3H 
signal at δ 1.60 correlated in the HMBC (Figure 96) spectrum with all above three 
carbons indicating a trisubstituted double bond. 
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Figure 94. gHSQC spectrum of palmadorin C (112) (500 MHz, CDCl3) 
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Figure 95. 1H NMR spectrum of palmadorin C (112) (500 MHz, CDCl3) 
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Figure 96. gHMBC spectrum of palmadorin C (112) (500 MHz, CDCl3)  
 
The 1H NMR signals at δ 1.27, depicting a singlet and integrating for three protons, 
displayed HMBC correlation to carbons C-4 (δ 145.2), C-5 (δ 37.80), C-6 (δ 43.14) and 
C-10 (δ 38.5). The connectivity from C-3 (δ 120.0) to C-10 (δ 46.9) via two methylenes 
C-1 (δ 18.2) and C-2 (δ 27.0) was established by COSY correlations (Figures 97, 98) 
giving rise to the A ring of palmadorin C. 
 
The 3H doublet at δ 1.01 displayed HMBC correlation to δ 73.9 (C-7) and 39.5 (C-8). A 
3H singlet at δ 0.99 correlated in the HMBC with δ 39.5 (C-8), 38.5 (C-9), 46.9 (C-10) 
and 37.6 (C-11) (Table 10). In addition, the 1H NMR signal at δ 1.37 (H-10) showed 
HMBC correlations to δ 18.2 (C-1), 145.2 (C-4), 37.8 (C-5), 43.1 (C-6), 22.0 (C-19) and 
 145
20.3 (C-20). Meanwhile, H-6b (δ 2.10) demonstrated HMBC cross peaks to δ 22.0 (C-
19), 73.9 (C-7) and 39.5 (C-8), establishing the B ring. 
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Figure 97. gCOSY spectrum of palmadorin C (112) (500 MHz, CDCl3) 
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Figure 98. Key HMBC and COSY correlations of palmadorin C (112) 
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Table 11.   NMR data of palmadorin C (112) (1H, 500 MHz, 13C, 125 MHz, CDC13) 
   
            δ   13 C 
 
δ 1H (ppm, mult. J (Hz) 
 
           gHMBC 
 
1 
 
2 
 
3 
4 
5 
6 
 
7 
8 
9 
10 
11 
 
      12 
 
13 
14 
15 
16 
17 
18 
19 
20 
1′ 
2′ 
3′ 
      18.2
      27.0
    120.0
    145.2
      37.8
      43.1
      73.9
      39.5
      38.5
      46.9
      37.6
      35.1
    163.4
    114.8
    167.0
      19.7
      12.7
      18.3
      22.0
      20.3
      63.1
      74.8
      63.1
 
     1.54 (1H, m) 
     1.58 (1H, m) 
     1.98 (1H, m) 
     2.08 (1H, m) 
     5.13 (1H, m) 
 
 
     1.39 (1H, m) 
     2.10 (1H, m) 
     4.02 (1H, m) 
     1.51 (1H, m) 
 
     1.37 (1H, m) 
     1.39 (1H, m) 
     1.51 (1H, m) 
     1.93 (1H, m) 
     1.98 (1H, m) 
 
     5.70 (1H, s) 
 
    2.16 (3H, s)   
    1.01 (3H, d, 7.5) 
    1.60 (3H, s) 
    1.27 (3H, s) 
    0.99 (1H, s) 
    3.82 (2H, d, 4.5) 
    4.91 (1H, m) 
    3.82 (2H, d, 4.5) 
 
 
 
 
 
 
 
 
4, 5, 10, 19, 
5, 7, 8, 9, 10, 19 
 
17 
 
1, 4, 5, 6, 9, 19, 20 
5, 10, 19 
8 
16 
 
 
12, 15, 16 
 
12, 13, 14 
7, 8 
3, 4, 5 
4, 5, 6, 10 
8, 9, 10, 11 
 
 
 
The singlet at δ 5.70 (H-14) indicated distinct HMBC correlations to δ 35.10 (C-12), 
167.0 (C-15) and 19.7 (C-16). Due to its relatively low field chemical shift, the methyl at 
δ 2.16 (H3-16) could be assigned as a vinyl methyl. It showed further HMBC correlation 
to the methine C-12 (δ 35.1), quaternary C-13 (δ 163.4) and C-14 (δ 114.9).  These 
assignments are consistent with a trisubstituted double bond conjugated to an ester 
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carbonyl. The connectivity of C-12 (δ 35.10) and C-9 (δ 38.5) via C-11 (δ 37.6) was 
established by the observed COSY correlations of H-11a (δ 1.39), H-11b (δ 1.51) with H-
12a (δ  1.93), H-12b (δ  1.98). 
 
HMBC correlation was observed between the multiplet at δ 4.92 (H-2′), attached to a 
hydroxymethine δ 74.8 and the ester carbonyl at δ 167.0. In addition, the multiplet at δ 
4.92 (H-2′) shows COSY correlation to the 4H doublet at δ 3.82 (H-1′/H-3′) which 
showed HSQC correlations to two hydroxymethines C-1′ and C-3′  (δ 63.1).  
 
Based on these data palmadorin C (112) was characterized as a diterpenoid glyceride. It 
shares similar pattern of glyceride formation with palmadorin A (110) and B (111) with 
the ester linkage established at C-2′ of the glycerol. This is relatively uncommon among 
diterpenoid glycerides. 
 
 
 
 
3.2.7 Stereochemistry determination of palmadorin C (112) 
 
The relative stereochemistry of palmadorin C was studied by NOE spectroscopy. The 
olefinic proton H-3 displayed strong ROESY correlations to H-2b and the vinylic methyl 
at δ 1.60 (H3-18). A cross peak for the methyls at H3-19 and H3-20 indicated that they 
both are on the same face of the decalin system. Similarly H-7 shows its spatial proximity 
with H-8 and H-6 by means of ROSEY correlations and H-6a in turn correlated to H-10. 
H-6a, H-7 and H-8 are therefore all oriented toward the opposite face of the decalin 
compared to H3-19 and H3-20 (Figure 99). 
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Figure 99.   Key ROESY correlations of palmadorin C (112) 
 
Mosher’s method was chosen to determine the stereochemistry of C-7 taking advantage 
of the secondary hydroxyl group. However, prior to that the primary hydroxyl groups in 
the glyceride moiety needed to be protected. 
 
3.2.7. 1 Diacetyl derivative of palmadorin C (114) 
 
Palmadorin C (112) was allowed to react with acetic anhydride overnight and the 
resultant product was separated and purified by chromatography on silica. Two 
equivalents of acetic anhydride was used to make sure the acetylation takes place only on 
desired primary hydroxyl groups. 
 
The purified product was identified as palmadorin C diacetate (114) by NMR 
spectroscopy (Figure 100, 101) and mass spectroscopy. 
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Scheme 4. Acetylation of palmadorin C (112) 
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Figure 100. 1H NMR spectrum of palmadorin C diacetate (114) (500 MHz, CDCl3) 
The 1H NMR spectrum of the diacetate showed a singlet at δ 2.06 indicative of a methyl 
group of an acetyl affirming that acetylation has taken place. In addition, instead of the 
doublet at δ 3.82 representing the H-1′ a, H-1′ b, H-3′ a and H-3′ b, a multiplet was 
observed at δ 4.23. The HSQC correlations confirmed their attached to C-1′and C-3′. A 
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HMBC correlation observed between the carbon at δ 170.8 representing the carbonyl of 
the acetyl group and the multiplet at δ 4.23 provided further confirmation for acetylation 
(Figure 102). 
 
The hydroxymethine proton at C-7 did not show a noticeable difference in its chemical 
shift affirming that it was not esterified. Further it did not show HMBC correlation to 
carbonyls. The other proton and carbon signals showed HMBC and COSY correlations in 
agreement with palmadorin C. 
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Figure 101. 13C NMR spectrum of palmadorin C diacetate (114) (125 MHz, CDCl3) 
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Figure 102.  Key HMBC correlations of palmadorin C diacetate (114) 
 
Analysis of the compound 114 by FABMS (Figure 103) displayed a prominent peak at 
m/z = 477.2 which was attributed to [M - H]+. This indicates a molecular weight of 478, 
consistent with the addition of two acetyl substituents. 
 
 
Figure 103. LRESIMS spectrum of palmadorin C diacetate (114)  
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3.2.7.2 R-MTPA ester of palmadorin C diacetate (115) 
The diacetate of palmadorin C (114) was treated with R-MTPACl for 48 hours and the 
product was separated and purified by chromatography on silica gel. The purified R-
MTPA ester 115 was analyzed by NMR and mass spectroscopic methods in order to 
confirm the formation of MTPA derivative. 
 
LRESIMS (Figure 104) of compound 115 produced a peak at m/z = 717.1 attributed to 
[M + Na]+. A HRFABMS produced a molecular mass of 717.3213 consistent with 
molecular formulae of C37H49F3O9 (calc. 717.3219) 
 
 
Figure 104. LRESIMS spectrum of palmadorin C diacetate R-MTPA ester (115) 
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The 1H NMR spectrum (Figure 105) confirmed the attachment of MTPA moiety by 
displaying two multiplets at δ 7.35 and 7.52, indicating the aromatic protons of the 
phenyl ring and the 3H singlet at δ 3.58 representing the methoxy group. The HSQC 
spectrum (Figure 106) showed that the proton that gives rise to the signal at δ 5.35 is 
attached to C-7. Attachment of the MTPA moiety to C-7 by means of an ester group was 
further illustrated by the significant decrease of the chemical shift of the neighboring 
protons. 
 
The sharp singlet at δ 0.53 was identified as the methyl group at C-19 by HMBC (Figure 
107) correlations to the quaternary δ 144.5 (C-4), methine 46.4 (C-10) and methylene 
40.4 (C-6). The 3H doublet at δ 0.92 (H3-17) and the 3H singlet δ 0.80 (H3-20), both 
show HMBC correlations to the carbons at δ 38.4 and 38.9, assigned to C-9 and C-8 
respectively. This assignment was further confirmed by the HMBC cross peaks observed 
between the singlet δ 0.80 and the carbon δ 46.4 (C-10). H-7 exhibited COSY correlation 
with proton signals δ 1.92, 1.37 and 1.69 indicating that they represent H-6a, H-6b and 
H-8. The 3H singlet at δ 1.43 was identified as the methyl at C-18 based on its HMBC 
correlations to δ 120.6 (C-3), 145.2 (C-4) and 37.3 (C-5).  
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Figure 105. 1H NMR spectrum of palmadorin C diacetate R-MTPA ester (115) (500 
MHz, CDCl3) 
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Figure 106.  gHSQC spectrum of palmadorin C diacetate R-MTPA ester (115) (500 MHz, 
CDCl3) 
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Figure 107. gHMBC spectrum of palmadorin C diacetate R-MTPA ester (115) (500 MHz, 
CDCl3) 
 
The rest of the carbon and proton resonances were not affected by the attachments of the 
MTPA moiety. 
 
3.2.7.3 S-MTPA ester of palmadorin C diacetate (116) 
The diacetate of palmadorin C (114) was treated with S-MTPACl for 48 hours and the 
product was separated and purified by chromatography on silica gel. The purified S-
MTPA ester (116) was analysed by NMR and mass spectroscopic methods in order to 
confirm the formation of the MTPA derivative. 
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LRESIMS of compound 116 (Figure 108) displayed m/z = 717.1 attributed to [M + Na]+. 
HRFABMS analysis produced a molecular mass of 717.322 consistent with molecular 
formula of C37H49F3O9 (Calc. 717.3219). 
 
 
Figure 108. LRESIMS of palmadorin C diacetate S-MTPA (116) 
 
The 13C NMR spectrum (Figure 109) of the product confirmed the formation of the 
MTPA derivative by demonstrating additional carbon signals at δ 127.36, 128.47 and 
129.65 indicative of the aromatic ring and δ 166.95 representing the carbonyl involved in 
the ester group. 
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Figure 109. 13C NMR spectrum of palmadorin C diacetate S-MTPA ester (116) (125 
MHz, CDCl3) 
 
The 1H NMR spectrum of 116 (Figure 110) provided evidence for the attachment of 
MTPA moiety by displaying two multiplets at δ 7.53and 7.37 indicating the aromatic 
protons belong to the phenyl ring and the 3H singlet at δ 3.49 representing the methoxy 
group. The HSQC correlations (Figure 111) showed that the proton that gives rise to the 
signal at δ 5.44 is attached to C-7. Attachment of the MTPA moiety to C-7 by means of 
an ester group was further illustrated by the significant decrease of the chemical shift of 
the neighboring protons. 
 
The sharp singlet at δ 0.93 (3H) displayed HMBC correlations (Figure 112) to the 
quaternary carbon δ 143.6 (C-4), the methine δ 46.6 (C-10) and methylene δ 40.1 (C-6). 
The doublet at δ 0.75 (3H) and the singlet δ 0.63 (3H) both show HMBC correlations to 
carbons at δ 38.4 (C-9) and 39.3 (C-8) indicating that they represent the methyls at C-17 
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and C-20 respectively. The latter singlet further displayed HMBC correlations with δ 
46.6 (C-10) and 37.2 (C-11) further supporting this assignment. The singlet (3H) at δ 
0.93 was assigned as C-19 considering its HMBC cross peaks with δ 143.6 (C-4), 37.4 
(C-5) and methine δ 40.06 (C-6). 
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Figure 110. 1H NMR spectrum of palmadorin C diacetate S-MTPA ester (116) (500 
MHz, CDCl3) 
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Figure 111.  gHSQC spectrum of palmadorin C diacetate S-MTPA ester (116) (500 MHz, 
CDCl3) 
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Figure 112. gHMBC spectrum of palmadorin C diacetate S-MTPA ester (116) (500 MHz, 
CDCl3) 
Based on COSY correlations exhibited by H-7, the proton signals δ 1.48, 2.06 and 1.65 
were identified as H-6a, H-6b and H-8 respectively. The vinyl methyl C-18 appeared at δ 
1.54 was assigned based on the HMBC relationships with δ 120.7 (C-3), 144.0 (C-4) and 
37.4 (C-5). The rest of the carbon and proton shifts were consistent with that observed for 
the starting material. 
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3.2.7.4 Application of Mosher’s method 
Once all the signals are assigned for the respective protons in a model according to the 
Mosher’s method (Figure 113), the stereochemistry of C-7 was found to be R. 
Considering the ROESY correlations observed, the final structure of palmadorin C was 
assigned as 5R, 7R, 8S, 9R, and 10R ( Figure 114). 
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Figure 113.  ∆δ value assignments for palmadorin C diacetate MTPA esters 
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Figure 114. Absolute stereochemistry of palmadorin C (112) 
 
  
 
 
 161
3.3 Summary 
Nudibranches, being shell-less molluscs, are known to employ defensive chemicals in 
order to survive against predators. A comprehensive chemical investigation of the 
Antarctic nudibranch Austrodoris kerguelenensis afforded a series of new clerodane 
diterpenoid glyceride esters named palmadorins, which may be involved in its chemical 
defense. The structure elucidation of palmerodorin A-C was accomplished by 
spectroscopic methods and semi-synthetic derivatizations.   
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Chapter 4   EXPERIMENTAL 
 
4.1 General Procedure 
 
Optical rotations were measured on an Autopol IV automatic polarimeter using Na lamp 
at 25˚C. Infrared spectra were obtained with Nicolete Avatar 320FT-IR as films. 
Ultraviolet-Visible experiments were measured on a Hewlett-Packard 8452A diode array 
UV-Vis spectrometer. 1H and 13C, gHMQC, gHSQC, gHMBC and 1H-1H COSY NMR 
spectra were obtained on a Varian Inova 500 instrument, operating at 500 MHz for 1H 
and 125 MHz for 13C, using residual protonated solvent as 1H internal standard or 13C 
absorption lines of solvents for 13C internal standard. 1H chemical shifts were recorded 
relative to δ 7.24 (CDCl3), 4.78 (CD3OD) and 2.50 (DMSO-d6) whereas the 13C shifts are 
referanced to δ 77.2 (CDCl3),   49.2 (CD3OD) and 39.5 (DMSO-d6).  
 
Low resonance mass spectra were recorded on a Aligent Teconologies LC/MSD VL  
electrospray ionization mass spectrometer. High resonance mass spectra were obtained 
on an Aligent Teconologies LC/MSD TOF electrospray ionization mass spectrometer.  
CD spectra were obtained with Aviv Instruments model 215 CD spectrometer. HPLC 
was performed on with a Shimadzu LC-8A multisolvent delivery system connected to a 
Shimadzu SPD-10A UV-VIS tunable absorbance detector and using YMC-Pack ODS-
AQ C-18 column. EM Science silica gel 60 of 230-400 mesh was used in flash column 
chromatography. TLC was carried out on Whatman K6F silica gel 60A TLC plates with 
0.25 mm thickness. They were visualized by spraying with 5% phosphomolybdic acid in 
EtOH and heating. 
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4.2 Isolation of Secondary metabolites from Synoicum adareanum 
Synoicum adareanum was collected at a depth of 80-100 feet at number of locations near 
Palmerstation in Antarctica by SCUBA diving, and the animals were frozen immediately 
after the collection. The samples were identified by Dr. Linda Cole, at the Smithsonian 
Institute, Washington, D.C. 
 
After freeze drying, 180 g of animals was sequentially extracted 3X with 1:1 
CH2Cl2/MeOH for one day each. Upon evaporation of the solvent under reduced 
pressure, a reddish brown highly viscous oil was obtained. It was partitioned with 
EtOAc/H2O and the EtOAc layer was separated, washed and dried with anhydrous 
Na2SO4. The removal of solvent under reduced pressure gave a reddish brown semisolid 
(2.2 g). 
 
Fractionation of the EtOAc extract was performed by step gradient flash chromatography 
on silica using 100 mL each of hexane, 2%, 5%, 7%, 10%, 15%, 20%, 25%, 30%, 40%, 
50%, 80% and 100% EtOAc in hexane followed by 5%, 10%, 15%,  20% MeOH in 
EtOAc. The factions 3, 5 and 6 were further separated by gradient elusion of 1%, 2%, 
5%, 7% and 10%  MeOH in CHCl3. Subsequent purification of eluate by HPLC using 
40% water in MeCN (isocratic elution, 2 mL per min) afforded compounds 58, 59, 60 
and 61 as white solids. The fractions 8, 9 and 10 upon further purification with HPLC 
using 50% water in MeCN (isocratic elution, 2 mL per min) yielded compounds 62 and 
63. Since 62 and 63 found to be unstable in DMSO, the NMR investigations were 
performed in CD3OD. 
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4.2.1 Palmerolide A (58) 
White solid; [α]24D –1.6 (c 0.5, MeOH); IR (thin film) 3360 (br), 2925, 2856, 1696, 1633, 
1517, 1392, 1275, 1190 and 1080. UV (MeOH) λmax (ε): 224 (2670), 242 (2800), 296 
(1775); 1H NMR (500 MHz, DMSO-d6 ) δ (multiplicity, J (Hz), assignment): 9.84 (1H, d, 
10.1, 24-NH) 6.85 (1H, dd, 10.1, 14.2, H-24) 6.71 (1H, ddd, 5.0, 9.9, 15.2, H-3) 6.49 
(2H, br, OCONH2) 6.04 (1H, dd, 11.1, 14.6, H-15) 5.85 (1H, d, 14.2, H-23)  5.77 (1H, d, 
15.3, H-2) 5.69 (1H, br s, 1.0, H-2′) 5.59 (1H, d, 11.4, H-16) 5.54 (1H, dd, 7.7, 15.0, H-8) 
5.48 (1H, dd, 2.9, 15.6, H-9) ) 5.41 (1H, ddd, 4.7, 10.1, 14.6, H-14) 5.20 (1H, d, 4.9, 10-
OH) 5.13 (1H, d, 9.6, H-21)  4.84 (1H, ddd, 1.3, 7.4, 11.2, H-19)  4.72 (1H, d, 3.9, 7-OH) 
4.48 (1H, dd, 5.0, 10.5, H-11) 4.14 (1H, br s, H-10) 3.82 (1H, ddd, 4.4, 7.4, 7.6, H-7) 
2.68 (1H, qdd, 6.5, 7.4, 9.6, H-20) 2.17 (1H, dd, 1.3, 13.2, H-18) 2.12 (3H, s, H-5′)  2.11 
(2H, m, H-4) 2.00 (1H, dd, 11.2, 13.2, H-18) 1.96 (2H, m, H-13) 1.83 (3H, s, H3-4′) 1.70 
(3H, s, H3-27) 1.61 (3H, s, H3-25) 1.59 (1H, m, H-12) 1.50 (1H, ddd, 4.5, 8.2, 11.2, H-6) 
1.30 (1H, m, H-6) 1.30 (1H, m, H-5) 1.05 (1H, m, H-5) 0.98 (1H, m, H-12) 0.90 (3H, d, 
6.5, H3-26) 13C NMR (125 MHz, DMSO-d6) δ (assignment): 165.3 (C-1), 163.1 (C-1′), 
156.6 (OCONH2), 151.7 (C-3′),  149.2 (C-3), 133.6 (C-8), 132.5 (C-22), 132.0 (C-14), 
131.5 (C-17), 129.7 (C-21), 128.9 (C-9), 126.1 (C-15), 125.7 (C-16), 121.8 (C-24), 120.3 
(C-2), 117.9 (C-2′), 116.4 (C-23), 73.7 (C-19), 72.5 (C-7), 72.3 (C-11), 69.00 (C-10), 
43.6 (C-18),  38.1 (C-6), 36.9 (C-20), 32.6 (C-4),  29.5 (C-13), 29.5 (12), 27.1 (C-4′), 
24.8 (C-5),  19.2 (C-5′),  16.9 (C-26),  16.2 (C-25),  12.6 (C-27) ; FABMS m/z (%) 737.5 
(5, [M+ + dtt]+ ), 585.5 (10 [M + H] +), 501.4 (200), 309.1 (13), 275.1 (5), 195.1 (15), 
155.1 (45): HRFABMS m/z 585.3539 (C33H49N2O7 requires 585.3540). 
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4.2.2 Preparation of MTPA esters of palmerolide A 
Palmerolide A (58) (5 mg, 0.0086 mmol) was dissolved in CH2Cl2 and treated with R- or 
S- methoxytrifluorophenylacetyl chloride (MTPACl) (10 eq) in the presence of Hunig’s 
base and DMAP. The reaction was stirred for 48 hrs. Upon concentration of the reaction 
mixture the two main products were purified by chromatography on silica gel (2% 
MeOH/CH2Cl2) followed by HPLC (silica gel 2% MeOH:CH2Cl2). 
 
4.2.2.1 Palmerolide A 7-[(R)-MTPA] Ester (64) 
Colorless solid; 1H NMR (500 MHz, CD3OD) δ (multiplicity, J (Hz), assignment): 7.92 
(s, NH), 7.52 – 7.45 (5H, m, Ph), 6.97 (d, 14.4, H-24), 6.83 (ddd, 5.2, 10.1, 15.5, H-3), 
6.12 (dd, 11.1, 14.2, H-15), 5.96 (d, 14.4, H-23) 5.99 (dd, 3.5, 15.5, H-9), 5.80 (d,15.5, 
H-2), 5.78 (ddd, 1.8, 8.6, 15.5, H-8), 5.74 (br t, 1.2, H-2′), 5.67 (d, 11.1, H-16), 5.48 (m, 
H-7), 5.47 (m, H-14), 5.19 (dd, 0.7, 9.9, H-21), 4.95 (m, H-19), 4.68 (ddd, 2.0, 5.3, 10.8, 
H-11), 4.34 (ddd, 1.9, 3.4, 5.2, H-10), 3.55 (s, OCH3), 2.77 (ddq, 6.6, 8.0, 9.9, H-20), 
2.26 (br d,12.5, H-18a), 2.20 (d, 1.2, H3-5′), 2.18 (m, H-4a), 2.10 (dd, 11.5, 12.8, H-18b), 
2.07 (m, H-4b), 2.06 (m, H2-13), 1.92 (d, 1.2, H3-4′), 1.82 (d, 0.7, H3-25), 1.69 (s, H3-27), 
1.68 (m, H-6a), 1.65 (m, H-12a), 1.62 (m, H-6b), 1.38 (m, H-5a), 1.24 (m, H-5b), 1.19 
(m, H-12b), 0.99 (d, 6.7, H3-26). 13C NMR (125 MHz, CD3OD)  δ (assignment): 166.8 
(C-1), 165.1 (C-1′), 158.3 (OCONH2), 153.7 (C-3′), 149.1 (C-3), 135.0 (C-9), 133.0 (C-
22), 132.0 (C-14), 131.8 (C-17), 130.8 (C-21), 129.7 (Ph), 128.4 (Ph), 128.4 (C-16) 127.5 
(Ph), 127.5 (C-8), 126.9 (C-15), 121.5 (C-24), 121.2 (C-2), 118.2 (C-23), 117.6 (C-2′), 
78.2 (C-7), 76.1 (C-11), 74.9 (C-19), 70.4 (C-10), 54.8 (OCH3), 43.7 (C-18), 37.3 (C-20), 
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33.9 (C-6), 32.2 (C-4), 30.1 (C-12), 29.6 (C-13), 26.2 (C-4′), 24.4 (C-5)  19.0 (C-5′), 16.2 
(C-26), 15.0 (C-27), 11.8 (C-25); LRESIMS m/z 823.1 [M + Na]+; HRESIMS m/z 
823.3779 (C43H55N2O9F3Na requires 823.3757). 
 
4.2.2.2 Palmerolide A 7, 10–[(R, R)-MTPA] diester (66). 
1H NMR (500 MHz, CD3OD)  δ (multiplicity, J (Hz), assignment): 7.91 (s, NH), 7.36-
7.47 (10H, m, Ph), 6.97 (d, 14.4, H-24), 6.78 (ddd, 5.6, 9.1, 15.3, H-3), 6.13 (dd, 10.7, 
5.1, 11-15), 5.96 (d, 14.4, H-23), 5.76 (d, 15.5, H-2), 5.74 (br t, 1.1, H-2`), 5.73 (dd, 5.8, 
15, 11-9), 5.66 (d, 10.6, H-16), 5.57 (m, H-8), 5.55 (m, H-10), 5.53 (m, H-7), 5.44 (dd, 
4.6, 10.0, H-14), 5.19 (d, 9.5, H-21), 4.95 (m, H-19), 4.84 (m, H-11), 3.58 (s, OCH3), 
3.49 (s, OCH3), 2.78 (ddq, 7.0, 7.1, 10.5, H-20), 2.26 (br d, 13.0, H-18a), 2.19 (d, 1.1, H-
5′), 2.16 (m, H-4a), 2.11 (dd, 11.5, 13.1, H-18b), 2.05 (m, H-13), 2.03 (m, H-4b), 1.92 (d, 
1.1, H-4′), 1.81 (d, 1.0, H-25), 1.68 (s, H-27), 1.65 (m, H-6a), 1.49 (m, H-6b), 1.43 (m, 
H-12a), 1.29 (m, H-5a), 1.12 (m, H-5b), 1.10 (m, H-12b), 0.99 (d, 7.0, H-26). 13C NMR 
(125 MHz, CD3OD) δ (assignment): 166.7 (C-1), 165.1 (C-1′), 153.9 (C-3′), 148.6 (C-3), 
133.3 (C-22), 132.0 (C-17), 131.8 (C-8), 131.0 (C-14), 130.9 (C-21), 130.0 (Ph), 128.7 
(Ph), 128.3 (C-16), 128.0 (C-9), 127.5 (C-15), 127.3 (Ph), 121.7 (C-24), 121.6 (C-2), 
118.3 (C-23), 117.7 (C-2`), 75.8 (C-10), 75.6 (C-7), 75.1 (C-19), 72.6(C-11), 55.4 
(OCH3), 54.8 (OCH3) 43.4 (C-18), 37.2 (C-20), 33.2 (C-6), 31.8 (C-4), 31.2 (C-12), 29.5 
(C-5), 28.0 (C-13), 26.1 (C-4′), 19.0 (C-5′), 16.4 (C-26), 14.8 (C-27), 11.5 (C-25). LR 
ESIMS m/z 1039.1 [M + Na]+. HRFABMS m/z 1039.4145 (C53H62N2O11F6 Na requires 
1039.4155). 
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4.2.2.3 Palmerolide A 7-[(S)-MTPA ester] (65) 
1H NMR (500 MHz, CD3OD) δ (multiplicity, J (Hz), assignment):  7.92 (s, NH), 7.50 – 
7.45 (5H, m, Ph), 6.97 (d, 14.4, H-24), 6.85 (ddd, 5.1, 10.0, 15.5, H-3), 6.11 (dd, 11.2, 
15.0, H-15), 5.96 (d, 14.7, H-23), 5.92 (dd, 3.4, 15.6, H-9), 5.82 (d,15.2, H-2), 5.74 (br t, 
1.2, H-2’), 5.68 (ddd, 1.8, 8.6, 15.2, H-8), 5.67 (d,15.0, H-16), 5.46 (m, H-7), 5.45 (dd, 
4.9, 8.8, H-14), 5.19 (d, 9.8, H-21),4.95 (m, H-19),  4.32 (ddd, 1.9, 3.2, 5.3, H-10), 4.66 
(ddd, 2.0, 5.2, 10.8, H-11), 3.55 (s, OCH3), 2.78 (ddq, 6.8, 7.5, 9.8, H-20), 2.26 (br d, 
12.7, H-18a), 2.24 (m, H-4a), 2.19 (d, 0.8, H-5’), 2.16 (m, H-4b), 2.09 (dd, 11.5, 12.4, H-
18b), 2.07 (m, H2-13), 1.92 (d, 0.8, H-4’), 1.83 (m, H-6a), 1.82 (s, H3-25), 1.72 (m, H-
6b), 1.69 (s, H3-27), 1.64 (m, H-12a), 1.46 (m, H-5a), 1.31 (m, H-5b), 1.17 (m, H-12b), 
0.99 (d, 6.9, H3-26). 13C NMR (125 MHz, CD3OD) (assignment): 167.0 (C-1), 165.2 (C-
1′), 158.3 (OCONH2), 153.8(C-3′), 149.2 (C-3), 134.8 (C-9), 133.2 (C-22), 132.0 (C-14), 
131.7(C-17), 130.8 (C-21), 129.6 (Ph), 128.5 (C-16), 128.4 (Ph), 127.4 (Ph), 127.3 (C-8), 
126.9 (C-15), 121.6 (C-24), 121.3 (C-2), 118.3 (C-23), 117.6 (C-2′), 78.5 (C-7), 76.2 (C-
11), 74.8 (C-19), 70.5 (C-10), 54.8 (OCH3) 43.8 (C-18), 37.3 (C-20), 34.2 (C-6) 32.3 (C-
4), 30.3 (C-12), 29.7(C-13), 26.3 (C-4′), 24.6 (C-5), 19.1 (C-5), 16.4 (C-26), 15.2 (C-27), 
11.9 (C-25). LRESIMS m/z 823.1 [M + Na]+, HRFABMS m/z 823.3747 
(C43H55N2O11F3Na requires 823.3757). 
 
4.2.2.4 Palmerolide A 7, 10-[(S, S)-MTPA] diester (67) 
1H NMR (500 MHz, CD3OD) δ (multiplicity, J (Hz), assignment): 7.92 (s, NH), 7.38-
7.50 (m, Ph), 6.97 (d, 14.4, H-24), 6.82 (ddd, 6.1, 8.3, 15.5, H-3), 6.10 (dd,11.1, 14.6, H-
15), 5.96 (d, 14.5, H-23), 5.80 (d, 15.5, H-2), 5.74 (br t, 1.1, H-2′), 5.70 (m, H-9), 5.64 (d, 
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11.1, H-16), 5.63 (m, H-10), 5.54 (m, H-7), 5.54 (m, H-8), 5.31 (dt, 4.2, 14.6, H-14), 5.19 
(d, 10.0, H-21), 4.96 (m, H-19), 4.71 (dd, 6.5, 12.1, H-19), 3.58 (s, OCH3), 3.43 (s, 
OCH3), 2.79 (ddq, 6.8, 7.5, 10.0, H-20), 2.26 (br d, 13.4, H-18a), 2.22 (m, H-4a), 2.19 (d, 
1.0, H-5′), 2.178 (m, H-4b), 2.11 (dd, 11.5, 11.9, H-18b), 1.99 (m, H-13b), 1.92 (d, 1.0, 
H-4’), 1.90 (m, H-13a), 1.82 (d,1.0, H-25), 1.78 (m, H-6a), 1.69 (m, H-6b), 1.68 (s, H-
27), 1.43 (m, H-12a), 1.41 (m, H-5a), 1.27 (m, H-5b), 1.24 (m, H-12b), 0.99 (d, 6.7, H-
26);  13C NMR (125 MHz, CD3OD) δ (assignment): 166.9 (C-1), 165.2 (C-1′), 153.6 (C-
3′), 149.1 (C-3), 133.5 (C-22), 132.1 (C-9), 132.0 (C-17), 131.1 (C-14), 130.8 (C-21), 
129.8 (C-8). 129.6 (Ph), 128.4 (Ph), 128.3 (C-16), 127.4 (Ph), 127.3 (C-15) 121.6 (C-24), 
121.5 (C-2), 118.3 (C-23), 117.6 (C-2′), 76.1 (C-7), 75.0 (C-10), 75.0 (C-19), 72.7 (C-
11), 55.2 (OCH3), 49.3 (OCH3), 42.6 (C-18), 37.3 (C-20), 34.2 (C-6), 32.1 (C-4), 30.8 
(C-12), 26.3 (C-4′), 26.1 (C-13), 24.6 (C-5), 19.2 (C-5′),16.0 (C-26), 15.3 (C-27), 11.9 
(C-25). LRESIMS m/z 1039.1 [M + Na]+, HRFABMS m/z 1039.4151 (C53H62N2O11F6Na  
requires 1039.4155). 
 
4.2.3 Palmerolide C (59) 
White solid; [α]25D -27.1 (c 0.1, MeOH); IR (thin film) cm-1: 3364 (br), 2933, 1697, 1637, 
1446, 1387, 1274, 1182, 1018, 978; UV (MeOH) λmax (ε): 216 (1002), 248 (635);  1H 
NMR (500 MHz, DMSO-d6) δ (multiplicity, J (Hz), assignment): 9.85 (1H, d, 10, 24-
NH), 6.85 (1H, dd, 9, 14.6, H-24), 6.77 (1H, ddd, 7.4, 7.5, 15.4, H-3), 6.37 (2H, br, 
CONH2), 6.08 (1H, dd, 12, 15, H-15), 5.85 (1H, d, 14.5, H-23),  5.73 (1H, d, 15.5, H-2), 
5.68 (1H, s, H-2′),  5.63 (1H, d, 11, H-16), 5.58 (1H, m, H-7), 5.54 (1H, m, H-6), 5.46 
(1H, ddd, 5, 10, 15, H-14), 5.15 (1H, d, 9.5, H-21),  4.85 (1H, ddd, 2.8, 7.8, 10.5, H-19), 
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4.72 (1H, d, 4.5, 9-OH), 4.62 (1H, d, 5, 8-OH), 4.56 (1H, ddd, 3, 7.5, 10.5, H-10), 3.96 
(1H, m, H-8), 3.56 (1H, m, H-9), 2.70 (1H, qdd, 6.7, 6.7, 9.8, H-20), 2.07 (1H, m), 2.18 
(1H, m, H-18), 2.13 (1H, m, H-4), 2.11 (3H, s, H3-5′), 2.07 (1H, m, H-18), 1.99 (1H, m, 
H-13), 1.98 (1H, m, H-5), 1.95 (1H, m, H-12), 1.90 (1H, m, H-13), 1.89 (1H, m, H-5), 
1.82 (3H, s, H3-4′), 1.69 (3H, s, H3-27), 1.59 (3H, s, H3-25),   1.49 (1H, m, H-11), 1.30 
(1H, m, H-11), 1.30 (1H, m, H-4), 0.90 (3H, d, 7, H3-26); 13C NMR (125 MHz, DMSO-
d6) δ (assignment): 166.9 (C-1), 164.0 (C-1′), 152.5 (C-3′), 149.8 (C-3), 133.3 (C-22), 
132.5 (C-17), 132.3 (C-14), 131.8 (C-6), 131.1 (C-7), 130.5 (C-21), 128.8 (C-16), 127.2 
(C-15), 122.8 (C-24), 122.0(C-2), 118.9 (C-2’), 117.2 (C-23), 75.6 (C-9), 74.7 (C-19), 
74.2 (C-10), 72.8 (C-8), 44.1(C-18), 37.4 (C-20), 33.3. 32.16 (C-5), 31.7 (C-4), 30.1 (C-
14), 30.1 (13), 28.7 (C-12), 28.7 (C-11), 27.4 (C-4′), 20.3 (C-5′), 17.7 (C-26), 16.5 (C-
25), 13.3 (C-27); ESIMS m/z (%) 608.3 (37, [M + H + Na]+), 607.3 (38, [M + Na]+), 
591.3 (40), 585.3 (15, [M + H]+), 567.3 (15), 503.3 (10), 485.3 (30), 424.2 (25), 389.2 
(46), 321 (20). HRESIMS m/z 585.3534 (C33H49N2O7 requires 585.3540). 
 
4.2.4 Palmerolide D (60) 
Colorless solid; [α]25D +67 (c 0.5, MeOH); IR (thin film) cm-1 3327, 2939, 2829, 2061, 
1716, 1558. 1455, 1261, 1025, 975; λmax (ε): 216 (1742), 248 (528); 1H NMR (500 MHz, 
DMSO-d6)  δ (multiplicity, J (Hz), assignment):  9.94 (1H, d , 10.3, 24-NH),  6.85 (1H, 
dd, 10.4, 15, H-24 ), 6.71(1H, ddd, 4, 11.5, 15.7, H-3),   6.45 (2H, br, OCONH2), 6.04 
(1H, dd, 11.6, 14, H-15), 5.86 (1H, d, 14.6, H-23), 5.81 (1H, s, H-2′), 5.76 (1H, d, 15.8, 
H-2), 5.59 (1H, d, 12, H-16), 5.53 (1H, m, H-8), 5.49 (1H, m, H-9), 5.41 (1H, ddd, 5, 10, 
14.9, H-14), 5.19 (1H, m, 10-OH), 5.14 (1H, d, 9.7, H-21), 4.84 (1H, m, H-19), 4.72 (2H, 
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d, H-6), 4.53 (1H, m, 7-OH), 4.48 (1H, m, H-11), 4.15 (1H, m, H-10), 3.82 (1H, m, H-7), 
2.68 (1H, m, H-20), 2.16 (1H, m, H-18b) 2.15 (1H, m, H-4b), 2.11 (1H, m, H-4a), 2.00 
(1H, m, H-18a), 1.98 (1H, m, H-5), 1.94 (2H, m, H-13), 1.94 (2H, m, 12), 1.76 (3H, s, 
H3-8′)  1.70 (3H, s, H3-27) 1.61 (3H, s, H3-7′) 1.60(3H, s, H3-25), 1.48 (1H, m, H-6b) 
1.30 (1H, m, H-6a)  0.89 (3H, d, 6.7, H3-26); 13C NMR (125 MHz, DMSO-d6) δ 
(assignment): 166.1 (C-1), 163.5 (C-1′), 157.4 (CONH2), 153.2 (C-3′), 150.0 (C-3),  
143.6 (C-5′), 134.2 (C-8), 133.6 (C-14), 133.3 (C-22), 132.2 (C-17), 130.7 (C-21), 129.6 
(C-9), 128.4 (C-16), 127.0 (C-15), 122.7 (C-24), 121.2 (C-2), 120.3 (C-2′), 117.5 (C-23), 
112.6 (C-6’), 75.8 (C-11), 74.5 (C-19),  73.2 (C-7), 69.9 (C-10),  43.9 (C-18),  40.8 (C-
4′), 38.4 (C-6), 37.3 (C-20), 30.1 (C-5), 33.0 (C-4), 30.0 (C-13) 30.0 (C-12), 24.8 (C-8′), 
22.7 (C-7′), 17.7 (C-26), 16.8 (C-25), 13.3 (C-27). ESIMS m/z (%) 625.6 (45, [M + H]+), 
615 (35), 585.3 (30), 520.4 (10), 432.3 (20), 349.4 (50), 305.2 (52); HR ESMS m/z 
625.3864 (C36H53N2O7 requires 625.3853) 
 
4.2.5 Palmerolide E (61) 
Colorless solid; [α]25D +17 (c 0.1, MeOH);  IR (thin film) cm-1 3635, 2940, 2830, , 1715, 
1637, 1540, 1387, 1276, 1194, 1079, 938 ; UV (MeOH) λmax (ε): 216 (1295), 248 (645);  
1H NMR (500 MHz, DMSO-d6 ) δ (multiplicity, J (Hz), assignment): 9.41 (1H, s, H-23),  
6.74 (1H,  ddd, 4.3, 11.5, 15.7, H-3),  6.55 (1H, dd, 1.5, 10.2, H-21), 6.48 (2H, br, 
CONH2),  6.05 (1H, dd, 10.8, 14.8, H-15),  5.78  (1H, d, 15.7, H-2), 5.61 (1H, d, 10.6, H-
16), 5.53 (1H, dd, 1.4, 8, H-8), 5.49  (1H, d, 2.9, H-9), 5.02 (1H, ddd, 2.1, 7.5, 10. H-19), 
4.47 (1H, ddd, 1.5, 5.1, 10.7, H-11), 4.12 (1H, m, H-10), 3.81 (1H, m, H-7), 2.94 (1H, 
qdd, 6.8, 7.1, 9.3, H-20), 2.16 (1H, m, H-18b), 2.14 (1H, m, H-4b), 2.11 (1H, m, H-4a), 
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2.09 (1H, m, H-18a), 1.95 (1H, m, H-13),  1.67 (3H, s, H3-26), 1.63 (3H, s, H3-24), 1.49 
(1H, m, H-6b), 1.30 (1H, m, H-5b), 1.29 (1H, m, H-6a), 1.05 (1H, m, H-5a), 1.01 (3H, d, 
6.8, H3-25); 13C NMR (125 MHz, DMSO-d6) δ (assignment): 196.3 (C-23), 166.1 (C-1), 
155.8 (C-21), 150.8 (C-3), 139.6 (C-22), 134.4 (C-8), 133.0 (C-17), 132.9 (C-14), 129.6 
(C-9), 128.7 (C-16), 127.3 (C-15), 121.2 (C-2), 76.1 (C-11), 73.3 (C-7), 73.0 (C-19), 70.1 
(C-10), 43.9 (C-18), 38.5 (C-6),  38.1 (C-20),  33.4 (C-4), 29.8 (C-12),  25.9 (C-5), 17.0 
(C-24), 16.5 (C-25), 9.9 (C-26); ESIMS m/z (%) 601.5 (40), 512.3 (30, [M + Na]+), 502.3 
(36), 490.3 (80), 472.4 (90), 437.2 (25), 393.3 (50), 349.2 (60), 305.2 (65), 273.1 (80), 
195.0 (64), 153 (90); HRESMS m/z 512.2634 (C27H39NO7Na requires 512.2624) 
 
4.2.6 Palmerolide B (62) 
White solid; [α]25D +1.6 (c 0.1, MeOH); IR (thin film) cm-1: 3514, 3433 (br), 1648, 1633, 
1510, 1392, 1275, 1190; UV (MeOH) λmax (ε): 216 (1756), 240(603); 1H NMR (500 
MHz, DMSO-d6)  δ (multiplicity, J (Hz), assignment): 6.86 (1H, d, 14.5, H-24), 6.74 
(1H, ddd, 5.0, 9.9, 15.2, H-3), 6.01 (1H, dd, 10.5, 14.5, H-15), 5.85 (1H, d, 15, H-23), 
5.72 (1H, m, H-9), 5.70 (1H, d, 13, H-2), 5.64 (1H, m, H-10), 5.64 (1H, br s, H-2′),  5.57 
(1H, d, 10.9, H-16), 5.38 (1H, m, H-14),  5.08 (1H, d, 10, H-21), 4.82 (1H, m, H-19), 
4.64 (1H, m, H-11), 4.57 (1H, m, H-7), 4.20 (1H, m, H-8), 2.68 (1H, qdd, 6.5, 7.4, 9.6, 
H-20), 2.15 (1H, m, H-18b), 2.14 (2H, m, H-4b), 2.10 (1H, m, H-4a), 2.09 (3H, s, H3-5′), 
1.99 (1H, m, H-18a), 1.96 (1H, m, H-13b), 1.81 (3H, s, H3-4′), 1.79 (1H, m, H-12b), 1.71 
(3H, s, H3-25), 1.58 (3H, s, H3-27), 1.55 (1H, m, H-6b), 1.53 (1H, m, H-12a), 1.34 (1H, 
m, H-5b), 1.21 (1H, m, H-13a), 1.14 (1H, m, H-5a), 1.08 (1H, m, H-6a), 0.88 (3H, d, 6.5, 
H3-26); 13C NMR (125 MHz, DMSO-d6) δ (assignment): 168.2 (C-1) 166.7 (C-1′), 159.8 
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(CONH2), 154.9 (C-3′), 150.7 (C-3), 134.5 (C-22),  133.4 (C-9), 133.3 (C-14), 132.8 (C-
7), 132.2 (C-21), 131.0 (C-10), 129.8 (C-16), 128.0 (C-15), 122.7 (C-24), 122.3 (C-2), 
119.6 (C-23), 118.9 (C-2′), 81.6 (C-11), 77.4 (C-7), 76.2 (C-19), 72.1 (C-8), 45.2 (C-18), 
38.7 (C-20), 36.6 (C-12), 34.0 (C-4), 31.8 (C-6), 30.9 (C-13), 27.7 (C-4′), 26.1 (C-5), 
20.4 (C-5′), 17.7 (C-26), 16.6 (C-27), 13.2 (C-25); LR ESIMS (-) m/z 663.3[M - H]+, 
LRESIMS (+) m/z 567.3 [M + H - H2SO4]+, HR ESIMS (-) m/z 663.29417 
(C33H47N2O10S requires. 663.29569), HR ESIMS (+) m/z 567.3430 (C33H46N2O6 requires 
567.3429) 
 
4.2.7 Palmerolide H (63) 
Colorless solid; [α]25D -27 (c 0.1, MeOH); IR (thin film) cm-1: 3515, 3400 (br), 2925, 
2856, 1653, 1633, 1517, 1208, 1040; UV (MeOH) λmax (ε): 217 (1232), 248 (712); 1H 
NMR (500 MHz, DMSO-d6 )  δ  (multiplicity, J (Hz), assignment): 6.87 (1H, d, 14.5, H-
24), 6.75 (1H, ddd, 4, 11.5, 15.7, H-3), 6.02 (1H, dd, 10, 14.5, H-15), 5.87 (1H, d, 14.6, 
H-24), 5.76 (1H, s, H-2′), 5.74 (1H, m, H-9)  5.70 (1H, d, 14, H-2), 5.63 (1H, m, H-10), 
5.57 (1H, d, 11.5, H-16), 5.38 (1H, m, H-14), 5.09 (1H, d, 10, H-21), 4.84 (1H, m, H-19), 
4.69 (2H, s, H-6′), 4.66(1H, m, H-11), 4.58 (1H, m, H-7), 4.20 (1H, m, H-8), 3.44 (2H, s, 
H-4′), 2.68 (1H, m, H-20), 2.15 (1H, m, H-18b),  2.14 (1H, m, H-4b), 2.11 (1H, m, H-4a), 
2.00 (1H, m, H-18a), 1.96 (1H, m, H-13b), 1.80 (1H, m, H-12b), 1.76 (3H, s, H3-8′),  1.72 
(3H, s, H3-25) 1.61 (3H, s, H3-7′) 1.59 (3H, S, H3-27), 1.56 (1H, m, H-b), 1.55 (1H, m, H-
12a), 1.32 (1H, m, H-5a), 1.21 (1H, m, H-13a),  1.18 (1H, m, H-5a), 1.10 (1H, m, H-6a) 
0.89 (3H, d, 6.7, H3-26); 13C NMR (125 MHz, DMSO-d6) δ (assignment): 168.2 (C-1), 
166.0 (C-1′), 159.9 (CONH2), 155.7 (C-3′), 150.7 (C-3), 144.6 (C-5′), 134.5 (C-22), 
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133.4 (C-14), 132.3 (C-21), 132.3 (C-9), 131.1 (C-10), 129.7 (C-16), 128.1 (C-15), 122.8 
(C-24), 122.3 (C-2), 120.5 (C-2′),  119.7 (C-23), 112.6 (C-6′) , 81.7 (C-11), 77.5 (C-7), 
76.2 (C-19), 72.2 (C-8), 45.2 (C-18), 42.1(C-4′), 38.7 (C-19), 36.6 (C-12),  33.9 (C-4), 
31.8 (C-6), 30.8 (C-13), 26.1 (C-5), 24.8 (C-8′), 22.4 (C-7′), 17.7 (C-26), 16.6 (C-27); 
LRESIMS (-) m/z 703.3 [M - H]+, LRESIMS (+) m/z 607.3 [M + H -H2SO4]+, HRESIMS 
703.3258 (C36H52N2O10S requires 703.3270 ) 
 
 
4.3 Isolation of Secondary metabolites from Austrodoris kerguelenensis 
 
Austrodoris kerguelenensis nudibranches were collected by SCUBA around Palmer 
Station Antarctica. They were frozen immediately after the collection.  Upon freeze 
drying, the nudibranchs were subsequently extracted with CHCl3 three times for 24 hours, 
sequentially. After evaporating the solvent under reduced pressure, a gummy, reddish 
brown solid 2.5 g was obtained. The CHCl3 extract was further fractionated into 12 
fractions by elution of increasing polarity gradient of EtOAc in n-hexane on silica gel.  
 
Investigation of each fraction by 1H NMR spectroscopy indicated that fractions 1-4 
contained a mixture of sterols and fatty acids.  Fractions 5 and 6 displayed peaks 
characteristic of steroids. Fractions 7-11 showed signals indicative of terpenoid 
glycerides. Further purification of factions 7, 9 and 10 by HPLC, first on silica gel 
(EtOAc/n-hexane, 2 mL/min) and then on C-18 (MeCN / H2O, 2 mL, min) afforded 
palmadorin A (110) (24 mg), palmadorin B (111) (7 mg) and palamadorin C (112) (7 mg). 
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4.3.1 Palmadorin A (110) 
Colorless oil; [α]25D +18 (c 0.05, MeOH); IR (thin film) cm-1: 3400 (br), 2969, 2864, 
1712, 1640, 1488, 1382, 1281, 1147, 1100, 1040 and 975. UV (MeOH) λmax (ε): 215 
(1001), 248 (499), 266 (484); 1H NMR (500 MHz, CDCl3) δ (multiplicity, J (Hz), 
assignment): 5.68 (br s, H-14), 4.91 (1H, m, H-2′), 4.48 (2H, d, 1.5, H-18), 3.83 (4H, d, 
4.8, H-1′ and H-3′), 2.27 (1H, m, H-3b), 2.14 (3H, S), 2.09 (1H, m, H-3a), 1.96 (1H, m, 
H-12b), 1.87 (1H, m, H-2), 1.85 (1H, m), 1.58 (1H, m, H-6b), 1.50 (1H, m, H-6a), 1.48 
(1H, m), 1.47 (1H, m, H-7b), 1.44 (1H, m, H-7a), 1.44 (1H, m, H-11b), 1.43 (1H, m, H-1) 
1.39 (1H, m, C-8), 1.33 (1H, m, H-11a), 1.23 (1H, m, H-2) , 1.03 (1H, m, H-10), 1.02 
(3H, s, H3-19), 0.79 (3H, d, 6, H3-17), 0.71 (3H, s, H3-20), 13C NMR(125 MHz, CDCl3) 
(assignment): 166.7 (C-15), 163.7 (C-13), 160.4 (C-4), 114.3 (C-14) 102.5 (C-18), 74.4 
(C-2′), 62.7 (C-1′), 62.7 (C-3′), 48.7 (C-10), 40.0 (C-5), 39.3 (C-9), 37.2 (C-6), 36.7 (C-8), 
36.1 (C-11), 34.6 (C-12), 33.0 (C-3), 28.6 (C-2), 27.4 (C-7), 21.6 (C-1), 20.8 (C-19), 19.5 
(C-16), 16.00 (C-17), 18.04 (C-20), LRFABMS m/z (%) 379.3 (52 [M]+), 361.2 (10); 
HRFABMS m/z 379.284200 (C23H39O4 requires 379.2844835). 
 
4.3.2 Ozonolysis of Palmadorin A (110) 
Compound 110 (5mg, 0.0132 mmol) was dissolved in 2mL of CH2Cl2 and allowed to 
react with O3 for 25 mins. The temperature of the reaction vessel was controlled at -80◦C. 
After 25 minitues the O3 supply was disconnected and DMS (5 drops) was added and 
allowed to react for 1.5 hours while allowing the reaction mixture to warm to room 
temperature. The solvent was evaporated under reduced pressure to obtain a crude 
product 8 mg as a colorless solid. This crude product was purified by chromatography 
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over silica using 30% EtOAc/hexane yeilding the ozonolysis product 113 as a white 
amorphous solid 1mg (0.038 mmol, 28.65%).  
 
4.3.3 Ozonolyzed product of Palmadorin A (113) 
 
Colorless solid; [α]25D +0.6 (c 0.05, MeOH); 1H NMR (500 MHz, CDCl3) δ (multiplicity, 
J (Hz), assignment): 2.58 (1H, m, H-3b), 2.34 (1H, m, H-12b), 2.23 (1H, m, H-3a), 2.16 
(3H, s, H3-14), 2.13 (1H, m, H-12a), 1.72 (1H, m, H-11b), 1.60(1H, m, H-6b), 1.56(1H, 
m, H-6a), 1.53 (1H, m, H-7b), 1.46 (1H, m, H-2b), 1.44 (1H, m, H-11a), 1.28 (1H, m, H-
7a), 1.24 (1H, m, H-2a), 1.20 (1H, m, H-10), 1.15 (3H, s, H3-17), 0.82 (3H, d, H3-17), 
0.73 (3H, s, H3-18); 13C NMR (125 MHz, CDCl3) (assignment): 216.3 (C-4), 209.0 (C-
13), 50.0 (C-10), 40.6 (C-9) 39.4 (C-5), 37.7 (C-12), 37.6 (C-3), 36.6 (C-8), 33.1 (C-6), 
30.8 (C-11), 30. 6 (C-14), 26.5 (C-2), 26.5 (C-7), 18.8 (C-17), 17.00 (C-18), 15.5 (C-15). 
EIMS m/z  (%) 175 (22), 122 (10), 95 (20), 43 (100), 41 (45), 28 (30). 
 
4.3.4 Palmadorin B (111) 
Colorless oil; [α]25D +24(c 0.05, MeOH); IR (thin film) cm-1  3360 (br), 2933, 2359, 
1718, 1642, 1448, 1383, 1219, 1145, 110, 909. UV (MeOH) λmax (ε): 214 (1063), 248 
(537), 264 (524); 1H NMR (500MHz, CDCl3) δ (multiplicity, J (Hz), assignment): 5.68 
(br s, H-14), 4.91 (1H, m, H-2′) 4.48 (2H, d, 1, H-18) 4.26 (2H, m, H-1′) 3.72 (2H, d, H-
3’) 2.27 (1H, m, H-3b), 2.14 (3H, s, H3-16), 2.09 (1H, m, H-3a), 2.05 (3H, S, COOCH3), 
1.86 (1H, m, H-2b), 1.85 (1H, m, H-12a), 1.57 (1H, m, H-6b), 1.47 (1H, m, H-6a), 1.47 
(1H, m, H-7b), 1.46 (1H, m, H-1b), 1.44 (1H, m, H-7a), 1.42 (1H, m, H-1a), 1.39 (1H, m, 
H-8), 1.33 (1H, m, H-11a), 1.21 (1H, m, H-2a), 1.03 (1H, m, H-10), 1.02 (3H, s, H3-19), 
0.78 (3H, d, 6.5, H3-17), 0.72 (3H, s, H-20) 13C NMR (125 MHz, CDCl3) (assignment); 
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171.2 (COOCH3), 166.8 (C-15), 163.9 (C-13), 160.7 (C-4), 114.7 (C-14), 102.9 (C-18),  
72.0 (C-2′), 62.9 (C-1′), 62.2 (C-3′), 49.1 (C-10),  40.4 (C-5), 39.7 (C-9), 37.7 (C-6), 37.0 
(C-8),  36.4 (C-11),  34.9 (C-12), 34.4 (C-3), 29.0 (C-2), 27.8 (C-7), 22.3 (C-19),  21.8 
(C-1), 21.2 (COOCH3),  19.8 (C-16), 18.5 (C-20), 16.4 (C-17); LRFABMS m/z (%) 
421.4 (36 [M+1]+), 379.4(8), 321.3(8), 287.3 (90);  HRFABMS m/z 421.2964 (C25H41O5 
requires 421.2954). 
 
4.3.5. Palmadorin C (112)  
Colorless oil; [α]25D +8(c 0.05, MeOH); IR (thin film) cm-1: 3389 (br), 2840, 1648, 1408, 
1228, 1219, 1109, 1015, 894. UV (MeOH) λmax (ε): 216 (1002), 248 (635); 1H NMR (500 
MHz, CDCl3) δ (multiplicity, J (Hz), assignment): 5.70 (1H, s, H-14), 5.13 (1H, m, H-3),  
4.91 (1H, m, H-2′), 4.02 (1H, m, H-7), 3.82 (4H, d, 4.5, H-1′ and H-3′)  2.16 (3H, s, H3-
16) 2.10 (1H, m, H-6b), 2.08 (1H, m, H-2b) 1.98 (1H, m, H-2a), 1.98 (1H, m, H-12b), 
1.93 (1H, m, H-12a), 1.60 (3H, s, H-18), 1.58 (1H, m, H-1b), 1.54 (1H, m, H-1a), 1.51 
(1H, m, H-11b),  1.51 (1H, m, H-8a),  1.39 (1H, m, H-11a),  1.39 (1H, m, H-6a), 1.37 
(1H, m, H-10), 1.27 (3H, s, H3-19), 1.01 (3H, d, 7.5, H-17),  0.99 (1H, s, H3-20); 13C 
NMR(125 MHz, CDCl3) (assignment):  166.9 (COOCH3), 163.4 (C-13), 145.2 (C-4), 
120.0 (C-3), 114.8 (C-14), 74.8 (C-2’), 73.9 (C-7), 63.1 (C-1′ and C-3′), 46.86 (C-10), 
43.1 (C-6), 39.5 (C-8), 38.5 (C-9), 37.8 (C-5), 37.57 (C-11), 35.1 (C-12), 27.0 (C-2), 22.0 
(C-19), 20.3 (C-20), 19.7 (C-16), 18.3 (C-18), 18.2 (C-1), 12.7 (C-17): FABMS (+) m/z 
(%) 377.4 (15, [M + H - H2O]+), 309.1(14), 195.1 (15), 153.1 (45), 135 (45). ESIMS (+) 
m/z (%) 377.4 (15 [M + H- H2O]+, HRFABMS m/z 378.1503 (C23H36O4 requires 
378.1467). 
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4.3.6 Acetylation of Palmadorin C (112)  
Palmadorin C (5mg, 0.0127 mmol) was dissolved in CH2Cl2 (1 mL) and treated with 
Ac2O (30 µL, 0.025 mmol) in the presence of DMAP (3 mg), Et3N (30 µL) for 24 hrs at 
25◦C. The reaction was quenched by the addition of few drops of MeOH. Upon 
evaporation of the solvent by reduced pressure the crude product was separated by 
chromatography over silica gel (EtOAc /hexane gradient elution) to obtain palmadorin C 
diacetate (114) (6mg, 0.0125 mmol, 98%). 
 
4.3.7 Palamadorin C diacetate (114) 
Colorless solid; [α]25D +12(c 0.05, MeOH); IR (thin film) cm-1: 3389 (br), 2834, 1648, 
1408, 1228, 1210, 1040, 1109, 1015, 894. 1H NMR(500 MHz, CDCl3) δ(multiplicity, J 
(Hz), assignment): 5.65 (1H, s, H-14), 5.26 (1H, m. H-2′), 4.23 (4H, m, H-1′ and 3′), 4.03 
(1H. m, H-7), 2.15 (3H, s, H3-16), 2.08 (1H, m, H-6b), 2.06 (3H, s, COOCH3), 2.05(1H, 
m , H-2b), 1.98 (1H, m, H-2b), 1.93 (1H, m, H-12b), 1.90 (1H, m, H-12a), 1.60 (3H, s, 
H3-18), 1.52 (1H, m, H-8), 1.48 (1H, m, H-11a), 1.38 (1H, m, H-6a), 1.38 (1H, m, H-10), 
1.37 (1H, m, H-11), 1.27 (3H, s, H3-19), 1.02 (3H, d, 7, H3-17), 1.00 (3H, s, H3-20).13C 
NMR (125 MHz, CDCl3) (assignment); 170.8 (COOCH3), 165.7 (C-15), 163.3 (C-13), 
145.2 (C-4), 120.0 (C-3), 114.7 (C-14), 73.9 (C-7), 68.2 (C-2′), 62.7 (C-1′& C-3′), 54.8 
(OCH3), 46.9 (C-10), 43.2 (C-6), 39.5 (C-8), 38.0 (C-9), 37.8 (C-5), 37.5 (C-11), 35.1 (C-
12), 26.9 (C-2), 21.8 (C-19), 20.2 (C-20), 19.7 (C-16), 12.7 (C-17); LRESIMS (-) m/z 
(%) 477.2 (78, [M - 1]+), 478.2 (20, [M]+).  
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4.3.8 Preparation of R-MTPA esters of Palmadorin C diacetate (114). 
 
Palamadorin A diacetate (3 mg, 0.0063 mmol) was dissolved in CH2Cl2 (500 µL) and 
allowed to reacted with R-MTPACl (50 mg, 0.07 mmol) in the presence of Hunig’s base 
(100 µL) and DMAP (1mg) for 48hrs. Conversion of the starting material to the products 
was monitored by TLC. Evaporation of the solvents gave a crude product of 20 mg. 
Further purification of this mixture by chromatography on slica gel (EtOAc/hexane 
gradient elution) gave compound (115) (1.5 mg, 0.0022 mmol, 34%). 
 
4.3.9 Palmadorin C diacetate R-MTPA (115) 
 
Colorless solid; [α]25D +10 (c 0.05, MeOH); IR (thin film) cm-1 3401 (br), 2825, 1662, 
1510, 1340, 1235, 1032, 1006, 860. 1H NMR (500 MHz, CDCl3) δ(multiplicity, J (Hz), 
assignment): 7.53 (2H, m, Ph), 7.35 (3H, m , Ph), 5.62 (1H, s, H-14), 5.25 (1H, m. H-2`), 
4.22 (4H, m, H-1` & 3`), 5.35 (1H. m, H-7), 3.59 (3H, s, OCH3) 2.13(3H, s, H3-16), 2.05 
(3H, s, COOCH3), 2.05 (1H, m , H-2b), 1.98 (1H, m, H-2b), 1.97 (1H, m, H-6b), 1.90 
(1H, m, H-12b), 1.88 (1H, m, H-12a), 1.43 (3H, s, H3-18), 1.52 (1H, m, H-8), 1.48 (1H, 
m, H-11a), 1.37 (1H, m, H-6a), 1.37 (1H, m, H-11), 1.31 (1H, m, H-10), 0.92 (3H, d, H3-
17), 0.80 (3H, s, H3-20) 0.53 (3H, s, H3-19). 13C NMR (125 MHz, CDCl3) (assignment); 
170.79(COOCH3), 166.9 (COOMTP), 165.7 (C-15), 162.7 (C-13), 145.2 (C-4), 129.7 
(Ph) 128.5 (Ph), 127.36 (Ph), 120.6 (C-3), 114.9 (C-14), 78.0 (C-7), 68.3 (C-2’), 62.7 (C-
1`& C-3`), 55.8 (OCH3) 46.4 (C-10), 40.4 (C-6), 39.1 (C-8), 38.2 (C-9), 37.3 (C-5), 37.1 
(C-11), 34.9 (C-12), 26.8 (C-2), 21.8 (C-19), 20.2 (C-20), 19.6 (C-16), 12.00 (C-17). 
HRESIMS m/z 717.3220 (C37H49O9F3 requires 717.3219). 
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4.3.10 Preparation of S-MTPA esters of Palmadorin C diacetate (114)  
 
Palamadorin A diacetate (114) (1mg, 0.0021 mmol) was dissolved in CH2Cl2 (300 µL) 
and allowed to reacted with S-MTPACl (50 mg, 0.07 mmol) in the presence of Hunig’s 
base (100 µL) and DMAP (1 mg) for 48 hrs. Conversion of the starting material to the 
products was monitored by TLC. Evaporation of the solvents gave a crude product of 20 
mg. Further purification of this mixture by chromatography on slica gel (EtOAc/hexane 
gradient elution) gave compound (116) (1 mg, 0.0014 mmol, 69%) 
 
4.3.11 Palmadorin C diacetate S-MTPA (116)  
 
 
Colorless solid; [α]25D -5(c 0.02, MeOH); IR (thin film) cm-1 3342 (br), 2905, 1658, 1408, 
1340, 1235, 1048, 1109, 1020, 870. 1H NMR (500 MHz, CDCl3) δ (multiplicity, J (Hz), 
assignment); 7.59 (1H, m, Ph), 7.53 (2H, m, Ph), 7.37 (2H, m, Ph) 5.61 (1H, s, H-14), 
5.24(1H, m. H-2′), 4.22 (4H, m, H-1′ & 3′), 5.44 (1H. m, H-7), 3.59 (3H, s, OCH3) 2.13 
(3H, s, H3-16), 2.07 (1H, m, H-2b), 2.05 (3H, s, COOCH3), 2.05 (1H, m , H-2b), 1.98 
(1H, m, H-2b), 2.06 (1H, m, H-6b), 1.90 (1H, m, H-2a), 1.90 (1H, m, H-12b), 1.86 (1H, 
m, H-12a), 1.65 (1H, m, H-8), 1.54 (3H, s, H3-18), 1.48 (1H, m, H-6a), 1.46 (1H, m, H-
11b), 1.35 (1H, m, H-10), 1.26 (1H, m, H-11a),  0.75 (3H, d, H3-17), 0.63 (3H, s, H3-20) 
0.94 (3H, s, H3-19). 13CNMR (125 MHz, CDCl3) (assignment): 170.8 (COOCH3), 167.0 
(COOMTP), 165.7 (C-15), 163.3 (C-13), 144.1 (C-4), 129.7 (Ph), 128.6 (Ph), 128.0 (Ph), 
127.6 ( Ph), 127.6 ( Ph), 120.0 (C-3), 114.7 (C-14), 73.9 (C-7), 68.2 (C-2’), 62.7 (C-1’& 
C-3’), 46.6 (C-10), 43.2 (C-6), 39.5 (C-8), 38.1 (C-9), 37.5 (C-11), 37.4 (C-5), 35.1 (C-
12), 26.9 (C-2), 20.8 (C-19), 20.2 (C-20), 19.7 (C-16), 12.7 (C-17). HRESIMS m/z 
717.3220 (C37H49O9 F3 requires 717.3219).  
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